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Abstract 
  
Title: “We got cancer”- A mixed methods study of quality of life and psychological distress in head 
and neck cancer patients and their families 
 
Background: A diagnosis of cancer and its subsequent treatment can have a profound impact on 
the quality of a person’s life, as well as on the lives of their partners and family members. While 
the role of families as a source of support is generally recognised, very little is known about the 
effect that a partners’ or family members’ distress levels may have on Head and Neck Cancer (HNC) 
patients’ quality of life (QoL).  
 
Aims: The aims of this thesis were; 1) to measure the levels of psychological distress of HNC 
patients and their partners and other family members; 2) explore the relationship between 
partner/family member psychological distress and patient QOL 3) to gain deeper understanding of 
the lived experiences of HNC couples, with specific focus on patients who had a partner with 
psychological distress before treatment. 
 
Method: This mixed methods longitudinal study recruited 90 newly diagnosed HNC patients and 74 
caregivers (partners n=50, family members n=24) which were followed over a period of 6-12 
months.  They completed the hospital and anxiety scale (HADS) and the WHO Quality of Life-BREF 
(WHOQOL-BREF) questionnaires before treatment and at 6 months following diagnosis. The 
qualitative phase of the study was completed 12 months following diagnosis, where a subsample 
of three HNC couples were purposively selected and interviewed about their experiences of HNC. 
 
Results:  There were three key findings within the present study.  Firstly, psychological distress in 
caregivers, particularly partners was higher than in HNC patients.  Secondly, HNC patients who had 
a caregiver with psychological distress showed lower QoL and finally, the qualitative study showed 
the negative impact of HNC on the patient-partner relationship. 
 
Conclusions: What this study has shown is the importance of the caregiver’s role in HNC, and how 
their psychological functioning has an effect on the patient’s functioning. If partners or family 
members are to become active agents of help for the patient, it is proposed they should first be 
prepared psychologically for the task. 
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Overview of thesis chapters  
 
 
Chapter 1: Literature review 
Chapter one presents an overview of Head and neck cancer (HNC), followed by an introduction to 
quality of life (QoL) and how it is currently measured within the HNC field. This chapter also 
introduces the current literature that has examined psychological distress in cancer patients, 
including the most up to date literature which has examined psychological distress in HNC patients. 
This chapter also presents the literature that has examined the impact of cancer on caregivers 
(family members and partners).  The aim of this chapter is to introduce the rationale for the 
hypotheses and methodology.  
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Chapter 2: Methods 
Chapter two introduces the sample, research design, study protocol including the data collection 
procedures, and details of the clinics patients were recruited from. It also presents the measures 
used to collect data and the statistical analyses that were used to analyse the data.  
 
Chapter 3: Results 
Chapter three presents the quantitative findings of this thesis. It begins by introducing the dataset, 
followed by results showing the prevalence of psychological distress in patients and their 
caregivers, and findings related to the proposed hypothesis. 
 
Chapter 4: Qualitative study 
 
This chapter is specifically focused on the qualitative component of this thesis and includes; a 
review of the current qualitative literature within HNC, an introduction to the qualitative method 
used in the study and details how participants were selected to take part. The chapter also presents 
an overview of each participant that was interviewed, and presents how the interview data was 
recorded and analysed. The results of the analysis are presented, followed by a discussion of the 
key findings including an evaluation of the qualitative methodology.   
 
Chapter 5: Overall Discussion 
 
This final chapter discusses the overall conclusions that can be drawn from the quantitative and the 
qualitative results of this study. A summary of the key findings are presented and how these relate 
to the original aims of the thesis. The methods are also critically discussed with suggestions to 
possible improvements. Finally, a discussion of the clinical significance of the results with reference 
to future proposed clinical interventions for patients and their caregivers are reported. 
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Introduction to thesis 
 
“To have and to hold, from this day forward, for better, for worse, for richer, for poorer, in 
sickness and in health, to love and to cherish, till death do us part, and here I pledge you my 
faithfulness” 
 
The real power of these words may not be fully appreciated until a traumatic event, like cancer, 
brings a deeper meaning to these vows and challenges a couple’s relationship.  When an individual 
is diagnosed with cancer, the partner is usually counted upon to become the primary helper. The 
well partner is expected to offer emotional support, adapt to the lifestyle changes brought about by 
the illness and be sensitive to the needs of the patient. These are high expectations that many 
partners want to meet, but may not be fully capable of doing so.  
 
The overall aim of this thesis is to provide a multi-dimensional insight into head and neck cancer 
(HNC) patient’s quality of life (QoL), which is currently lacking in the literature. The aim is to go 
beyond the traditional concept of QoL which currently focuses primarily on the measurement of 
symptoms and disability - commonly referred to as health related QoL (HRQOL). 
 
I aim to highlight and introduce the broader impact of HNC on the QoL of patients such as social 
relationships, psychological impact, environmental factors and how the effect of cancer on family 
and partners can have a negative impact on patients.   
 
This will be achieved using a mixed methods approach, where quantitative measures and 
qualitative interviews will be utilised to examine the impact of HNC on patients QoL. This project 
introduces a holistic method to examining QoL in HNC patients, defining QoL as a state of physical, 
mental and social wellbeing, not just the absence of disease and ill-health. 
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1 Literature review 
 
I begin this chapter by presenting an overview of Head and neck cancer (HNC), followed by the 
current quality of life literature within this field. I will also introduce the prevalence of psychological 
distress in cancer patients, including the most up to date literature which has examined 
psychological distress in HNC patients. Finally I will present the literature that has examined the 
impact of cancer on caregivers (family members and partners).  The aim of this chapter is to 
introduce the rationale for the hypotheses and methodology. The review is limited to areas 
relevant to the thesis title. However, where only limited data exist on HNC, results from 
heterogeneous cancer groups are also included. 
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 Head and neck cancer 
Head and neck cancer include malignancies that arise on the lips and in the mouth, pharynx 
(including the nasopharynx, oropharynx and hypopharynx), larynx, salivary glands, and paranasal 
sinuses (see Figure 1). Cancers at different sites have different course and variable histopathological 
types, although squamous cell carcinoma (SCC) is by far the most common (Mehanna, De Boer, & 
Morton, 2008). The anatomical sites affected are important for functions such as speech, 
swallowing, taste and smell, so the cancers and their treatment may have considerable functional 
sequelae with subsequent impairment of quality of life (QoL). Decisions about treatment are usually 
complex, and treating clinicians must balance efficacy of treatment and likelihood of survival with 
potential functional and QoL outcomes. Patients and their carers will often also need considerable 
support during and after treatment (Hodges & Humphris, 2009). 
 
Figure 1 Head and neck cancer regions 
1
                                                          
1 Image and extracted from http://www.cancer.gov/cancertopics/factsheet/Sites-Types/head-and-neck 
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 How common is head and neck cancer and who gets it? 
In 2012, the World Health Organisation (WHO) estimated that there were approximately 750,000 
new cases of head and neck cancer and approximately 300,000 deaths each year worldwide(Ferlay 
et al., 2014).  In the UK, there were just over 9000 new HNC cases (larynx, lip and oral cavity, 
nasopharynx and other oropharynx), with the most common sites being the oral cavity (3,137 cases 
a year). Table 1 reports the incidence of HNC in 2012, with predicted rates of incidence for 2015 
(GlOBOCAN 2012, WHO) 
 
Table 1 Incidence of HNC in UK 2012, with predicted rates for 2015. 
 
 HNC Cancer 
(larynx, lip and oral cavity, nasopharynx and Other oropharynx) 
 
Year Estimated number of new cancers 
(all ages) 
Male Female Both sexes 
2012  6811 2885 9696 
            ages < 65 3619 1374 4993 
            ages >= 65 3192 1511 4703 
 
22015  7132 2992 10124 
            ages < 65 3659 1391 5050 
            ages >= 65 3473 1601 5074 
 
 Demographic change 321 107 428 
             ages < 65 40 17 57 
             ages >= 65 281 90 371 
 GLOBOCAN 2012 (IARC), WHO    
                                                          
2The table and figures were created using the GLOBOCAN 2012, cancer incidence and mortality cancer register 
http://globocan.iarc.fr 
  
GLOBOCAN uses population forecasts from the United Nations, World Population prospects, the 2012 revision. 
Numbers are computed using age-specific rates and corresponding populations for 10 age-groups. 
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The male to female ratio reported by large epidemiological studies and national cancer registries 
varies but generally is from 2:1 to 4:1 depending on the site of the disease (WHO, 2008).  However, 
within the oral cavity which is the most common within the UK, around 67% are diagnosed in men 
with 33% in women, giving a male: female ratio of around 2:1 (Ferlay et al., 2014).  
Figure 2  shows the predicted incidence rate for 2015 in males and females. 
The incidence of HNC has plateaued in many parts of the world but sub-types, such as oral and 
oropharyngeal cancer, continue to increase, both in the UK and worldwide.  
 
Figure 2 Predicted incidence rates of HNC by Gender (2015)  
  
 
Several retrospective analyses from patients recruited in randomised trials as well as retrospective 
studies have shown recent changes in the epidemiology and pathogenesis of head and neck cancers 
related to the human papillomavirus, (HPV), especially oropharyngeal carcinoma (Duvvuri & Myers, 
2009), for example, the UK has seen a doubling in the incidence of oropharyngeal cancer from 
1/100 000 population to 2.3/100 000 in just over a decade (Oxford Cancer Intelligence Unit, 2010).  
This significant increase in HPV associated HNC cancers may explain the increase in predicted rates 
reported in Table 1 and  
Figure 2.  HPV associated cancers tend to occur in people who are younger than the average person 
with HNC, and have an overall better response to treatment and prognosis (Pulte & Brenner, 2010).  
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 What are the risk factors for head and neck cancer? 
1.1.2.1 Tobacco and Alcohol 
The major risk factors include; tobacco (smoking), smokeless tobacco (chewing, powdered, inhaled) 
areca nut consumption (itself a carcinogen) and alcohol (Purdue et al., 2009) 
Tobacco has been shown to significantly increase the risk of cancer of the mouth, with a particularly 
high incidence in South Asia (India, Pakistan, Bangladesh), where tobacco, areca and slaked lime are 
held in the mouth as the betel quid or ‘paan’(Conway et al., 2009). Smoking is more strongly 
associated with laryngeal cancer and alcohol consumption with cancers of the pharynx and oral 
cavity. In general, smokers are 10-times more likely to get HNC compared to never-smokers (Argiris, 
Karamouzis, Raben, & Ferris, 2008; Conway et al., 2009) but this is as high as 27 times in oral 
squamous cell carcinomas and 12 times in laryngeal SCC (Argiris et al., 2008).  
Heavy alcohol consumption is also an independent risk factor and alcohol and tobacco can 
synergistically interact to increase risk.  Purdue and colleagues (2009) pooled data from 15 case-
control studies of HNC (9,107 cases, 14,219 controls) and showed that non-smokers who have three 
or more alcoholic drinks (beer or spirits) a day had double the risk (odds ratio 2.04, 95% confidence 
interval 1.29 to 3.21) of developing the disease compared with non-drinkers (Purdue et al., 2009). 
1.1.2.2 Genetic factors 
Most people who smoke and drink do not develop HNC. The International Head and Neck Cancer 
Epidemiology Consortium (INHANCE) carried out pooled analyses of epidemiological studies that 
examined risks associated with the disease .This work confirmed the role of genetic predisposition 
that had been suggested by small studies. Their findings showed a family history of head and neck 
cancer in a first degree relative was associated with a 1.7 fold (1.2 to 2.3) increased risk of 
developing the disease (Conway et al., 2009). 
1.1.2.3 Viral infection 
As highlighted earlier, HPV has attracted significant attention in the last decade, with recent 
observational studies showing this virus as a strong risk factor for the development of HNC, 
especially oropharyngeal cancer. A multinational observational study that compared 5642 cases of 
HNC  with 6069 controls found the risk of developing oropharyngeal carcinoma was associated 
with; a history of six or more lifetime sexual partners, four or more lifetime oral sex partners and 
earlier age of first sexual intercourse.  Patients are generally younger (usually 40-50 years old) and 
often do not report the usual risk factors of smoking or high alcohol intake and often will present 
with a small primary tumour and large neck nodes (Pulte & Brenner, 2010).  
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1.1.2.4 Other risk factors 
Some evidence also points to a role of occupational exposure, poor dental hygiene and dietary 
factors such as low fruit and vegetable intake (Argiris et al., 2008; Conway et al., 2009). 
 How does head and neck cancer present? 
Patients with HNC present with a variety of symptoms, depending on the function of the site where 
they originate. Laryngeal cancers commonly present with hoarseness, whereas pharyngeal cancers 
often present late with dysphagia or sore throat. Patients with early disease stand a better chance 
of cure or increased survival. However one of the major issues associated with HNC is that in the 
early stages, it may be asymptomatic, meaning patients are more likely to present with more 
advanced disease stage (Hiten, 2012). 
 
Table 2 identifies “Red flag” signs and symptoms that practice guidelines consider warranting 
urgent referral and consultation with a specialist head and neck clinician. UK guidelines specify that 
urgent referral should mean that patients are seen within two weeks. 
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3Table 2 “Red flag” symptoms and signs of head and neck cancer 
Symptoms 
 
Sore throat 
Hoarseness 
Stridor 
Difficulty in swallowing 
Lump in neck 
Unilateral ear pain 
  Signs 
Red or white patch in the mouth 
Oral ulceration, swelling, or loose tooth 
Lateral neck mass 
Rapidly growing thyroid mass 
Cranial nerve palsy 
Orbital mass 
Unilateral ear effusion 
(Scottish Intercollegiate Guidelines Network (SIGN) & Network, 2006, pp. 6–8)  
 
 Medical and surgical treatment 
The treatment plan for an individual patient depends on a number of factors, including the exact 
location of the tumour, the stage of the cancer, and patient age and general health. Treatment 
modalities can include surgery, radiation therapy, chemotherapy, targeted therapy, or a 
combination of treatments (Jacobi, Van Der Molen, Huiskens, Van Rossum, & Hilgers, 2010).  
For anatomical sub-sites such as the oral cavity, salivary glands and sinuses, surgery is often the first 
line of treatment, with radiotherapy given post-operatively to optimise tumour control (Bonner et 
al., 2010). Although treatment varies by sub-site, the goal of organ preservation is always important 
because crucial functions such as speech and swallowing are often at risk (Jacobi et al., 2010; 
Rogers et al., 2003).  The negative impact upon these functions may be as important as the cancer 
itself in terms of impact on QoL. 
                                                          
3 “Red flag symptoms have been extracted from the Scottish Intercollegiate Guidelines Network (SIGN) & 
Network, 2006(Scottish Intercollegiate Guidelines Network (SIGN) & Network, 2006) 
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1.1.4.1 Side effects of treatment 
Radiotherapy:  The systematic clinical investigation of organ-preserving radiotherapy and chemo 
radiotherapy regimens suggested that these regimens could produce overall survival results as 
good as surgical resection for patients with loco regionally advanced squamous-cell cancer of the 
head and neck (Bonner et al., 2010). Despite these advances, treatment side effects are often 
significant and life changing.  These can include; substantial or permanent reduction in salivary 
production leading to a chronic dry mouth (xerostomia), swallowing difficulties (dysphagia), and 
altered or diminished taste (dysgeusia). Also, radiation-related swelling and fibrosis can cause 
airway problems resulting in tracheostomy dependence (Chen et al., 2012). The interaction of 
certain factors, such as chemotherapy, may amplify adverse effects of treatment and persist for 
long durations if chemotherapy is delivered concurrently with radiation (Epstein, Robertson, & 
Emerton, 2001; Magné et al., 2001). 
 
Surgery: Advances in surgical treatment and reconstructive techniques have enabled enormous 
improvements in functional and cosmetic outcomes (Wehage & Fansa, 2011). However, surgery still 
imposes its own long- term problems. Profound alterations in QoL often result from undesirable 
cosmetic outcomes related to the surgical removal of cancer and organ tissue (e.g. eyes, nose, 
larynx, tongue and facial skin, mandible) and reconstruction with regional or free-flaps, resultant 
scarring of the head, neck and donor sites, and chronic tracheostomy or tracheostomy dependence 
(Rogers et al., 2003; Wehage & Fansa, 2011).  Facial disfigurement can lead to embarrassment and 
social avoidance, thereby compromising patients QoL (Minako et al., 2010). Furthermore, 
reconstructive options include the harvest of tissue from distant sites such as the forearm or the 
leg, which may further limit function and impact negatively on QoL (Rogers et al., 2003).  
 Prognosis 
Despite various therapeutic interventions, including surgery, radiotherapy, and chemotherapy, the 
5-year survival rate for this HNC has improved only marginally during the past two decades 
(Leoncini et al., 2015). For patients with disease confined to the head and neck, there are two major 
and distinct patterns of treatment failures after definitive therapy: recurrence of primary disease 
(local, regional or distant) and development of second primary cancer. The 5-year survival rate after 
second primary cancer diagnosis is about 8% if the malignancy is outside the head and neck area, 
and increased to 30% if the second primary cancer is an HNC. The 5 year survival expectation differs 
among HNC sites. In a recent study Leoncini and colleagues (2015)  found five-year overall survival 
was 62% for HNC cases, 55% for oral cavity, 53% for oropharynx, 41% for hypopharynx, and 71% for 
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larynx.  About 40 to 60% of HNC patients developed recurrences and around 20% of HNCs develop 
second primary cancer, both being associated with poorer survival.   
 
In the UK, a recent regional audit presented a one year and three year survival analysis for oral 
cavity cancer (Oxford Cancer Intelligence Unit, 2010). The 1 year relative survival for patients 
diagnosed between 2004 and 2011 with oral cavity cancer in England and Wales remained stable at 
80% for men and 81% for women in 2011. The 3 year relative survival has significantly improved for 
men, rising from 58% in 2004 to 2006 to 66% in 2008 to 2010. Over the same time 3 year relative 
survival also increased for women, from 64% in 2004 to 2006 to 68% in 2008 to 2010 (Oxford 
Cancer Intelligence Unit, 2010).  
 
 Summary of head and neck cancer 
Head and neck cancer presents unique difficulties when compared to other cancers. The face has 
an integral role in social and emotional expression and communication, and changes in its anatomy 
or function can have potentially devastating consequences. The main treatment modalities for HNC 
are surgery, radiotherapy and chemotherapy, and these may be used in combination. These 
treatments, often extensive, can result in unpleasant side-effects and sequelae. These include 
extensive soreness and dryness of the mouth and neck, (leading to difficulty with swallowing and 
speech), limitation in social (and sexual) activities, and feelings of isolation (Mehanna, De Boer, & 
Morton, 2008).   For those patients undergoing surgical treatments there is the additional burden of 
visible and potentially extensive facial and neck disfigurement, which can be difficult to conceal.  
 
Although the main aim of treatment of any cancer is to prolong life, maintaining and ensuring QoL 
of patients is as significant.  The epidemiology and presentation of HNC appears to be changing, 
with patients of certain HNC cancers being younger with better survival outcomes. This puts QoL 
more in the forefront than ever, as individuals undergoing extensive treatment may be faced with 
the long term effects for longer periods. Therefore, ensuring QoL becomes a significant issue. 
  
 24 
 
 
 Head and Neck Cancer, and QoL 
Over the past 30 years, QoL has become a respected construct for evaluating the effectiveness of 
treatment in healthcare. This is evidenced not only by the significant increase in associated 
literature, but also by the increased sophistication in its measurement and the increase in the 
number of QoL questionnaires.  Oncology has particularly welcomed it as an essential outcome 
measure, with treatment considerations often incorporating not only prognosis, but also impact 
upon patient QoL. 
 What is QoL? 
In research, the difficulty lies in the need to define QoL when evaluating health care outcomes, 
particularly when making judgements and comparisons across disciplines and the 
recommendations become based on QoL.   
 
The literature contains a bewildering array of definitions, with centrality around health status, 
physical functioning and symptoms.  In mainstream psychology, QoL is defined as a “conscious 
cognitive judgment of satisfaction with one's life”(Pavot, 1993), whereas  within medical research  
the term health related QoL (HRQOL) is commonly used which focuses on symptoms, illness and 
treatment  and often neglects the broader constructs such as standard of living, social relationships, 
psychological impact, and environmental factors.   
 
The World Health Organization (WHO) defines QoL as; 
 
“Individuals’ perception of their position in life in the context of the culture and value systems in 
which they live and in relation to their goals, expectations, standards and concerns. It is a broad 
ranging concept incorporating in a complex way the persons’ physical health, psychological state, 
level of independence, social relationships, personal beliefs and their relationships to salient 
features of the environment” 
 (The WHOQOL Group, 1998, p. 3)4 
 
The significance of this definition is it highlights the subjective concept of QoL, which, as WHO 
suggests, is embedded in cultural, social and environmental context. The quote clearly indicates a 
different model of measuring healthcare outcomes, however, the current QoL and HNC literature is 
                                                          
4 Definition extracted- World Health Organization: Measuring QoL, (1997). 
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still embedded within a medical model of health care, where functional outcomes and clinical 
measures such as survival and physical functioning take precedence. 
 
Morton, (1995) published a seminal paper highlighting ‘the evolution of QoL in HNC’ (Morton,  
1995) and suggested that QoL is frequently referred to and used in HNC, but it is not clearly 
defined. Similarly, Gotay and Moore  believed HNC would benefit from a multidimensional QoL 
approach, due to the ”multitude of its impact of treatment and long term impact on individuals 
lives post treatment and beyond” (Gotay and Moore; 1992; as cited in Morton. 1995, p. 1029) 
 
'While research in QoL is a challenging area, in many ways head and neck cancer is ideally suited to 
such an endeavour”, Gotay and Moore (1992; as cited in Morton 1995, p. 1029) 
 Literature measuring HRQOL in HNC 
Table 3 summarises 18 studies from 2000-2015 that represent a summary of key findings within the 
HNC and HRQoL literature. 
 
Table 3 Summary of HRQOL findings in HNC patients. 
First Authors, 
year. 
Aims of research Summary of results and principle findings HRQOL measure 
    
Van Nieuwenhuizen, 
Buffart, Brug, René 
Leemans, & 
Verdonck-de Leeuw, 
(2015) 
Systematic review of and survival in patients 
HNC, adjusted for important clinical, 
demographic and lifestyle-related factors 
(n=19). 
Strong evidence for a positive association between pre-
treatment physical functioning and survival and between 
change in global QoL from pre-treatment to 6months after 
treatment and survival.  
 
Several inconsistent findings, with insufficient evidence for 
an association with survival of other HRQoL domains, 
including role, emotional, cognitive and social functioning, 
mental health and well-being. 
review 
Bilal, Doss, Cella, & 
Rogers, (2014) 
The study aimed to identify potential socio-
demographic and clinical prognostic value of 
HRQoL in head and neck cancer patients in a 
developing country 
 
Treatment status, tumour stage and tumour site had the 
strongest negative impact on patients HRQoL,  
 
Treatment type, marital status, employment status and age 
were moderately associated with HRQOL. 
 
Weak associated factors of HRQoL with a small effect size 
included tumour size and type, gender, education level and 
ethnicity. 
5 (FACT-H&N) 
Funk, Karnell, & 
Christensen, (2012) 
HRQOL reported by 5-year head and neck 
cancer survivors and factors that predicted 
these long-term scores. 
 
Those who are functioning poorly 1 year after diagnosis were 
still reporting poor QoL 5 years post treatment. 
Eating problems, persistent pain were good predictors. 
Overall QoL (QOL). 
Osthus, Aarstad, 
Olofsson, & Aarstad, 
(2011) 
To examine the survival prediction of head 
and neck HRQoL scores among successfully 
treated and cognitive functioning HNC 
patients 
 
 ‘‘feeling ill’’, 
‘‘sexuality’’,  
‘‘open mouth’’,  
‘‘swallowing’’, and ‘‘pain’’ specifically predicted survival. 
EORTC QLQ- H&N35  
  
Johansson, Rydén, & 
Finizia, (2011) 
HRQOL and survival in patients treated for 
laryngeal cancer. 
Tumour site and stage showed no effect on adjustment 
response and HRQOL. 
EORTC QLQ-C30 + 
H&N35) 
                                                          
5 FACT - The Functional Assessment of Cancer Therapy -Head and Neck 
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Jacobi, Van De 
Molen, Huiskens, 
Van Rossum 
&Hilgersl., 2010) 
The effects on voice and speech of advanced 
head and neck cancer and its treatment by 
means of chemo radiotherapy (CRT). 
 
Overall, the studies indicated that voice and speech 
degenerated during CRT, improved again 12months after 
treatment and exceeded pre-treatment levels after 1year or 
longer. (no baseline measure) 
Various outcome 
measures 
Vartanian & 
Kowalski, (2009) 
To evaluate the acceptance of major surgical 
procedures and QoL among long-term 
survivors of advanced head and neck cancer  
Vast majority of patients considered a radical surgical 
procedure an acceptable treatment and reported a good 
QoL. Most patients (91.2%) reported that they would 
undergo the same treatment if they had it to do again, and 
95.6% reported that they would not like to exchange their 
present outcome for another treatment option with a lower 
chance of cure but with a possibly improved QoL. 
University of 
Washington QoL 
Questionnaire (UW-
QOL) 
    
Van Der Schroeff, 
Derks, Hordijk, & De 
Leeuw, (2007) 
HRQOL in HNC patients No significant differences in survival or overall QOL between 
older and younger head and neck cancer patients. 
EORTC QLQ-C30 and 
H&N35 
García-Peris et al., 
(2007) 
Prevalence of dysphagia in head and neck 
cancer patients treated with surgery and 
radiotherapy or chemo-radiotherapy 
Dysphagia negatively affects HNC QoL.  Self-report QoL 
(Van Der Schroeff et 
al., 2007) 
HRQOL in HNC patients aged 75+. 
 
The survival rate after 3-6 years for younger patients was 
36%, as compared to 31% in the older patient group.  
 
Higher tumour stages, more co-morbidity and non-standard 
treatment showed to be independent prognostic factors for 
mortality.  
 
No significant differences in survival or overall QOL between 
older and younger head and neck cancer patients six years 
following diagnosis. 
EORTC QLQ-C30 and 
H&N35  
Chandu, Smith, & 
Rogers, (2006) 
Clinical and socio-demographics factors 
associated with HRQOL. 
Long-term HRQOL of HNC patients seems good with HRQOL 
at 1 year being equivalent to long-term HRQOL. 
review 
Mehanna & Morton, 
(2006) 
To assess whether pre-treatment and post-
treatment QoL (QOL) is associated with long-
term survival in patients with head and neck 
cancer (over 10 years). 
 
At 10 years, before treatment, patients with low QOL had no 
significantly increased odds of death. In contrast, after 
treatment, patients with low QOL at 1 year had significantly 
increased odds of death even after adjustment for 
covariates. 
 
 
 
Auckland QOL 
questionnaire 
before treatment 
and 12 months 
Rogers et al., (2006) A cross-sectional postal survey was 
undertaken of patients treated for 
oral/oropharyngeal squamous cell carcinoma 
by primary surgery compared to national 
reference data. 
Patients under 60 years of age fared significantly worse than 
expected for their age but this was not so for older patients.  
 
6UW-QOL v4) and 
the 7EuroQol EQ-5D. 
    
El-Deiry et al., 
(2005) 
To compare the long-term, health-related 
quality-of-life outcomes in patients with 
advanced head and neck cancer (HNC) treated 
with surgery and postoperative radiation 
therapy (SRT) or concurrent chemotherapy 
and radiation therapy (CRT) 
 
As nonsurgical means of treating HNC have become more 
aggressive and surgical techniques have become more 
focused on function preservation and rehabilitation, the 
overall health-related QoL resulting from these different 
approaches is similar. 
Head and neck 
cancer-specific 
health-related QoL 
from the Head and 
Neck Cancer 
Inventory. 
Duffy et al., (2002) The relationship between smoking, alcohol 
intake, depressive symptoms and QoL in HNC 
 
Smoking was negatively associated with five scales of the SF-
36V including Physical Functioning, General Health, Vitality, 
Social Functioning, and Role-Emotional Health. 
SF-36V 
Hammerlid & Taft, 
(2001) 
To examine HRQOL of HNC cancer survivors 
compared with general population norms 
(Swedish population). 
 
No difference Age and gender with general population, 
except on the role-physical functioning scale.  
 
Treatment-related side-effects and disease-specific problems 
(e.g., swallowing, local pain and dry mouth) significantly 
worse than norm values.  
 
Female HNC patients generally scored better than the norms 
on both the SF-36 and the EORTC QLQ-C30  
 
Male patients scored significantly worse on most SF-36 
scales.  
 
the SF-36 Health 
Survey (Short Form 
36)  
 
EORTC QLQ-C30 and 
QLQ-H&N35  
                                                          
6 University of Washington QoL Questionnaire Version 4-UW-QOLv4 
7 EuroQol EQ-5D. 
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Patients over 65 years more often scored worse than the 
norm than did patients <65. 
 
Clinically relevant differences were found on the majority of 
SF-36 scales in comparison of tumour sites,  
 
Patients with small (stage I+II) versus advanced (stage III+IV) 
tumours revealed few differences.  
 
Three years after diagnosis H&N cancer patients still suffer 
significant functional limitations/problems related to their 
disease and its treatment but these problems do not 
generally affect their overall HRQL. Tumour stage no longer 
differentiates HRQL at 3 years; however, factors related to 
the patients' age, gender and location of the tumour appear 
to have bearing on their reported health status. 
De Graeff et al., 
(2000) 
long-term changes of QoL and mood in 
patients HNC treated with surgery and/or 
radiotherapy 
There was limited deterioration of physical and role 
functioning and of many head and neck symptoms at 6 
months, with improvement thereafter.  
 
After 36 months only physical functioning, taste/ smell, dry 
mouth, and sticky saliva were significantly worse, compared 
with baseline.  
Females, higher cancer stage, and combination treatment 
were associated with more symptoms and worse 
functioning.  
 
Treatment for head and neck cancer results in short-term 
morbidity, most of which resolves within 1 year.  
8EORTC & HN35  
Weymuller et al., 
(2000) 
To undertake a QOL analysis of head and neck 
cancer, a disease-specific QOL tool, the 
University of Washington Quality-of-Life (UW-
QOL) questionnaire, 
The results of this study demonstrated that the shoulder 
domain question of the UW-QOL questionnaire was able to 
discriminate among selective neck dissection, modified 
radical neck dissection, and radical neck dissection. Similar 
analysis of other domains (speech, swallowing, etc.) will be 
much more complex, since the surgical interventions, such as 
composite resection, are not as well defined as the 
variations of neck dissection. 
When patients with advanced oropharyngeal cancer were 
asked how their health had changed since prior to tumour 
identification, those who were treated with surgery 
perceived that their health was better, but those who were 
treated with chemo radiation perceived that their health was 
worse. 
UW-QOL 
 
Table 3 highlights two main issues of QoL literature in HNC. Firstly, a variety of instruments are 
being used to measure HRQoL, which predominantly focus on the physical and functional outcomes 
of patients. This is evidently of significant importance; however it is only presenting a one 
dimensional view of HNC patients' QoL. Secondly, several inconsistencies exist across the literature, 
particularly the association between demographic and clinical factors. For example, some studies 
suggest younger patients show worse QoL (Rogers, Bijaya, Goru, Lowe, & Humphris, 2006) and 
others suggesting minimal differences (Hammerlid, Bjordal, Ahlner-Elmqvist, Jannert, Kaasa,  & 
Sullivan 1997; Hammerlid & Taft, 2001).  Hammerlid and colleagues, (2001) showed patients with 
stage 1 and stage 2 disease compared to stage 3 and 4 tumours revealed few differences in their 
HRQoL scores (Hammerlid & Taft, 2001) whereas Bilal et al (2014) showed tumour stage to be 
strongly associated with patients' QoL, where later stage disease was associated with worse QoL 
                                                          
8 EORTC- European Organization for Research and Treatment of Cancer 
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(Bilal et al., 2014).  What is evident from the review of the literature is the need for researchers and 
clinicians to shift beliefs that only physical factors such as tumour stage, type of surgery, extent of 
cancer and number of physical side effects will impact patients QoL. Measures of disease alone are 
insufficient ways of measuring an individual’s QoL, particularly within HNC. There is a pressing need 
to expand research on the clinical and social usefulness of current functional and symptom related 
measures.  
 World Health Organisation QoL measure- WHOQOL-BREF  
The world health organisation (WHO) developed a QoL instrument which aims to capture the multi-
dimensional domains of QoL and goes beyond functional and symptom related constructs.  It was 
developed by the WHO group in 15 international field centres in an attempt to develop a QoL 
assessment that would be cross culturally valid and also provide a measure of individuals QOL from 
a multi-dimensional perspective (Skevington, & Lotfy, 2004). It has been specifically developed to 
go beyond HRQOL and provides less focus on specific functional impairments and allows an insight 
into wider constructs of individuals QoL. (Figure 3) 
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Figure 3 WHOQOL-BREF: Diagram showing each facet that makes up the four domains of QoL of WHOQOL-BREF 
questionnaire(Skevington, Lotfy, & O’Connell, 2004, p. 307) 
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At the time of this review, to our knowledge only four studies have been published using the 
WHOQOL-BREF within the HNC population. However, these four studies had all been conducted by 
the same research group in Zurich within one sample of HNC patients. In these studies, Zwahlen 
and colleagues (2008) found high levels of QoL in all four domains. They reported little differences 
were shown between a healthy, age- matched population (Zwahlen et al., 2008; Jenewein et al., 
2008, Drabe, Zwahlen, & Büchi, 2008) and the HNC sample.  
 
One explanation for this high QoL may be due to the individuals’ expectations and experiences of 
health and illness. Carr et al (2001) suggested that an individual’s perception of QoL may be based 
more on their expectations and experiences of health, rather than the disease itself.  If the 
expectations do not match the experience of health, the level of QoL will be low. Conversely, 
someone who has adapted his expectations to the change in his health due to a severe illness might 
experience a significant improvement of QoL (Carr, Gibson, & Robinson, 2001). QoL may become 
more influenced by perceptions of the illness and expectations of treatment than the actual illness 
itself. This would suggest that the psychological experience of the cancer might have a greater 
impact on a patient’s QoL than the physical ordeal. 
 
 Summary of HNC and QOL 
 
There is no consensus on the definition of QoL with definitions ranging from those with holistic 
emphasis on the social, emotional, and physical well-being of patients after treatment to those that 
describe the impact on a person’s health (HRQOL).  The WHOQOL-BREF provides a more 
comprehensive measure of treatment outcome than conventional measures that have been used 
with HNC. It allows individuals to summarise the judgments people make to describe their 
experiences of health and illness. This is what distinguishes the WHOQOL-BREF measure from the 
measure of disability such as the EORTC, FACT-G and UWQOL that ask predominantly about 
functional and symptom related facets. As Carr and colleagues (Carr et al., 2001) suggested; people 
assess their QoL by comparing their expectations with their experience which may account for the 
reason why patients with severe disease such as HNC may report good QoL. Primarily focusing on 
QoL instruments may be detrimental for this reason and inclusion of additional measurements, 
particularly a measure of psychological distress, may allow a deeper insight into the impact of 
cancer on an individual’s well-being.  
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 Psychological distress and Head and Neck Cancer 
 Defining psychological distress in cancer 
Despite its importance, “psychological distress” is a general and ill-defined construct that includes a 
wide variety of different components and manifestations. In specific reference to cancer, the 
National Comprehensive Cancer Network defined psychological distress as:  
  
 “An unpleasant experience of an emotional, psychological, social, or spiritual nature that 
interferes with the ability to cope with cancer treatment. It extends along a continuum, from 
common normal feelings of vulnerability, sadness, and fears, to problems that are disabling, such 
as true depression, anxiety, panic, and feeling isolated or in a spiritual crisis.”  
(National Comprehensive Cancer Network, 1999, p. 113) 
 
As the above description indicates, some degree of distress is normal. From time to time, most 
patients with cancer will have brief episodes of sad or anxious mood, loss of interest in activities, 
sleep problems, thoughts of hopelessness and helplessness, or worries about potential catastrophe. 
These are normal reactions to cancer, and often they assist in the process of adjustment. The real 
challenge is distinguishing a ‘normal’ reaction to cancer from an individual who is experiencing 
psychological distress.  
 Depression disorder v. depressive symptoms 
Depressive disorder (DD) refers to a clinically diagnosed condition often preceded by a clinical 
interview based upon diagnostic criteria for depressive disorders from the diagnostic statistical 
manual (DSM; American Psychiatric Association, 2013) or international classification of disorders 
(ICD-10) see Table 4.  A DD is a condition that is characterised by recurrent episodes of depressed 
mood and disturbed cognitive function  
Depressive symptoms are common, transient and experienced by most people in their lifetime, 
especially in response to a stressor. Symptoms are often measured using self-report instruments 
such as the hospital depression and anxiety scale (HADS) which is frequently used within the 
healthcare setting (Zigmond & Snaith, 1983). These questionnaires are very useful in that they give 
an indication of how many symptoms are present at the time of completing the questionnaire. The 
questionnaires are brief and provide a useful tool in a clinical setting by drawing attention to 
patients who may be suffering from DD. For example, in the HADS depression subscale of the 
questionnaire, if a patient scored 7 to 10 (out of 14) they have a sufficient number of depressive 
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symptoms to be considered as suffering from depression (Peveler, Carson, & Rodin, 2002; Zigmond 
& Snaith, 1983). 
 
It is important to note that self-reported questionnaires for depression are not designed to yield a 
discrete diagnosis of depression. They are constructed to measure depression as a single dimension 
of psychopathology, assessing symptoms associated with a potential depressive episode.  These 
instruments are often measuring depressed mood rather than depression as a clinical diagnosis. 
However there is significant evidence that recurrent or persistent mild, subclinical symptoms are an 
important precursor to a potential depressive episode (Katz, Kopek, Waldron, Devins, & Tomlinson, 
2004; Mitchell, Meader, & Symonds, 2010; Snaith, 2003).  
 
Table 4 ICD and DSM-IV criteria for depression 
ICD-10 DSM-IV 
Lowering of mood, reduction of energy and decrease in 
activity. 
Five (or more) of the following symptoms have been present 
during the same 2 week period and represent a change from a 
previous functioning; at least one of the symptoms is either; 
depressed mood or loss of interest or pleasure. 
The lowered mood varies little from day to day and is 
unresponsive to circumstances. 
 
Depressed mood most of the day, nearly every day 
Capacity for enjoyment, interest and concentration is 
reduced and marked tiredness after even minimum 
effort is common. 
 
Marked or diminished interest in all, or almost all, activities 
most of the day, nearly every day. 
Disturbed sleep.  
Significant weight loss when not dieting or weight gain or 
decrease in appetite nearly every day. 
Self-esteem and self-confidence are almost always 
reduced and even in the mild form, some ideas of guilt 
or worthlessness are often present. 
 
Insomnia or hypersomnia nearly every day 
May be accompanied by: Early waking in the morning; 
several hours before usual time 
Psychomotor agitation or retardation nearly every day 
(observable by others, not merely subjective feelings of 
restlessness or being slowed down) 
Depression worst in the morning  
Fatigue or loss of energy nearly every day 
Marked psychomotor retardation 
 
 
Feelings of worthlessness or excessive or inappropriate guilt 
(which may be delusional) nearly every day 
Agitation   
Diminished ability to think or concentrate, or indecisiveness 
nearly every day 
Loss of appetite, weight loss  
Recurrent thoughts of death, recurrent suicidal ideation, plan 
or attempt. 
Loss of libido 
 
 
 
Depending on the number and severity of symptoms, a 
depressive episode may be specified as mild, moderate 
or severe 
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 Measuring psychological distress in cancer 
 
Clinically significant depressive symptoms occur 2-3 times more frequently in people affected with 
cancer compared to the general population (Peveler et al., 2002). While general QoL measures will 
often contain domains for emotional and social well-being they are often not able to detect clinical 
levels of psychological distress. Thus, when screening for prevalence of psychological distress, a 
measure that is able to detect high depressive symptoms compared to ‘normal’ cancer related 
distress is essential. 
 
1.3.3.1 Hospital Depression and Anxiety Scale (HADS) 
The HADS (Zigmond & Snaith, 1983) is one of the most commonly used questionnaires for 
identifying psychological distress in oncology patients (Katz et al., 2004; Mitchell, Ferguson, Gill, 
Paul, & Symonds, 2013; Rogers et al., 2006). It is a 14 item self-assessment scale which has two 
factors, anxiety (HADS-A) and depression (HADS-D). Scores are constructed by summation, whereby 
increasing scores indicate increasing burden. There is a lack of consensus about what the optimal 
cut-off score should be for the HADS when it is used as a screening test to detect cases of minor 
and major depression. Cut-off scores recommended in the literature have ranged from a low of 7 
(Razavi et al., 1990) to a high of 11 (Clarke et al., 1993). Authors of the instrument recommend the 
optimal cut off point to be ≥8 for the identification of high symptoms of depression, which is most 
commonly reported. A global score for psychological distress may also be calculated, by adding the 
depression and anxiety scores together and the optimal screening score of 15, described by Kugaya 
et al (Kugaya, Akechi, Okuyama, & Nakano, 2000) and Mitchell et al (Mitchell , Meader, & Symonds, 
2010). In an international review examining the experiences with HADS in different clinical settings, 
Hermann (1997) found high acceptability amongst patients with some studies reporting 100% 
response rates. It has also shown high reliability with internal consistencies (Cronbach alphas) of 
the English versions between 0.80 to 0.93, which means the instrument is reliably measuring 
symptoms of depression and anxiety in medically ill patients.  It does, however, not allow one to 
make definite diagnoses and gives a dimensional rather than categorical representation of mood.  
 Psychological distress in HNC patients 
As previously highlighted, the 5-year survival rate for some HNC tumour sites is now greater than 
50%.  As a result, HNC patients’ QoL and psychological adjustment to treatment are increasingly 
important. Zabora and colleagues (2001) examined 4496 people with various malignancies. The 
site-specific results of this study indicated that HNC was among the six types of cancer with the 
highest mean score for depression when measured within 90 days of diagnosis. This may be for 
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several reasons, including; the observable physical disfigurement following treatment, disruption in 
communication ability and impairment in overall functioning which may increase the likelihood of 
psychological reactions. Also, patients with HNC tumours may be more likely than those with cancer 
in other sites to have histories of drinking, smoking, or using other substances to cope with stress. 
 
 9 Table 5 presents a summary of eleven studies from 1997-2014 that have utilised the HADS 
questionnaire to measure psychological distress in HNC patients.   
 
Table 5 Prevalence of psychological distress in HNC patients 
First Authors, year. Country Prevalence of 
depression  
HADS 
CUT OFF 
Treatment, and Time point Summary of results and 
principle findings 
Chen & Chang, 
(2004) 
Taiwan 25% ≥11 (Chemotherapy (76%)  
Not reported (24%) 
Increased depressed; insomnia, 
pain,  
Hutton & Williams, 
(2001) 
UK 22% ≥8 After treatment (surgery or 
surgery and adjuvant 8 months 
or longer). 
Depression decreased with age 
Hammerlid et al., 
(1997) 
 
Sweden 20%  
(before 
treatment) 15%  
(3 months) 
14%  
(6 months) 
13% 
(12 months) 
≥8 Diagnosis to 12 months 
 
Radiation or brachytherapy 
(% not reported) 
Highest depression 2-3 months 
following treatment 
 
Hammerlid, 
Mercke, Sullivan, & 
& Westin, (1998) 
 
Sweden 23%  
(before 
treatment) 
 
26%  
(1 months)  
 
13%  
(3 months) 
 
14%  
(after 
treatment) 
 
24%  
(12 months) 
≥11 Before and after treatment. 
 
Radiation (68%) 
Chemo+ radiation (20%) 
Laryngectomy and radiation 
(12%) 
Patients with large tumours at 
diagnosis and 12 months more 
frequently depressed than 
patients with small tumours, 
 
Kelly, Paleri, Downs, 
& & Shah, (2007) 
 
UK 43%  
(before 
treatment) 
32%  
(during 
treatment) 
24%  
Not 
reported 
Radiation or chemotherapy 
(100%) 
Patients experienced 
deterioration in QoL and 
increase in depression scores 
over the course of the 
treatment 
                                                          
9 Studies were extracted from  Haisfield-Wolfe, McGuire, Soeken, Geiger-Brown, & De Forge, (2009 )systematic review examining the 
prevalence of and correlate of depression among patients with HNC- however only studies using the HADS questionnaire were extracted. 
Recent studies have also been added to the review table. 
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(following 
treatment) 
Kugaya, Akechi, 
Okuymama, et al., 
(2000) 
 
Japan 17% ≥15 After treatment (not reported) Depression was associated with 
education, living alone, 
advanced cancer stage and 
alcohol abuse. 
Pandey et al., 
(2007) 
 
India 10% ≥8 Time of treatment 
Surgery (32%) 
Radiation (33%) 
Multi-modality 35 
Depression was correlated with 
emotional distress 
Social distress 
Anxiety. 
Depression was also correlated 
with activity of daily living. 
Rose & Yates, 
(2001) 
 
Australia 10%  
(before 
treatment) 
41%  
(6 weeks 
following) 
30%  
(one month 
post treatment)  
≥8 Radiation (100%) No significant change in 
depression between 6 weeks 
and one month 
Rogers, Bijaya, 
Goru, Lowe, & 
Humphris, (2006) 
UK 11% ≥11 Surgery (69%) 
Surgery and adjuvant (32%)   
cross-sectional survey, a notable 
minority 
of patients were anxious or 
depressed after primary surgery 
with or without adjuvant 
radiotherapy for oral and 
oropharyngeal squamous cell 
carcinoma 
Shiraz et al 2014 UK 39% ≥8 Not specified Patients with high scores on the 
HADS reported poorer QoL, and 
40% of those with high levels of 
psychological distress were 
willing to consider psychological 
support. 
Verdonck-de 
Leeuw, I M 
Erenstein, Van der 
Linden, Kuik, de 
Bree, & & Leemans, 
(2007) 
 
 
Netherlands 27% ≥12 After treatment;  
Parotidectomy or radiation (39%) 
Surgery and radiation (39%) 
Chemotherapy and radiation 
(22%) 
Higher depression was 
associated with presence of 
feeding tube, fewer social 
contacts, passive coping style, 
and non-expression of emotions. 
 
Table 5 shows a review of HADS in HNC patients and shows prevalence ranging from 10-43%, both 
nationally and internationally.  Scores ≥8 appear to be the most commonly reported cut off scores. 
However prevalence rates appear to vary according to the treatment and the time point at which 
the patient completes the questionnaire. 
10A recent study examining the prevalence of psychological distress in HNC patients was conducted 
by Shiraz et al 2014 who found 37% of HNC patients presented with high depressive symptoms on 
                                                          
10 This paper was the pilot study for the thesis and was published in the British Journal of Oral and Maxillofacial Surgery 2014 see 
appendix 8.1 for copy of the publication. 
 
Shiraz, F., Rahtz, E., Bhui, K., Hutchison, I., & Korszun, A. (2014). Quality of life, psychological wellbeing and treatment needs of trauma 
and head and neck cancer patients. British Journal of Oral and Maxillofacial Surgery, 52(6), 513–517 
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the HADS questionnaire, and 44% showed elevated symptoms of anxiety. Patients with high 
depression and anxiety levels also reported lower quality of life. Forty per cent of those with high 
levels of psychological distress indicated a need for more support in coping emotionally with their 
condition (Shiraz, Rahtz, Bhui, Hutchison, & Korszun, 2014)   
 
Psychological distress in HNC is essential to study as comorbid illnesses can complicate treatment 
and may lead to poor adherence to treatment recommendations thus leading to poorer QoL.   
The prevalence of depression in HNC cancer varies significantly by assessment method (i.e., self-
report measures vs. diagnostic interview), but indicates that approximately 15 to 50% of patients 
suffer some degree of depression at any given point across the disease trajectory.      
    
  Impact of psychological distress on Patient QoL 
It’s only in the last few years that healthcare providers involved in HNC have begun to examine the 
potential role psychological distress may have on a patient’s QoL. Howren and colleagues (2010) 
found that depressive symptoms at diagnosis and before treatment were associated with poorer 
HRQOL one year later. This was prevalent even after adjusting for baseline HRQOL as well as age, 
gender, marital status, disease site and stage, alcohol and tobacco use, and physical comorbidities.  
Similarly, in a cohort of laryngeal patients, Johansson et al (2011) also found an association 
between increased anxiety and depressive symptoms and lower HRQOL (Johansson et al., 2011). 
Hammerlid et al (2001) found the long term impact of psychological distress with patients with 
depressive symptoms at diagnosis still reporting lower QoL 3 years post diagnosis.  These findings 
have significant implications as depression is a treatable condition and early intervention could help 
reduce future deterioration in patients QoL.  
 HNC specific factors contributing to psychological distress 
Several factors specific to HNC have been associated with increased psychological distress in HNC 
patients. Dysfunction as a result of treatment may increase psychological distress and therefore 
have a major impact on patients QoL. Researchers have noted that the impairments in voice, 
speech, and swallowing caused by radiation therapy can negatively impact overall QoL and social 
functioning, above the impairments produced by surgery (Epstein et al., 2001).  Also, post-
treatment disfigurement and dysfunction are significant problems for many HNC patients. Patients 
may have visible scarring and structural changes due to surgical removal of bone and tissue; may 
have neck stoma after laryngectomies; or may experience swelling that distorts appearance. 
However, there has been mixed evidence related to post-treatment disfigurement increased 
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depression. Katz et al (2000) reviewed six studies addressing disfigurement specifically in HNC 
patients; four of the six studies showed no relation of objective measures of disfigurement to 
aspects of QOL(Katz, Irish, Devins, Rodin, & Gullane, 2000).  On the other hand, although the degree 
of objective disfigurement may not be associated with QOL, it may still limit specific areas like social 
functioning (Dropkin, 1999).  Certain individual factors interact with disfigurement to produce 
distress and there are subgroups of HNC patients who cope less effectively with disfigurement. For 
example, a person whose identity has always been strongly based on appearance or on 
communication ability may be much more likely than someone whose identity is not, to have 
greater distress at lower levels of disfigurement (Hagedoorn & Molleman, 2006). This therefore 
highlights an individual’s perceptions about the disfigurement rather than the actual disfigurement 
that may be contributed to the increased levels of psychological distress. 
 
The way individuals appraise their illness may be a vital indicator in explaining why some patients 
will experience poorer quality of life (QoL) and elevated levels of psychological distress compared 
with others. Leventhal’s (1984, Leventhal, Brissette, & Leventhal, 2003) Self-Regulatory Model 
(SRM) suggests that when an individual is confronted with an illness or condition, they will attempt 
to assign meaning by accessing their perceptions about the illness. The self-regulation model of 
illness is made up of five components that guide an individual’s illness perceptions and coping 
efforts: 1) identity: the label or name given to the condition and the symptoms that goes with it, 2) 
cause: the individualistic ideas about perceived cause of the condition, 3) time-line: the predictive 
belief about how long the condition will last, 4) consequences: individual belief about consequences 
of illness, 5) control/curability: the beliefs about whether the condition can be cured and kept 
under control (see Figure 4).  Upon receiving a diagnosis of cancer, patients will create a mental 
representation of why they think they developed the cancer,  gather knowledge about what they 
need to do to make themselves better and how they can self-regulate their emotional response.  
Some research suggests that individuals who perceive the cause of their cancer as within their 
control are more likely to change the behaviours that they believe contributed to their disease 
(Rabin & Pinto, 2006). A novel feature of the model is that it highlights how people regulate their 
coping responses both to illness danger (what is the health threat and what can I do about it) and to 
the person’s regulation of controlling their emotions by engaging in behaviours to reduce the 
emotional impact (how do I feel, and what can I do to make myself feel better).  The model predicts 
that the impact of a problem will be mediated by a person’s cognitions and these will influence 
their emotional responses, coping behaviours and appraisals. 
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Figure 4: Leventhal self-regulation model (1984) 
Scharloo and colleagues,(2005) tested the self-regulation model and found that patients who 
perceived  fewer symptoms, had less belief in illness and/or symptoms as cyclical in nature, a less 
strong emotional response to illness and less belief in their own behaviour causing the illness were 
associated with better functioning (Scharloo et al., 2005). Similarly, Foley et al,(2006) found cancer 
patients  who perceived  their cancer as a ‘positive’ experience had the highest QOL compared to  
those who resented cancer reporting increased psychological distress (Foley et al., 2006).  
 
The literature examining psychological distress and QoL is still in its early stages, and further studies 
are required to assess the role psychological distress has on individuals’ QoL but also the impact of 
cancer on the wider network.  
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 Psychological impact of Cancer on Caregivers - Partners and Family 
members 
When an individual is diagnosed with cancer, there is a social and cultural expectation for partners 
or family members to become the providers of practical and emotional support. Most caregivers 
cope well with the role with some studies showing certain individuals are able to gain positive 
experiences following cancer, reporting more closeness in relationships and personal strength (Ruf, 
Büchi, Moergeli, Zwahlen, & Jenewein, 2009). However an important minority become highly 
distressed and we still know very little about the consequences of cancer patients having a highly 
distressed partner or family member.  
 
 Prevalence of psychological distress in caregivers 
Following cancer diagnosis, families, particularly the partner, are among the most important 
resources for patients coping with cancer and cancer-induced life changes. Too often, the 
responsibility for complex care resides with spouse caregivers in particular, without regard for their 
resource or skills to provide the care. As caregiving increases, partners may experience a collection 
of physical, mental and social consequences that may exceed those of their ill partner. 
Braun et al (2007) assessed the prevalence of psychological distress among advanced cancer 
patients (lung and GI) and their spouses (101 couples of patients and caregivers). Forty per cent of 
the spouse caregivers reported clinical levels of depression, compared to 20% reported in their ill 
partners. They also found patients who had a partner who reported low symptoms of psychological 
distress did better physically and emotionally (Braun, Mikulincer, Rydall, Walsh, & Rodin, 2007). The 
cross-sectional nature of the study limits our ability to determine causal relationships however 
highlights that the elevated levels of psychological distress in partners can have a negative impact 
on the patient.  
The few studies that have examined prevalence of psychological distress in HNC are showing similar 
results. Vickery et al (2003) examined levels of psychological distress in HNC patients and their 
partners. Forty percent of partners compared to Fourteen per cent of patients were reporting 
clinical levels of anxiety.  Levels of anxiety were higher in partners of patients who had received 
surgery and radiotherapy compared to radiotherapy alone. Interestingly, there was no difference 
between patients and their partners’ levels of depressive symptoms, both reported prevalence of 
11% (Vickery, Latchford, Hewison, Bellew, & Feber, 2003).  It should be noted, however, that the 
psychological distress was measured at one time point only and it is likely that the process of 
psychological distress is not a static entity and is changeable across time.  Hodges et al, (2005) 
examined the prevalence of anxiety and depressive symptoms at 3 and 6 months following 
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diagnosis in a cohort of HNC patients and carers (86 partners, 13 non partners). They found, 3 
months following diagnosis patients and their caregivers were showing similar levels of depressive 
symptoms (14% and 13% in carers). However, caregivers were reporting significantly higher levels 
of anxiety; 21% in patients and 37% in caregivers (Hodges, Humphris, & Macfarlane, 2005).  
These findings suggest that caregivers are reporting significantly higher symptoms of anxiety for up 
to 6 months following diagnosis. Zwahlen et al (2008) examined the psychiatric morbidity in 
successfully treated oral cavity squamous cell cancer survivors (mean 3 years since surgery). Results 
showed 39% of wives compared to 16% of patients reported increased levels of psychological 
distress. These findings highlight that in a proportion of caregivers are finding difficulty in adjusting 
to their partner’s diagnosis for up to three years following treatment. 
These studies emphasise the increased levels of psychological distress amongst partners of cancer 
patients. There have been very few studies that have examined the prevalence of psychological 
problems among non-partners. What evidence there is suggests that non-partner carers can also 
develop high levels of psychological distress.  Bowman and colleagues (2006) found that family 
members appraised the cancer experience as more stressful than did cancer patients themselves. 
They appeared to be less able to let go of the diagnosis and treatment phase of the disease and 
continued to have a negative appraisal of the overall cancer experience (Bowman, Rose, & 
Deimling, 2006). Kissane and colleagues (1994) examined families of patients receiving palliative 
care and found that 35% of spouses and 28% children were showing clinically relevant symptoms of 
depression (Kissane et al., 1994). Edwards and Clarke, (2004) examined levels of psychological 
distress amongst colorectal, breast and prostate relatives. They found patients’ illness 
characteristics i.e. cancer type, physical functioning, type of treatment appear to be risk factors for 
patients’ psychological distress but not for relatives’ depression and anxiety. Almost 13% of 
patients compared to 21% of relatives reported clinically relevant symptoms of depression 
(Edwards & Clarke, 2004). 
 Why are caregivers showing higher psychological distress then patients?  
There is some evidence that women are generally more distressed than their male counterparts, 
regardless of their role as a patient or partner (Hagedoorn, Kreicbergs, & Appel, 2011; Hagedoorn, 
Sanderman, Bolks, Tuinstra , 2008; Ybema, Kuijer, Hagedoorn, & Buunk, 2002). One possible 
explanation for this gender phenomenon could be that women’s emotional life is more affected by 
their partners’ well-being. Women’s roles, particularly in couples and families, might commit them 
to being nurturing and, therefore, more reactive to stressors in significant others (Pitceathly & 
Maguire, 2003). Apart from gender, a number of explanations have been presented for the 
increased levels of distress in partners compared to patients. The experience of illness and 
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treatment is clearly different for a partner. They themselves are not facing the threat of death or 
suffering but are faced with the prospect of losing or caring for their partner. Such a prospect may 
induce feelings of helplessness, as they are unable to take a direct role in fighting the cancer 
(Pitceathly, Maguire, Haddad, & Fletcher, 2005). This may also be applicable in family members 
(Vickery et al., 2003). The prevalence studies show a prolonged effect of increased distress. Bigatti 
et al (2001) suggested psychological distress in partners may become prolonged because partners 
disregard their own problems in order to focus exclusively on patients’ needs. (Bigatti, Wagner, 
Lydon-Lam, Steiner, & Miller, 2011). This may have consequences on a partner’s health, which 
could also result in negative consequences for a patient with cancer. Also, stressors with which 
couples are confronted with may be quite different depending on the role of the patient within the 
relationship. If the patient is the financial supporter, the illness may be associated with forced 
retirement and financial strains, but If the patient is the primary housekeeper the social 
relationships may be more likely to change (Hagedoorn, Sanderman, Bolks, Tuinstra, & Coyne, 
2008; Ybema et al., 2002). 
 
The Transactional Model of Stress and Coping (Lazarus & Folkman, 1987) provides a framework for 
evaluating the processes of coping with stressful events and provides an explanation as to why some 
partner’s may experience higher psychological distress than the patient. Table 6 summarises the key 
constructs of the Transaction Model of Stress and Coping. According to this model, partner’ s may be 
appraising patient’s cancer more negatively, perceiving little control  over the outcome and 
therefore suffer with increased feelings of helplessness in addition to negative thoughts about losing 
their partner. Partners who experience elevated levels of psychological distress will find it more 
difficult to adopt positive coping strategies therefore choosing to engage in maladaptive coping 
behaviours which not only has a negative effect on their own wellbeing but potentially affect the 
social support provided to the patient.  
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Table 6 Transactional model of stress and coping framework 
Concept Definition 
Primary Appraisal Evaluation of the significance of a stressor or threatening event. 
Secondary 
Appraisal 
Evaluation of the controllability of the stressor and a person’s coping 
resources. 
 
Coping Behaviours  
 
Actual strategies used to mediate primary and secondary appraisals. 
Problem 
management 
 
Strategies directed at changing a stressful situation. 
Emotional 
regulation 
 
Strategies aimed at changing the way one thinks or feels about a stressful 
situation. 
Meaning-based 
coping 
Coping processes that induce positive emotion, which in turn sustains the 
coping process by allowing re-enactment of problem- or emotion focused 
coping. 
Outcomes of 
coping 
Emotional well-being, functional status, health behaviours. 
 
Dispositional 
coping styles 
Generalized ways of behaving that can affect a person’s emotional or 
functional reaction to a stressor; relatively stable across time and situations. 
Optimism Tendency to have generalized positive expectancies for outcomes. 
Information 
Seeking 
Attentional styles that are vigilant (monitoring) versus those that involve 
avoidance (blunting) 
    
(Glanz, Rimer, & Viswanath, 2008, pp. 214–215) 
 
 
Significant evidence highlights the positive effects of social support on a patient’s wellbeing (Cohen 
& Wills, 1985; Lutgendorf et al., 2005; Minako et al., 2010).  Several hypotheses have been 
proposed for this positive association. Berkman and Glass, (2000) suggested social support has a  
positive impact on individuals due to meeting basic human needs for companionship, intimacy, a 
sense of belonging, and reassurance of one’s worth as a person, supportive ties may enhance well-
being and health, regardless of stress levels (Berkman, Glass, Brissette, & Seeman, 2000).  A second 
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hypothesis is proposed by Thoits, (1995) who suggested an individual’s social support network may 
help them reinterpret events or problems in a more positive and constructive light.  This “buffering 
effect” is the underlying mechanism to enhance individuals coping responses when experiencing a 
stressor such as cancer. Research involving people going through major life transitions such as 
cancer has shown how social support from partner and family influence the coping process and 
buffer the effects of the stressor on health (Cohen & Wills, 1985; Hagedoorn & Kuijer, 2000; 
Lutgendorf et al., 2005). A study by Bigatti in 2011 showed that partners who perceived low social 
support had increased psychological distress and ineffective coping strategies (Bigatti et al., 2011).  
 
This therefore proposes several implications for the quality of social support a partner or caregiver 
may provide when experiencing increased level of psychological distress. The effects of negative 
social support have not been studied within HNC, however, a recent study by Manne 1997, 
identified patients who perceived negative responses from their partners reported increased 
psychological distress and lower QoL (Manne, Taylor, Dougherty, & Kemeny, 1997; Manne, Ostroff, 
Winkel, & Grana, 2005). 
 Effects of cancer on caregivers 
Stenberg et al (2010) recently conducted a systematic review which examined the effects of caring 
for a patient with cancer (Stenberg, Ruland, & Miaskowski, 2010). The findings were based on 192 
studies published between 1990-2008 which reported a range of problems reported by both family 
and partner caregivers. 
 
Table 7 draws attention to the wide array of problems experienced by caregivers, which go beyond 
providing emotional and practical support to patients. Partners and family members are reporting 
physical health problems as well as reporting isolation, loneliness and loss of intimacy in 
relationships (Stenberg et al., 2010). 
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11Table 7 Physical, Emotional, Social and Burden experienced by partners and family members of cancer 
patients 
 
Physical Health 
problems 
  
Emotional problems 
and reaction 
  
Social problems 
  
Burden related to 
responsibilities and 
impact on daily life 
 
Pain 
 
 Anxiety  Financial 
difficulties 
 Direct care for 
patient 
Back pain  Anxiety for own 
health 
  
Change in 
employment 
status 
  
Emotional support 
Leg pain  Not wanting to 
leave patient alone 
  
Giving up work 
 Accompanying 
patient to 
appointments 
Sleep 
problems 
 Worry  Role strain   
Filling out forms 
 
Loss of energy 
 Depression  Balancing 
multiple roles 
  
Make decisions 
 
Loss of weight 
 Fear of recurrence   
Less marital 
satisfaction 
  
Monitor activities of 
the patient 
 
Tired 
 Hopelessness   
Spousal role 
problems 
  
Provide medical or 
nursing treatments 
 
Muscle 
tension 
 Scared about 
surgery and risks 
  
Isolation 
  
Report symptoms 
progress 
 
Fatigue 
 Feelings of 
inadequacy 
 Loneliness   
Cannot practice 
hobbies 
 
Headache 
  
Easily irritated 
 Loss of intimacy   
Disrupted schedule 
 
Poor sleep 
quality 
  
Panic 
 Regret and 
feelings of loss of 
connectedness 
  
Loss of independence 
 
Loss of 
physical 
strength 
 Self-doubt   
Difficult to get 
help 
 Restricted social life 
 
The review by Stenberg and colleagues (2010) gives an overview into the complex range of 
challenges faced for caregivers of cancer patients and summarises the vast spectrum of difficulties 
that have been reported. In summary, the most frequently reported problems were emotional (e.g. 
anxiety, depression and fear) and social problems (e.g. financial difficulties, role strain, isolation).  
  
                                                          
11 Table has been constructed from extractions from a systematic review conducted by Stenberg, Ruland & Miaskowski who conducted a 
systematic review on the effects of caring for a patient with cancer.  Extracted from Sternberg et al 2010, pg. 1015-1017 
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 Conclusions 
Cancer and its treatment precipitates profound changes in the family system, including disruptions 
in daily household routines, financial and emotional strain, and role changes engendered by a wide 
array of complex caregiving responsibilities (Ostroff, Ross, Steinglass, Ronis-Tobin, & Singh, 2004). 
The similarity in levels of depression and anxiety between patients, partners and family members 
suggest that common factors impact on the whole family and suggests that individual events 
reverberate throughout the whole family system. However, not all partners and family member are 
reporting elevated levels of psychological distress, and in some cases some couple are able to 
reflect on the positive experiences of cancer.  
It is important that professionals involved in the on-going care of cancer patients and their families 
are aware of the increasing demands made on caregivers and the specific problems they perceive in 
caregiving. Family and partners are the key social support systems during the cancer trajectory, and 
according to the “buffer hypothesis” (Cohen & Wills, 1985) act as an anti-stressor reducing the 
negative impact of the disease. If caregivers are increasingly distressed, this social support system 
may become more detrimental than positive.  
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 Overall literature review conclusions 
 
Head and neck cancers were traditionally associated with older men who smoke and consume 
alcohol, however the epidemiology and presentation of HNC appears to be changing, with patients 
with certain HNC cancers being younger with better survival outcomes. This puts QoL more in the 
forefront, as individuals undergoing extensive treatment may be faced with the long term effects 
for longer periods. Therefore, ensuring QoL becomes a significant issue. 
 
Traditional QoL measures in HNC (i.e., EORTC-QLQ, FACT-G, UWQOL) are useful for measuring 
functional outcomes in HNC patients but do not give the global impact of HNC and patients’ 
perception of overall life satisfaction. Therefore, there is a need to assess QoL from a 
multidimensional construct which will allow us to bridge boundaries between disciplines and 
supplement an alternative perspective to HNC patients’ QoL, which is currently lacking in the 
literature.  
 
The current literature is also showing that increased psychological distress is associated with poorer 
QoL. Further research is required to examine the impact of psychological distress on HNC patients’ 
physical, social relationships, lifestyle and environmental factors.  
 
There have been inconsistencies in the prevalence of psychological distress in HNC patients, 
potentially due to the different methods of assessing depressive symptomatology and different time 
points reported. Thus there is a need for further studies to measure the prevalence before and 
following treatment to examine if HNC patients levels of psychological distress increases over time.  
 
There have been very few studies that have looked at levels of psychological distress (anxiety and 
depression) in partners and family members of HNC patients, particularly within the UK.  Thus 
further examination examining the prevalence of psychological distress amongst partners and family 
members of HNC patients is required. There is a significant need to identify which factors contribute 
to patients’ and caregivers’ psychological distress, particularly if high psychological distress in 
caregivers has a negative impact on the patient’s QoL and psychological wellbeing.  
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 Aims and Hypotheses 
 
The main aims of this study were: 
 
1. To measure the prevalence of psychological distress (symptoms of anxiety and depression) 
in HNC patients, and caregivers (partners and family members) at two- time points; before 
treatment and 6-12 months following treatment. 
 
2. To examine the association of patient and caregiver psychological distress on HNC patients’ 
QoL and to test the following hypotheses; 
 
I. Before treatment, HNC patients who have high levels of psychological distress 
(symptoms of depression and anxiety) have poorer QoL 
 
II. Patients whose partners and family members have high levels of psychological 
distress (anxiety and depression) have poorer QoL.  
 
III. HNC patients with high depression and anxiety before treatment will show poorer 
quality of life 6-12 months following diagnosis  
 
IV. HNC patients with partners who show high levels of distress have poorer QoL 6-12 
months following diagnosis 
 
3. To explore the “lived experiences” of HNC patient-partner couples, where partners 
reported high levels of psychological distress before treatment (qualitative) 
 
 
The associations between other possible explanatory factors on patient QoL, i.e.  Socio-
demographic variables and clinical related variables such as treatment, stage of disease, and cancer 
site were also investigated. 
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2 Method 
 
 
This chapter introduces the study protocol including the data collection procedures, details of the 
clinics patients were recruited from, the measures used to collect data and the statistical analyses 
that were used to analyse the data. The methodology for the qualitative phase of this thesis is 
detailed in chapter 4. The participants who took part in the quantitative and qualitative phases of 
the study were recruited from the clinics and procedures detailed in this chapter. 
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 Research Design 
A mixed methods prospective study was used to answer the proposed research aims. (See chapter 
4 for qualitative methods). 
 Ethics 
Ethics approval was obtained from the NRES Committee London, Camberwell St Giles -. REC 
reference:12/LO/0351 
 Head and neck cancer clinics 
The study participants were drawn from HNC patients and their caregivers’ (partner or family 
member of HNC patient) who were treated for HNC between July 2012 and January 2014. 
Participants were recruited from outpatient clinics at the Macmillan Cancer Centre, University 
College London Hospital (UCLH) and St Bartholomew’s Hospital. Both clinics are multidisciplinary 
consisting of maxillofacial surgeons, ear nose and throat surgeons, speech therapists, dieticians, 
oncologists and cancer nurse specialists.  
 Inclusion and exclusion criteria 
Participants were identified and assessed for eligibility at the weekly multidisciplinary (MDT) 
meetings at each site, where newly referred and existing patients are reviewed. The clinical care 
team identified suitable patients based on the specified eligibility criteria (see Table 8).  The 
inclusion criteria for patients were: aged 18 and over (no upper age limit specified), a biopsy 
confirmed primary tumour of the Head and neck, and a treatment plan of curative intent. Due to 
small numbers of new patients, recurrent HNC cancer patients were also included in this study. 
Patients were not eligible for the project if they were undergoing palliative treatment, English was 
not their first language or if consultants felt that a patient’s participation was inappropriate. 
 
See Table 8 and Table 9 for detailed patient and caregiver inclusion and exclusion criteria.  
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Caregivers were selected through patient’s nomination and for the purpose of this study; a 
caregiver is defined as; 
i) Partner or spouse of patient,  
ii) Relative or family member of patient,  
Caregivers were only approached to participate following the permission from the patient. HNC 
patients who did not have a partner or family member were still included in the study sample.   
 Sample inclusion / exclusion criteria 
 
Table 8 Patients inclusion and exclusion criteria for recruitment  
 
Patients Inclusion criteria 
 
 
 
Patients Exclusion Criteria 
All patients were required to have a primary 
diagnosis of HNC.  
Patients receiving being treated palliative / 
end of life treatment,  
 
Newly diagnosed or recurrent primary HNC 
 
 
Head and Neck Cancer not patients primary 
cancer e.g. Skin excluded  
Curative treatment intent (all treatment types 
included) 
 
 
Patients treated neurologically- e.g., brain 
Cancer 
Aged 18 or over (no upper age limit)  Inability to read, write or speak English  
 
Questionnaires are only available in English, 
and the researchers are only able to seek 
consent, administer questionnaires and 
conduct interviews in English. 
 
Fluency in English Cognitive impairment where patients may 
be unable to give informed consent, or 
understand the questionnaires and 
interviews. 
 Patients with active psychosis or severe 
mental illness which may affect capacity to 
consent 
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Table 9 Caregiver inclusion and exclusion criteria for recruitment 
 
 Self-report Measures 
The following questionnaires were administered to both patients and caregivers, before 
treatment and 6-12 months post diagnosis. 
 WHOQOL-BREF 
 
The WHOQOL-BREF consists of 26 items providing scores for four domains related to QoL: 
physical health (7 items), psychological health (6 items), social relationships (3 items), and 
environment (8 items). Ratings range from 1 (very poor) to 5 (very good).  Figure 5 shows each 
item covered within each QOL domain. 
Caregiver Inclusion criteria 
 
Exclusion criteria 
Partners of patients must be a co-resident, and have 
been living with the patient for at least 6 months.   
Inability to speak, read or write English 
Immediate relative as specified by patient  Cognitive impairment where patients may 
be unable to give informed consent, or 
understand the questionnaires and 
interviews. 
Aged 18 or over (no upper age limit)  Patients with active psychosis or severe 
mental illness which may affect capacity to 
consent 
Fluency in English Primary diagnosis of Cancer 
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Figure 5 Four QoL domains of WHOQOL-BREF questionnaire 
 
 
2.3.1.1  Scoring and interpretation of WHOQOL-BREF 
All items are rated on a 5-point scale assessing intensity, capacity, frequency or evaluation 
(satisfaction). Following reversal of negative items, domain scores are summed and transformed 
into percentile scores (scale range: 0–100). The higher the score, better the quality of life. 
The WHOQOL- BREF is used as a continuous scale and is not recommended to be categorised.  
 Hospital Anxiety and Depression Scale (HADS)  
The HADS was selected to identify patients and caregivers with high levels of psychological distress 
(anxiety and depressive symptoms). 
2.3.2.1 Scoring and interpretation of HADS 
HADS is a 14-item self-assessment scale with two subscales; anxiety and depression. Each item on 
the HADS has a Likert response scale rated from 0 to 3. Answers range from 0-21. Scores for anxiety 
and depression are summed with increasing scores indicating increasing symptoms. As 
recommended by the 12authors, scores of ≥8 indicate possible anxiety or depression. An overall 
distress score (HADS-T) can also be summed by adding scores of HADS-Depression and HADS-
Anxiety subscale. A cut off score of ≥15 for HADS-T indicates elevated psychological distress. 
 
 
                                                          
12 (Zigmond & Snaith, 1983) 
Domain 1: Physical 
(7 items)
•Pain and discomfort
•Energy and fatigue
•Sleep and rest
•Dependence on 
medication
•Mobility
•Activities of daily living
•Working capacity
Domain 2: Psychological
(6 items)
•Positive feelings
•Negative feelings
•Self esteem
•Thinking learning 
memory and 
concentration
•Body image
Domain 3: Social 
(3 items)
•Personal relations
•Sex / intimacy
•Practical  social support
Domain 4: 
Environmental
(8 items)
•Financial resources
•Information and skills
•Recreation and leisure
•Home environment
•Access to health and 
social care
•Physical safety and 
security
•Physical environment
 53 
 
 
 
 
 
 
 
Figure 6 Hospital anxiety and Depression Scale: Subscale and Items 
 
 
 
 
 
 
 
Figure 6 shows each subscale and item on the HADS questionnaire (see appendix 8.2 for patient 
and caregiver questionnaire, consent form and information sheet) 
 
 
  
HADS-Depression
(7 items)
•I still enjoy the things i use to
•I can laugh annd see the funny 
side of things
•I feel cheerful
•I feel as if i am slowed down
•I have lost interst in my 
appearance
•I look forward with enjoyment 
to things
•I can enjoy a good book, radio, 
or television programme
•Total score  0-21
HADS-Anxiety
(7items)
•I feel tense or wound up
•I get a sort of frightened 
feeling as if something awfu l is 
about to happen
•Worrying thoughts go through 
my mind
•I can sit at ease and feel 
relaxed
•I get a sort of frightened felling 
like butterflies in the stomach
•I feel restless as if i have to be 
on the move
•I get sudden feelings of panic
• Total score 0- 21
HADS- Total psychological 
distress
(14 Items)
•HADS-Depression + HADS-
Anxiety
•Total score =0-42
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 Demographic and medical information 
 Socio-demographic  
The socio-demographic variables collected from all participants included; 
 Age  
 Gender  
 Education level    
 Marital status  
 Ethnicity  
 Religion 
 Current Employment status  
 Clinical variables 
The following clinical variables were also collected by the researcher. To ensure accurate coding of 
clinical variables, in particular staging, all clinical variables were coded with the assistance of an oral 
maxillofacial registrar and the patients treating consultant.  
 Treatment 
 First or Cancer recurrence   (First cancer v. recurrence)  
 13Cancer staging (early loco-regionally advanced)   
 Tumour type (SCC V. Non SCC) 
 Site of tumour (oral cavity v oropharynx v other sites including nasopharynx, larynx, salivary 
gland and unknown primary) 
 Tumour Node Metastases (TNM) 
 Surgery specific variables  
The following variables were also collected from patients who underwent surgery. 
 Did patient undergo a tracheostomy? (yes v no) 
 Was patient in ITU following treatment? (yes v no) 
 Did patient undergo a free flap reconstruction? (yes v no) 
 Did patient have a nasogastric tube? (yes v no) 
 
                                                          
13 The Cancer staging was performed in accordance with the AJCC staging system for head and neck cancer. 
*Descher,D.G. & Day, T, (2008)  American joint committee on Cancer (AJCC), Early stage  disease: Stage I,II 
Locoregionally advanced: Stage III or IV. 
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 Procedure 
All patients and caregivers were recruited from University College London Hospital (UCLH) or St 
Bartholomew’s Hospital East London. Patients were identified at weekly multidisciplinary meetings 
and assessed for eligibility by a HNC clinician. Recruitment of participants took place at the weekly 
outpatient Head and neck cancer clinic. Patients were invited to join the study after confirmation of 
their diagnosis and treatment plan. The researcher was always introduced to the patient by their 
treating clinician. The patient was given information about the study and given the choice to 
consent at the clinic or take the information sheets and questionnaires home and return in the 
freepost envelope.  Caregivers were recruited after permission from the patient was given for them 
to be involved in the study. Written informed consent was obtained from patients and their 
caregivers individually.   
 
Figure 7, presents a consort diagram, reporting the total participants approached and number who 
consented and took part in the study.  See Figure 8, for a step by step process of patient and 
caregiver recruitment 
 
 Timing of Questionnaires 
2.5.1.1 Time point 1 (before treatment)  
Time point 1 was defined as the period before treatment commenced. All participants were 
recruited within 0 – 3 weeks. Only questionnaires that were completed before treatment (time 
point 1) were included in time point 1 analysis.  
2.5.1.2 Time point 2 (6-12 months following diagnosis)  
Only participants who completed questionnaires before treatment were eligible to take part in time 
point 2.   
 
At both time points participants were provided with freepost envelopes to return their 
questionnaires. Participants were also informed that they might be selected for an interview 12 
months following diagnosis (qualitative study, see chapter4). 
 
Figure 9, and Figure 10 show the completion of questionnaires by HNC patients and their caregivers 
at each time points. 
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Total participant screened 
N=232  
Lost to follow-up (n=31) 
Reasons: 
 Death (n=12),  
 Too ill to comply (n=6),  
 Incomplete data (n=2),  
 No questionnaire returned (n=11) 
 
 
Full data set 
N=90 
 
(Completed WHOQOL-BREF, HADS) 
 
 
Before treatment 
T1 
  
Patients N=124 
 Caregivers N=109  
Partners                n= 69 
Family members:  n=40 
Total participants eligible 
N=192 
Consented 
Caregivers N=89  
Partners                n= 58 
Family members:  n=31 
 Consented 
Patients N=99 
Declined 
N=25 
Declined 
N=20 
Time point 2 
(6-12 months) 
 
Caregivers 
Full data set 
N=74 
 
(Completed WHOQOL-BREF, HADS) 
 
 
 
Full data set 
N=59 
 
(completed WHOQOL-BREF, HADS) 
 
 
Loss to follow-
up 
n=30 
 
Caregivers 
Full data set 
N=40 
 
(Completed WHOQOL-BREF, HADS) 
 
 
Lost to follow-up (n=34) 
Reasons: 
 Patient death (n=12),  
 No questionnaire returned (n=12) 
 Incomplete data ( n=8) 
 Partners ill health  (n=6)No questionnaire returned (n=10) 
 
Loss to follow-
up 
n=34 
Recruitment consort diagram: 
 
UCLH 
n= 69 
BARTS 
n=163 
Not Eligible  
N=40 
*English not first language 
Patient: n=21 
Partner: n=11 
Family: n=8 
 
Figure 7 consort diagram of participant 
recruitment  
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Figure 8 Step by step process of participant recruitment 
 
  
Recruitment complete
When final questionnaire has been returned, thank you letter sent.
Follow-up questionnaires
Researcher checked NHS client record system (CRS) to check status of patient (i.e. alive / deceased) before questionnaires  
are sent. 
Patients were called by researcher to inform particpants that questionnaire was due to be sent.
Questionniares:
Baseline: initial questionnaires to be completed before treatment, given opportunity to complete in clinic or handed 
questionnaires to complete and return in freepost envelope. 
Participant consent: 
Researcher informs patient of study design and  patient is given choice to consent at clinic or take home and return in 
freepost envelope. A copy of signed consent form sent in post along with thank you letter for agreeing to take part.
Eligibility: 
At weekly clinic, clinician informs patient of study after consultation. Researcher introduced to patient by the treating 
clinician.
Patient identification: 
Recruitment Process
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Figure 9 Questionnaires completed by HNC patients at Time point 1 and Time point 2 
 
 
 
 
 
Diagram shows the number of HNC patients who completed the HADS and WHOQOL-BREF 
questionnaires before treatment (time point 1) and 6-12 months following treatment (time 
point 2).  
 
 
 
 
 
 
 
 
Patient
Timepoint 1
(n=90)
(before treatment)
Time point 2
6-12 months
HADS
n=59
WHOQOL
n=59
HADS
n=90
WHOQOL
n=90
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Figure 10 Questionnaires completed by Caregivers of HNC patients before treatment (time point 1) and 
6-12 months following treatment (time point 2). 
 
 
 
 
  
Caregiver
Timepoint 1 
n=74
(before treatment)
Time point 2
(n=40)
6-12 months
Partner
n=30
HADS
(n=30)
WHOQOL
(n=30)
Family member
n=10
HADS
(n=10) 
WHOQOL
(n=10)
Partner
n=50 
HADS
(n=50)
WHOQOL
(n=50)
Family member
n=24
HADS
(n=24)
WHOQOL
(n=24)
Diagram shows the number of partners and family members who completed the HADS and 
WHOQOL-BREF questionnaires before treatment and 6-12 months following treatment 
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 Statistical Analysis 
 
To ensure accuracy of statistical analysis and coding of data, double data entry was undertaken. All 
data was coded and analysed using 14STATA 12.0.  
 
The mean scores and standard deviations of all self-report measures were examined. Median scores 
were also derived due to the non-normal distribution of data within both self-report measures. T-
tests were applied for planned comparisons of means, however due to the non-normal distribution 
of data, non-parametric statistics such as the Wilcoxon- matched paired test and Mann-Whitney U 
test were used to compare median scores across groups (i.e. comparing patients and partners levels 
of distress. The chi square and Fisher’s exact tests were conducted to examine the 
representativeness of follow up participants  
To undertake parametric linear and multivariate regression analysis the four dimensions of 
WHOQOL-BREF were normalised when used as the outcome (Cohen,Cohen,West, & Aiken., 2002). 
The transformation was achieved using the STATA zero-skewness log function lnskew0.  The 
transformation to make the data approximate the normal distribution, allows for parametric 
regression to be fitted.  
 
Regression modelling was undertaken to test the hypothesis.  Univariate analysis examined the 
significant associations between predictor variables and outcome. A stepwise modelling approach 
was performed, where each psychological factor that was significantly associated to 0.05 levels was 
entered into a multivariate model. The aims of the model were to investigate which psychological 
factors were most strongly associated with patient QoL. The same data modelling was undertaken 
when examining the association between clinical and socio-demographic factors and patient QoL. 
 
A path analysis was conducted to provide estimates of the magnitude and significance of the 
hypothesised causal connections between patient depression, caregiver depression and patient 
physical quality of life. A mediation analysis further examined the statistical associations identified in 
the path analysis. 
                                                          
14 StataCorp. 2011. Stata Statistical Software: Release 12. College Station, TX: StataCorp LP. 
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3 Results 
 
This chapter presents the quantitative findings from this thesis. It begins by introducing the dataset, 
followed by:  
 
1. Results showing the prevalence of psychological distress in patients and their caregivers 
(Research aim 1 of the thesis) 
2. Testing the hypothesis that psychological distress is associated with patient QoL (hypothesis I 
and iv) 
3. Testing the hypothesis that caregiver psychological distress is associated with patient QoL 
(hypothesis ii and iv) 
4. Exploring the associations between other explanatory factors of QoL; socio demographics and 
clinical factors 
 
The findings of each research aim are summarised, with overall discussion of key findings in chapter 
five. The qualitative results (research aim 3) are presented in chapter four. 
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 Quantitative Results 
 
A total of 124 HNC patients were eligible to take part in the study. In total, 90 patients completed 
HADS and WHOQOL-BREF before treatment (65 male and 25 female patients) see Table 10 and 
Table 11 for patient demographics and clinical information. The age of the total sample ranged 
between the ages 27 to 94 years, with patients being predominantly White British, male with mean 
age of 64. Sixty-six per cent were married or living with a partner. The clinical variables of the 
patient sample showed the majority were newly diagnosed (85%), with 46% having a diagnosis of 
cancer of the oral cavity.  
A total of 109 caregivers (partners n=69 and family members n=40) were approached to take part in 
the study. Twenty declined participation, with 11 caregivers (55%) citing the experience of 
undertaking research too stressful at the present time. Nine chose not to return questionnaires 
before treatment without any reason given. A total 74 caregivers (partner n=50, family members n= 
24) completed the HADS and WHOQOL-BREF questionnaire before treatment, (female=59 and male 
=15).  This sample was predominantly White British, female, with a mean age 56.  
 
Table 10 shows the socio-demographics of caregivers. Figure 11 presents the number of caregivers 
recruited before treatment with a breakdown of their relationship to HNC patient. 
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Figure 11 Caregiver sample n=74 
 
 
 
Figure 11 shows the number of caregivers recruited by relationship HNC patient 
Partner, 
68%
(n=50)
Daughter, 13%
(n=10)
Son, 7%
(n=5)
Sister, 7%
(n=5)
Mother, 
1%
(n=1)
Cousin, 
4%
(n=3)
Relationship to patient
n=74
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Table 10 Socio-demographics of HNC patients (n=90) and Caregivers (n=74) who completed questionnaires 
before treatment (time point 1) 
 
Patient 
N=90 
Caregiver 
N=74 
 M (SD)  M(SD)  
Age 64(13)  56(12)  
Age grp 
 
 (%) 
 
 % 
18-59 32 35.6 42 56.8 
60-74 38 42.2 22 29.7 
75-95 20 22.2 9 12.2 
Missing 0 0 1 1.4 
Gender     
Male 65 72.2 15 20.3 
Female 25 27.8 59 79.7 
Marital status     
Married/ living with partner 59 65.6 62 83.8 
Single 18 20.0 7 9.5 
Divorced/widowed 13 14.4 4 5.4 
Education     
None 42 46.7 22 29.7 
G.C.S.E/equivalent 26 28.9 26 35.1 
Higher Education 22 24.4 24 32.4 
Missing 0 0 2 2.7 
Ethnicity     
White British/White other 75 83.3 62 83.8 
Black British/Black other 5 5.6 1 1.4 
Asian British/Asian other 8 8.9 7 9.5 
Other 2 2.2 3 4.1 
Missing 0 0 1 1.4 
Employment     
Full time  / Part time 28 31.1 37 50.0 
Unemployed 21 23.3 15 20.3 
Retired 38 42.2 21 28.4 
Not specified  3 3.3 0 0.0 
Missing 0 0 1 1.4 
Religion     
No religion 24 26.7 27 36.5 
Religion specified 66 73.3 47 63.5 
 
Table 10 shows the socio demographics of all participants (patients n=90, and caregivers n=74) who 
completed questionnaires before treatment (time point 1). 
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Table 11 Clinical information for patient sample who completed time point 1 (N=90) 
Patient Sample  (N=90) 
Clinical variables   
Cancer N % 
First Cancer 77 85.6 
Recurrence 13 14.4 
Site     
Oral cavity 41 45.6 
Oropharynx 23 25.6 
Nasopharynx 3 3.3 
Larynx 10 11.1 
Salivary gland 6 6.7 
Unknown primary 7 7.8 
SCC   
Yes 78 86.7 
No 12 13.3 
Stage     
Early(stage I-II) 31 34.4 
Loco regionally advanced 
disease (stage III-IV) 
56 62.2 
Missing 3 3.3 
T classification   
X 9 10.0 
1 26 28.9 
2 21 23.3 
3 5 5.6 
4 29 32.2 
Treatment     
Surgery alone 40 44.4 
Surgery +Adjuvant treatment 37 41.1 
Radiotherapy only 4 4.4 
Chemo+ Radiotherapy 9 10.0 
Table 11 shows the clinical details of all patients who completed questionnaires before treatment 
(n=90). 
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 Subsample:  
 
Table 12 and Table 13 present the clinical and socio-demographic information of a subset the total 
sample of participants who completed the questionnaires at both time points, i.e. before treatment 
and 6-12 months following treatment. 
 
HNC patients: From the 90 patients who completed questionnaires before treatment, 59 
completed the questionnaires at both time points (before treatment and 6-12 months following 
diagnosis). This represented a 67% response rate. There were no statistically significant differences 
between socio-demographics of patients who completed both time points compared to the 31 non 
respondents (p>0.05). However, 83% of the 31 non respondents had been diagnosed with 15loco-
regionally advanced disease, and were less likely to take part at time point 2 (see Table 12 which 
shows the clinical variables of patients who completed questionnaires at both time points) 
However, the sample at time point 2 was still equally proportioned in terms of stage of cancer 
(early stage n= 26, loco-regionally advanced n= 31) thus not significantly biased to early stage 
patients. The main reasons for patient attrition included; patient death n=12, patient ill health n= 
10, patient withdrew n=2, lost to follow n=7. 
 
Caregivers: From the 74 caregivers who completed questionnaires before treatment, forty 
(Partners n=30, family members n=10) completed questionnaires at both time points, representing 
a 54% (n=34) response rate.  There were no statistically significant differences between socio 
demographics of caregivers who completed both time points compared to the 34 non respondents 
(p>0.05). The main reasons for caregiver attrition included; patient death (n=12), partners ill health 
(n=6), incomplete questionnaire data (n=8), and loss to follow up where no questionnaire was 
returned (n=12)  
 
 
 
  
                                                          
15 Stage of disease was coded by based on the American joint committee on Cancer (AJCC), Early stage 
disease: Stage I, II Locoregionally advanced: Stage III or IV guidelines. These were coded by a HNC 
maxillofacial registrar to ensure clinical accuracy (Descher,D.G. & Day, T, 2008) .  
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Table 12 Clinical Variables of HNC patients in who completed both time points (n=59) and non -
respondents (n=31) 
   Non respondents (n=31) 
Clinical variables 
 (n=59) 
 
 
 P16-
value  
Cancer  %  % 0.04 
First Cancer 49 83.1 28 90.3  
Recurrence 11 18.6 3 9.7  
Site     0.54 
Oral cavity 27 45.8 15 48.4  
Oropharynx 16 27.1 7 22.6  
Nasopharynx 2 3.4 1 3.2  
Larynx 8 13.6 2 6.5  
Salivary gland 3 5.1 3 9.7  
Unknown primary 4 6.8 3 9.7  
Stage      0.01 
Early(stage I-II) 26 44.1 6 19.4  
Loco regionally advanced 
disease (stage III-IV) 31 
 
52.5 25 
 
80.6  
T classification     0.13 
     X 5 8.5 1 3.2  
1 21 35.6 5 16.1  
2 16 27.1 5 16.1  
3 2 3.4 3 9.7  
4 16 27.1 14 45.2  
Treatment     0.92 
Surgery alone 26 44.1 15 48.4  
Surgery +adjuvant treatment 25 42.4 12 38.7  
Radiotherapy only 3 5.1 1 3.2  
Chemo+ radiotherapy 6 10.2 3 9.7  
  
Table 12 shows the clinical variable for the subset of patients who completed questionnaires at 
both time points.   
                                                          
16 Fisher’s exact to examine the association between those that responded compared to non-respondents. 
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Table 13 Socio-demographics of HNC patients (n=59) and Caregivers (40) who completed questionnaires at 
both time points (before treatment and 6-12 months following diagnosis). 
 
Patient 
N=59  
Caregiver 
N=40  
Age grp  %  % 
18-59 25 42.4 22 55.0 
60-74 26 44.1 13 32.5 
75-95 8 13.6 5 12.5 
Gender     
Male 43 72.9 6 15.0 
Female 16 27.1 34 85.0 
Marital status     
Married/ living with partner 37 62.7 34 85.0 
Single 16 27.1 4 10.0 
Divorced/widowed 6 10.2 2 5.0 
Education     
None 25 42.4 10 25.0 
G.C.S.E/equivalent 17 28.8 13 32.5 
Higher Education 17 28.8 16 40.0 
Missing data 0 0.0 1 2.5 
Ethnicity     
White British/White other 51 86.4 37 92.5 
Black British/Black other 3 5.1 1 2.5 
Asian British/Asian other 4 6.8 2 5.0 
Other 1 1.7 0 0.0 
Employment     
Full time  / part time 21 35.6 21 52.5 
Unemployed 16 27.1 6 15.0 
Retired 20 33.9 12 30.0 
Not specified 2 3.4 1 2.5 
Religion     
No religion 22 37.3 16 40.0 
religion specified 37 62.7 24 60.0 
 
Table 13 shows socio-demographic details of patients and caregivers who completed study at both 
time points, before treatment and 6-12 months following treatment. 
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 Prevalence of psychological distress in HNC patients, partners and 
Caregivers 
 
We begin with the analysis of prevalence rates in the 90 patients and 74 caregivers who completed 
HADS questionnaire before treatment (Table 10 for socio-demographics and Table 11 clinical 
information on this participant sample).   
 
 Prevalence psychological distress in HNC patients before treatment 
 
Table 14 shows the prevalence rates of depression, anxiety and total psychological distress 
symptoms in HNC patients before treatment.  Scores of 8 or above were taken to indicate high 
symptoms of anxiety or depression (Zigmond & Snaith, 1983). The prevalence rates of patients with 
high symptoms (scores of 8 or above) of psychological distress before treatment ranged between 
20% and 41%.  
Table 14 Prevalence (%) of symptoms of depression, anxiety and total psychological distress before 
treatment  
 
 
 
 
 
 
 
 
 
 
 
 
 
 Patient Gender and psychological distress before treatment  
 
Before treatment, female HNC patients (n=25) showed significantly higher symptoms of anxiety; χ² 
(1,) = 10.33, p= 0.001) and total psychological distress; χ² (1,) = 6.19, p= 0.013 when compared to 
                                                          
 
 HNC patients 
N=90 
 17Cut off 
score 
N % 
    
HADS-Depression ≥ 8 18 20 
 0-7 72 80 
    
HADS-Anxiety ≥ 8 37 41 
 0-7 53 59 
    
HADS-Total psychological 
distress 
≥ 15 29 32 
 0-14 61 68 
 70 
 
male patients. There was no statistical difference between depressive symptoms (p>0.05).  Figure 12 
shows the proportion (%) of male and female patients with high symptoms of depression, anxiety 
and total psychological distress before treatment 
Figure 12 Male and Female HNC patients showing high symptoms of depression, anxiety and total 
psychological distress before treatment (n=90). 
 
Figure 12 shows female patients are reporting elevated symptoms of depression, anxiety and total 
psychological distress; however there was no statistical significance between depressive symptoms and 
gender of patient. 
 Prevalence psychological distress in caregivers of HNC patients before treatment 
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Figure 13 shows the prevalence rates of 18high levels of psychological distress between patients and 
caregivers before treatment. Caregivers showed significantly higher depression, anxiety and total 
psychological distress.  These differences were statistically significant (p<0.05)19 
 
Figure 13 Prevalence of high symptoms of depression, anxiety and total psychological distress before 
treatment in patients (n=90) and caregiver sample (n=74) 
 
 
 Comparing prevalence of psychological distress between HNC patients and their 
partners before treatment 
 
                                                          
18 Cut off scores 8 and above for depression and anxiety, 15 and above for total psychological distress 
 
19 Chi squared test showed a statistically significant difference in prevalence between patient and caregiver psychological distress. 
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Further analysis compared levels of psychological distress HNC couples (n= 50). The odds ratio for 
partner distress was 3.80 with a 95% confidence interval of 1.48-9.75. This suggests before 
treatment, partners’ were nearly 4 times more likely to report higher symptoms of depression than 
HNC patients. This was statistically significant at the .05 level.  The odds ratio values for anxiety and 
total psychological distress are shown in Table 15 where partners of HNC patients showed 
significantly higher proportion of psychological distress (depression, anxiety and total psychological) 
than HNC patients.  
 
         Table 15 Odds ratio of psychological distress between patients and partners 
 
 
 
 
 
 
 
 
 
 
Table 15 shows before treatment partners are showing significantly higher odds of showing 
elevated symptoms of depression, anxiety and total psychological distress than HNC patient. 
 
 
Figure 14 shows the levels of psychological distress before treatment in patients ranged between 
16% and 30% compared to 43% and 77% in their partner’s (n=50). These differences were 
statistically significant, suggesting partners are reported higher depression, anxiety and total 
psychological distress before treatment. When examining the prevalence rates of high levels of 
anxiety and depressive symptoms in HNC couples; patients who experienced high symptoms of 
depression (8 out of 50= 16% of total sample), 98% (7 out of the 8 patients) also had a partner who 
had high symptoms of depression (p>0.005).Also, from the 40% of patients (20 /50) who 
experienced high symptoms of anxiety, 85% (17 out of 20) also had a partner with elevated levels of 
anxiety (p>0.05).
                                                          
20 HNC Patients reference group.  
 
Partner OR 
N=50 
 
20OR 
[95% CI] P-value 
Depression 
  3.80 [1.48-9.75] 0.005 
Anxiety  4.26[1.83-9.97] 0.001 
Total psychological 
distress   4.53[1.95-10.51] 0.001 
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Figure 14 Prevalence of psychological distress in HNC patients and their Partners before treatment 
 
 * P ≤ 0.05 ** P ≤ 0.01 *** P ≤ 0.001 
Figure 14 shows before treatment, partners are showing statistically higher symptoms of depression, anxiety 
and total psychological distress when compared to HNC patient. 
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 Comparing prevalence rates of psychological distress within caregivers 
 
A sub group analysis examining the difference in prevalence levels between partners (n=50) and 
family member’s (n=24) was also undertaken. Results showed that before treatment partners were 
more likely to report elevated symptoms of depression, anxiety and total psychological distress 
than other family members. 
 
Figure 15 Prevalence of psychological distress in partners of HNC patients compare d to family members of 
HNC patients 
 
* P ≤ 0.05  
 
Figure 15 shows partners of HNC patients are showing higher symptoms of depression and total 
psychological distress than family members of HNC patients. The difference in prevalence levels were 
statistically significant 21(p<0.05). There was no statistical difference between levels of anxiety; both 
partner and family members are showing high symptoms before treatment. 
  
                                                          
21 Fisher’s exact test  
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 Prevalence levels of psychological distress in participants who 
completed HADS at two time points  
 Prevalence rates in HNC patients before treatment and 6-12 months following 
treatment 
 
Fifty-nine HNC patients (43 male, 16 female) completed the HADS questionnaire, before treatment 
and 6-12 months following diagnosis. Seventy-three per cent (n=43) of this sample were male with 
a mean age of 62 (SD 11.9, range 29-82). See Table 13, for socio-demographics of patients and 
Table 12 for clinical details. 
 
Table 16 shows a longitudinal assessment of HNC patients with clinically high levels of depression, 
anxiety and total psychological distress; before treatment and 6-12 months following diagnosis. 
Similar to the cross sectional analysis, patients prevalence rates of psychological distress before 
treatment ranged between 17% to 27%, however 6-12 months following diagnosis prevalence rates 
ranged between 25% and 32% There was no significant differences between gender and levels of 
psychological distress 6-12 months diagnosis (p>0.05). 
 
Table 16 Compares prevalence psychological distress in HNC patients who completed HADS before 
treatment and 6-12 months post treatment (n=59) 
 
Table 16 shows an increase in depressive symptoms, with a small decrease in anxiety and 
psychological distress 6-12 months following treatment. 
                                                          
22 HADS cut off scores as recommended by 22Zigmond and Snaith; where HNC patients have been grouped according to their scores on 
the HADS questionnaire. Scores 0-7 is within ‘normal range’ with scores 8 and above relating to a possible mood disorder. The total 
psychological distress indicates scores 15 above suggesting high levels of total psychological distress. 
 
 HADS  
Before treatment 
HADS  
6-12 months 
N=59 22Cut off 
score 
n %  
n 
 
% 
      
HADS-Depression ≥ 8 10 17 16 27 
 0-7 49 83 43 73 
      
HADS-Anxiety ≥ 8 24 41 19 32 
 0-7 35 59 40 68 
      
HADS-Total psychological 
distress 
≥ 15 16 27  
15 
 
25 
 0-14 43 73 44 75 
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 Prevalence of psychological distress in caregivers before treatment and 6-12 
months following treatment 
 
A total of 40 caregivers (30 partners, 10 family members) completed the HADS questionnaire at 
both time points (before treatment and 6-12 months following diagnosis). The majority of the 
sample was female (n=34, male; n-=6), with mean age of 58 (SD 12.5, range 31-85). 
 
(See Table 13 for socio-demographics of caregivers who completed HADS before treatment and 6-
12 months following treatment). 
 
Table 17 Prevalence of psychological distress in Caregivers before treatment and 6-12 months following 
treatment 
 
  
Table 17 shows a longitudinal assessment of caregivers with clinically high levels of depression, 
anxiety and total psychological distress; before treatment and 6-12 months following diagnosis. 
Similar to the cross sectional analysis, caregivers prevalence rates of psychological distress before 
treatment ranged between 38% and 58%. These high prevalence rates continued 6-12 months 
following diagnosis, with prevalence rates ranging between 28% and 60%. Longitudinal analysis 
showed caregiver’s reported higher symptoms of depression and anxiety than patients before 
treatment and 6-12 months following diagnosis.  These findings also highlight symptoms of 
psychological distress are not just transient reactions that occur following diagnosis. For a 
 HADS  
 
Caregivers  
N=40 
 
Before treatment 
 
6-12 months 
 Cut off 
score 
n %  
n 
 
% 
      
HADS-Depression ≥ 8 15 38 11 28 
 0-7 25 63 29 73 
      
HADS-Anxiety ≥ 8 30 75 24 60 
 0-7 10 25 16 40 
      
HADS-Total psychological 
distress 
≥ 15 23 58  
18 
 
45 
 0-14 17 43 22 55 
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proportion of caregivers, elevated symptoms continue 6 to 12 months, particularly symptoms of 
anxiety 
 Prevalence of psychological distress in HNC Couples before treatment and 6-12 
months following treatment 
 
Figure 16 shows longitudinal assessment of prevalence rates in HNC patients and their partners 
(n=30). Graph showed partners’ of HNC patients reported higher prevalence of depression, anxiety 
and total psychological distress before treatment and 6 to 12 months following treatment. These 
differences were statistically significant (p<0.05). Although, HNC partner’s levels of distress 
decreased slightly over time, it still remained higher than patients. At 6-12 months, prevalence 
levels of psychological distress ranged between 31% and 66%, compared to 20%and 23% in HNC 
patients.  
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Figure 16 Changes over time in the % prevalence of high HADS scores in HNC couples (n=30)   
 
   
  
 
Figure 16 shows the difference in prevalence of psychological distress between HNC patients, and their partners. Partners of HNC patients are showing 
higher levels of psychological distress than HNC patient before treatment (time point 1) which continues 6-12 months following diagnosis (time point 2).
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  Summary of prevalence of psychological distress 
HNC cancer patients reported high symptoms of psychological distress, before treatment and 6-12 
months following treatment. However, caregivers particularly the partner of the HNC patients is 
showing significantly higher symptoms of depression and anxiety than HNC patients at both time 
points. Partners are also showing significantly higher levels of psychological distress, when 
compared to family members. This highlight the different emotional experience partners may 
experience when compared to family members.  
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 The association of patient and caregiver psychological distress on HNC 
patients’ QoL  
 Descriptive Analysis: Patient QoL and Psychological distress 
 
Descriptive analysis showed before treatment, HNC patients with elevated symptoms of depression 
and anxiety reported lower mean QoL scores.  
 
 
Table 18 showed patients with high symptoms of depression and anxiety showed considerably lower 
mean scores within all four QoL domains, particularly physical QoL, when compared to patients with 
low symptoms of depression anxiety. 
                                                          
23 Depression: Patient Low depression: HADS-D:≤ 8; High depression : HADS-D≥8 
 
24 Anxiety: Patient low anxiety: HADS-A ≤8; patient high anxiety: HADS≥8 
Table 18 mean scores of patient QoL by their level of depression and anxiety symptoms (n=90) 
   HNC patient psychological distress  
   23Depression 
   Low  
(n=72) 
High  
(n=18) 
Patient Quality of 
life 
WHOQOL-BREF 
 Domains  
 Mean SD Mean Std. Dev. 
  Physical  71.42 (19.34) 44.39 (25.14) 
  Psychological  68.94 (13.62) 51.11 (14.00) 
  Social relationships  78.75 (17.07) 58.39 (22.78) 
  Environment  78.72 (15.06) 58.50 (18.52) 
  24Anxiety 
 
   Low 
(n=53) 
High 
(n=37) 
  Physical  71.96 (20.64) 57.49 (24.21) 
  Psychological  66.58 (14.03) 63.65 (17.20) 
  Social relationships  78.23 (19.39) 69.59 (19.94) 
  Environment  77.62 (16.66) 70.46 (18.45) 
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 Descriptive Analysis: Patient QoL and Caregiver Psychological distress 
 
Similarly, Table 19 showed HNC patients with a caregiver reporting high symptoms of depression or 
anxiety, also showed lower mean scores in the physical, psychological, social relationship and 
environment QoL domains (before treatment). This difference is particularly evident when 
compared to patients who had a caregiver showing low symptoms of anxiety and depression. 
Scores were particularly lower within the social relationships domains, suggesting the impact on 
patient’s personal relationships, perceived social support and intimacy. High depressive scores in 
caregivers showed a greater decline in patients QoL when compared to high anxiety scores. 
  
                                                          
25 Depression: Patient Low depression: HADS-D:≤ 8; High depression : HADS-D≥8 
 
26 Anxiety: Patient low anxiety: HADS-A ≤8; patient High anxiety: HADS≥8 
Table 19 Before treatment: Mean and SD scores of patient QoL by level of depression and anxiety 
symptoms caregivers   
   Caregiver psychological distress  
N=74 
   25Depression 
Patient Quality of 
life 
  Low  
(n=72) 
High  
(n=18) 
 WHOQOL Domain   Mean SD Mean Std. Dev. 
  Physical  73.24 17.25 57.83 24.28 
  Psychological  68.33 14.08 61.54 11.16 
  Social relationships  80.72 14.97 67.75 24.02 
  Environmental   80.35 13.94 68.88 19.77 
   
  26Anxiety 
 
   Low 
(n=53) 
High 
(n=37) 
  Physical  72.82 14.16 65.73 23.39 
  Psychological  68.27 14.32 64.96 13.08 
  Social relationships  80.41 14.97 74.38 21.01 
  Environmental   79.73 14.97 74.90 17.72 
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 Testing the association between patient and caregiver psychological distress 
before treatment and patient QoL (Testing hypothesis i and ii) 
 
A univariate regression analysis was undertaken to construct a statistical model to predict  the 
impact of each  of the following 27psychological factors: 1) Patient anxiety (HADS-A), 2) Patient 
depression (HADS-D), 3) Patient total psychological distress(HADS-T) 4) caregiver anxiety (HADS-A) 
5) Caregiver depression (HADS-D) 6) caregiver total psychological distress HADS-T  on the four 
28WHOQOL-BREF domains: physical , psychological, social relationships and environment:  (outcome 
measures). A stepwise modelling approach was performed, where each psychological factor that 
was significantly associated (0.05 levels) with each QoL domain, was entered into a multivariate 
model. The aim of the model was to identify psychological factors that were most strongly 
associated with patient QoL before treatment.  
 
3.3.3.1 Univariate Model examining the association between patient psychological 
distress, caregiver psychological distress and patient QoL 
 
Table 20 shows the univariate analysis of the statistically significant associations between 
psychological factors and patient quality of life. 
The findings of the univariate analysis showed there was a statistically significant association 
between patients with high symptoms of depression, anxiety and total psychological distress before 
treatment and their physical quality of life, suggested an impact of psychological distress on 
patients QoL. This association was still present, when adjusted for patient gender and age. 
This association was also shown in the psychological, social relationships and environment domains 
(p<0.05). Patient anxiety was also statistically associated with physical, social relationships and 
                                                          
27 Psychological factors measured by cut off scores of the Hospital depression and anxiety scale : Anxiety :HADS-A, Depression  HADS-D, 
Total psychological distress  
 
28 The WHOQOL -Bref domains were log transformed to allow a linear regression model to be fitted to the data. When the scale was 
transformed due to the negative skew of the data, the scale was transformed and converted the negative beta coefficients to represent a 
positive change i.e. negative coefficient shows better quality of life. Thus the direction of change in the transformed variables are 
represented by negative coefficient meaning a positive change and a positive coefficient meaning a decrease in quality of life scores.   
 To make the transformed beta coefficients clinically meaningful the coefficients were back transformed to represent a percentage 
change. This percentage change allowed interpreting the effect of the variable on the outcome variable and is a standard procedure 
when transforming variables. 
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environment domain, however there was no association between patient anxiety and the 
psychological domain of WHOQOL-BREF (p>0.05).  
Also univariate analysis showed a statistical significant association between patients QoL and 
Caregiver depression. This suggests patients who had a caregiver reporting high symptoms of 
depression before treatment, were reporting significantly lower QoL. 
Table 20 shows HNC patients are reporting 35% lower scores within the physical quality of life 
domain [β%=35, CI95% 21-46, P<0.01] when they had a caregiver who had high symptoms of 
depression before treatment. Caregiver depression was also significantly associated with patients 
psychological, social relationship and environment QoL domains (p<0.01). There was no association 
between caregiver anxiety and patients QoL (P>0.05).  
Table 20 univariate statistical associations between psychological factors and patient quality of life 
(outcome) 
WHOQOL-BREF 
domain 
    
 N Predictor variables: 29Percentage 
Change [95%CI] 
p value 
Physical  
 
    
 90 Patient Depression 35  [21-46] 0.01 
 90 Patient Anxiety 22  [9-34] 0.01 
 90 Patient Total Psychological Distress 36  [26-45] 0.01 
 74 Caregiver  Depression  22   [8-35] 0.01 
     
Psychological 
 
    
 90 Patient Depression 27  [17-36] 0.01 
 90 Caregiver Depression 13  [2-23] 0.02 
 74 Caregiver Total Psychological Distress 10  [1-21] 0.06 
     
Social 
Relationships  
    
 90 Patient Depression 27  [14-38] 0.01 
 90 Patient Anxiety 15  [1-26] 0.03 
 74 Caregiver Depression 18  [4-30] 0.02 
 74 Caregiver Total Psychological Distress 15  [0-27] 0.05 
     
Environmental 
 
    
 90 Patient Depression 32  [20-43] 0.01 
 90 Patient Total Psychological Distress 30  [20-39] 0.01 
 90 Patient Anxiety 14  [0-26] 0.05 
 74 Caregiver Depression  20  [5-32] 0.01 
                                                          
29Percentage change represents the  back transformed regression coefficient:  
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3.3.3.2 Multivariate model examining the association of patient depression and 
caregiver depression, on patient QoL (adjusted for age and gender).  
 
The multivariate analysis included the variables that were significantly associated with patients low 
QoL from the univariate analysis shown in Table 20. Due to small sample size, multivariate analysis 
was limited to the number of variables that could be entered into the model. Therefore, patient 
depression and caregiver depression were entered in the same model. The results showed 
caregiver depression was still significantly associated with patients physical QoL [30β% 17, 95% CI 1-
31, P=0.04].   This suggested caregiver depression is showing an independent association with 
patients physical QoL, even when patient depression is within the same model (Table 21). However, 
there was no statistical significant association between caregiver depression and patients 
psychological, social and environmental domain) before treatment when patient depression was 
added to the model. (p>0.05). This may be due to small sample size, reducing the statistical power 
of the model.  
  
                                                          
30 Β% represents percentage change 
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Table 21 Adjusted β% model of patient and caregiver depression and QoL domains 
 
WHOQOL-BREF 
domain 
   
  
 
Predictor variables: 
Percentage 
Change 
[95%CI] 
 
p-value 
Physical  
n=74 
   
 *Patient Depression 20   [0-36] 0.05 
 *Caregiver  Depression  17   [1-31] 0.04 
    
Psychological 
n=74 
   
 *Patient Depression 19  [6-31] 0.01 
 Caregiver Depression 7    [-5-18] 0.23 
    
Social 
relationships  
n=74 
   
 Patient Depression 15 [-6-32] 0.14 
 Caregiver Depression 14 [-3-28] 0.09 
    
Environmental 
n=74 
   
 *Patient Depression 26 [7-41] 0.01 
 Caregiver Depression 12 [-5-26] 0.15 
*Statistically significant associations 
 
Table 21 shows the multivariate model found patient depression and caregiver depression had an 
independent association with patient QoL before treatment. However, the table showed, both 
factors (patient and caregiver depression) remain significant when tested within the same model. 
There was no significant association between caregiver depression and the psychological, social 
relationships and environment domain (p>0.05). 
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Table 22 showed the final model, comparing the univariate model (unadjusted model) percentage 
change scores with multivariate model percentage change scores (adjusted model).   
 
Table 22 shows the unadjusted and adjusted percentage change [95% CI] in physical QoL for patient and 
caregiver depression (adjusted for patient age and gender). 
 
Table 22 shows patients depression contributes the most significantly to patients physical QoL (20 
per cent change in QoL) however multivariate analysis found caregiver depression has an 
independent association thus contributing to this association. These associations were still present 
when adjusted for patient age. 
 
 
To assess this association further, a pathway and mediation analysis was undertaken. This aimed to 
assess the amount of variance caregiver depression contributed to patient physical quality of life 
and establish direction of effect. 
  
WHOQOL-
BREF  
Predictor 
variables 
Percentage 
Change 
[95%CI] 
 
Unadjusted 
  
 
 
 
 
p-value 
Percentage 
Change 
[95%CI] 
 
Adjusted 
 
 
 
 
 
p-value 
Physical:  
n=74 
 
 
Patient 
depression 
 
 
 
35  [21-46] 
 
 
 
0.01 
 
 
 
20 [0-36] 
 
 
 
0.05* 
  
 
Caregiver 
depression 
 
 
22  [8-35] 
 
 
 
0.01 
 
 
17 [1-31] 
 
 
0.04* 
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 Path analysis 
A path analysis was conducted to provide estimates of the magnitude and significance of the 
hypothesised causal connections between patient depression, caregiver depression and patient 
physical quality of life. The path diagram in figure 16 shows the standardised β coefficients between 
these associations on the 31log transformed scale. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17 shows a path analysis diagram with standardised parameters (p<0.05). Arrows represent 
the direction of the significant associations. Width of arrows varies according to strength of 
association to aid interpretation. 
 
 
Path analysis showed  a strong correlation between patient and caregiver depression, and  an 
independent significant association between caregiver depression and patient physical quality of 
life and an independent significant association between caregiver depression and patient physical 
quality of life .To examine these associations further, a mediation analysis was conducted.
                                                          
31 The WHOQOL- bref was log transformed, when the scale was log transformed due to the negative skew of the original WHOQOL-BREF 
domains, the scale was transformed and converted the negative coefficients to represent a positive change i.e. negative coefficient shows 
better quality of life. Thus the direction of change in the transformed variables represent the following;  negative coefficient meaning a 
positive change i.e. better quality of life, and a positive coefficient meaning a decrease in quality of life scores. 
 
Figure 17 Path analysis diagram showing the associations between patient depression, caregiver depression and 
patient physical QoL 
0.24* 
0.18* 
0.49* 
*P<0.05 
Patient 
Depression 
Patient Physical 
QoL 
Caregiver 
depression 
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 Mediation Analysis: 
 
A mediation analysis was conducted in 32STATA 12 using the 33medeff command.  
Results of the mediation analysis show the standardized indirect effect was 0.26 [95% CI 0.15-0.75], 
this indirect effect was statistically significant p<0.10.This suggests that 26% of the total effect of 
patient depression and patient physical QoL was mediated by caregiver depression (Figure 18). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18 illustrates the relationship between patient depression and patient physical QoL was 
mediated by caregiver depression. 
 
 
The mediation analysis suggested that before treatment, if patients have a caregiver with 
depression in addition to their own depression- they are more likely to report lower physical 
QoL(before treatment) compared to patients who do not have a distressed caregiver.  
 
                                                          
32 StataCorp. 2011. Stata Statistical Software: Release 12. College Station, TX: StataCorp LP. 
 
33  medeff is the command for estimating mediation effects for a variety of data types.  For a continuous mediator variable and a 
continuous outcome variable, the results will be identical to the usual Baron and Kenny method.  The command can however, 
accommodate other data types, including binary outcomes and mediators, and   calculate the correct estimates. 
 
MV: 
Caregiver 
depression 
Patient 
Depression 
Patient Physical 
QoL 
Figure 18 Standardised regression coefficients for the relationship between patient depression and 
patient physical quality of life as mediated by caregiver depression 
 
 
 
 
 
 
 
26% 
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 Does psychological distress before treatment predict QoL 6-12 months 
following diagnosis? (Longitudinal analysis: testing hypothesis 3 and 4) 
 
A descriptive analysis looked at the patterns across mean scores, followed by a regression analysis 
to test the association between psychological distress before treatment and patient QoL 6-12 
months following diagnosis. 
 
 Descriptive analysis: Patient psychological before treatment and patient QoL 6-12 
months following diagnosis. 
 
HNC patients who reported 34high symptoms of depression before treatment, reported lower mean 
scores in all four quality of life domains 6-12 months following diagnosis. The following graphs show 
the mean patient QoL scores for each domain; physical Figure 19, psychological, Figure 20, social 
relationships Figure 21 and environment domain Figure 22 by scores of patients depressive 
symptoms before treatment.  
  
                                                          
34 Depression: High levels of depressive symptoms are based on a score of 8 or above on the Hospital anxiety 
and depression scale (HADS).  Patient low depression is based on a score of 0-7 on the HADS. 
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Figure 19 changes over time in PHYSICAL QoL in patients with high depression compared with 
patients with low depression scores.  
 
 
Figure 19 shows a decline in physical QoL over time in both high and low depression groups. 
However, patients had high symptoms of depression before treatment reported lower mean scores 
6-12 months following diagnosis than patients who reported low depressive symptoms. 
 
Figure 20 changes over time in PSYCHOLOGICAL QoL in patients with high depression scores before 
treatment 
 
 
Figure 20 shows patients with low scores of depression before treatment show no change in mean score 
within the psychological QoL domain 6-12 months following diagnosis. In contrast, patients who reported 
high symptoms of depression before treatment reported lower mean scores at both time points. 
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Figure 21 changes over time in SOCIAL RELATIONSHIPS in patients with high depression scores before 
treatment 
 
 
Figure 21 shows a decline in the social relationships domain for patients in the high and low 
depression groups. However, patients in the high depression group showed lower mean scores at 
both time points. 
 
Figure 22 changes over time in ENVIRONMENT QoL in patients with high depression scores before 
treatment 
 
 
Figure 22 shows a decline over time for patients in the high and low depression group, however patients with 
high depression scores before treatment showed lower mean scores 6-12 months following diagnosis. 
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 Descriptive analysis: Caregiver (partner only) psychological distress before 
treatment and patient QoL 6-12 months following diagnosis. 
 
HNC patients who had partner (n=30) reporting high symptoms of depression before treatment, 
reported lower QoL over time. The following graphs show patient QoL scores over time by level of 
depressive symptoms in partners before treatment. Patients mean physical QoL is presented in 
Figure 23, Psychological in Figure 24, Social relationships in Figure 25 and environment domain in 
Figure 26. 
 
 
Figure 23 changes over time in patients PHYSICAL QOL by PARTNER depression scores before 
treatment 
 
 
Figure 23 shows patients who had with partner with high symptoms of depression before 
treatment were showing lower physical QoL 6-12 months following diagnosis.  
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Figure 24 changes over time in patients PSYCHOLOGICAL QOL by PARTNER depression scores before 
treatment 
 
 
Figure 24 shows patients who had a partner with low depression before treatment, had better 
psychological QoL 6-12 months following diagnosis. In contrast, patients whose partner reported 
high symptoms of depression before treatment, showed lower psychological QoL over time. This 
particularly highlights the negative impact of partners’ depressive symptoms on patients 
psychological wellbeing. 
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Figure 25 changes over time in patients SOCIAL RELATIONSHIPS by PARTNER depression scores before 
treatment 
 
 
Figure 25 shows patients reported lower scores at 6-12 months in the social relationships domain, when they 
had a partner who reported high symptoms of depression before treatment. 
 
 
Figure 26 changes over time in patients ENVIRONMENT QOL by PARTNER depression scores before 
treatment 
 
 
Figure 26 shows lower scores within the environment domains when patient’s partner is 
showing high symptoms of depression at diagnosis.
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 Testing the association between patient psychological distress and 
caregiver psychological distress before treatment on patient QoL 6-12 
months following diagnosis (Testing hypothesis iii and iv) 
 
The results of the univariate regression analysis addressing patient psychological distress before 
treatment and patient QoL 6-12 months following diagnosis indicated patients with high 
psychological distress showed lower QoL in the physical, psychological, and environment domains 6-
12 months following diagnosis (Table 23). This suggests patient’s psychological distress before 
treatment is associated with their QoL 6-12 months following diagnosis. There was no association 
between patient depression before treatment and the social relationships domain 6-12 months 
following diagnosis.  
 
Table 23 Showing the association between depression before treatment (time point 1) and quality of life 
domains 6-12 months following diagnosis (time point 2), n=59. 
 
Table 23 shows the percentage change and 95% confidence intervals for each QoL domain by 
patients’ depressive symptoms before treatment. 
 
A second univariate analysis indicated that partner’s with elevated depressive symptoms before 
treatment was associated with patient QoL 6-12 months following diagnosis, see Table 24. Findings 
showed, patients were reported 29% lower scores in physical QoL, and 29% lower scores in 
psychological QoL 6-12 months post diagnosis (p<0.05). 
Predictor variable     
Patient Depression 
Before treatment  
Patient QoL 
6-12 months 
N Percentage 
Change 
[95%CI] 
p-value 
 Physical 59 30[1-51] 0.04* 
     
 Psychological 59  35 [13-51] 0.01* 
     
 Social Relationships 59 19 [-7 to 39] 0.13 
     
 Environment 59 33[7-51] 0.02* 
 96 
 
 
Table 24: Showing the association between depression in HNC couples and quality of life 6-12 months 
following diagnosis, n=30. 
 N=30 
Patient QoL Domain Predictor Variable  Percentage 
Change [95%CI] 
p-value 
Physical Patient depression  34 [-2-57] 0.06 
 Partner depression  29 [3-49] 0.03* 
     
Psychological Patient depression  36 [6-57] 0.02* 
 Partner depression  29 [5-47] 0.03* 
     
Social Relationships Patient depression  26 [-3 to 47] 0.08* 
 Partner depression  19[-4 to 37] 0.10 
     
Environment Patient depression  36[2-59] 0.04* 
 Partner depression 
 
 16[-16 to 39] 0.29 
 
*p<0.05  
Table 24 shows the percentage change and 95% confidence intervals for each QoL domain by 
patients depressive symptoms before treatment. 
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 Summary of patient and caregiver psychological distress on HNC 
patients’ QoL  
 
A significant association between psychological distress and patient QoL was found at each of the 
data collection points.  
 
Testing Hypothesis i and Hypothesis ii: Psychological distress and patient QoL before treatment. 
 
The univariate model showed that; patients with high depression and high anxiety reported lower 
QoL within all four domains. Elevated depressive symptoms showed the strongest statistical 
association (p<0.001).  Caregiver depression was also significantly associated with lower patient 
QoL in the physical, psychological, social relationships and environment quality of life domains 
(univariate model). 
 
A multivariate model (adjusted for patient age and gender) showed patients with high symptoms of 
depression and caregivers with high symptoms of depression were both independently associated 
with patients physical QoL (p<0.05) when tested within the same regression model. The 
multivariate model showed no statistical association between caregiver depression and the 
psychological, social relationships and environment domain, however, descriptive statistics showed 
clinically meaningful differences in mean scores with those  patients who had a caregiver showing 
elevated symptoms of depression before treatment, report lower mean scores within the physical, 
psychological, social relationships and environment domains (Table 19).  To examine the direction of 
these associations, pathway and mediation analyses were conducted. A mediation analysis 
suggested that before treatment, if patients had a caregiver with depression in addition to their 
own depression, they were more likely to report lower physical QoL(before treatment) compared to 
patients who did not have a distressed caregiver (p<0.05). This provided evidence and supported 
hypotheses i and ii which proposed that before treatment, patients have poorer quality of life if 
HNC patients and their caregivers have high levels of psychological distress. 
 
The results found an association between psychological distress and patients QoL but more 
significantly highlighted the influence of caregiver depression on patients physical QoL, which has 
not been previously shown within HNC.  
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Testing hypotheses iii and iv: Psychological distress before treatment and patients QoL 6-12 
months following diagnosis. 
Due to limitations in sample size, it was not possible to undertake multivariate analyses on model 
two, thus these findings are based on an unadjusted univariate model. The statistical model 
showed there was an association between psychological distress before treatment and patient QoL 
6-12 months following diagnosis within all four QoL domains. This model supported the proposed 
hypothesis which predicted patients who show elevated depression before treatment will show 
poorer quality of life at 6-12 months post diagnosis. There was also a univariate analysis indicated 
patients who had a partner with elevated depression before treatment showed poorer QoL 6-12 
months post diagnosis, providing further support for proposed hypotheses iii and iv. 
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 Role of socio-demographic and Clinical factors on patient QoL 
 
The previous results sections 3.2 to 3.8 described the sample and reported on the associations 
between psychological distress in patients and caregivers and patients QoL. This section 
investigates the association between socio-demographic factors and clinical variables on patients 
QoL. Although, not the primary aim of this thesis, it was important to examine the role of these 
factors on patient QoL. 
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 Descriptive Analysis: Patient QoL and Socio demographic variables 
 
In total, 90 HNC patients completed the WHOQOL-BREF self-report measure before treatment.  The 
total sample ranged between the ages 27-94, with patients predominantly White British, male with 
mean age of 64. Sixty-six per cent were married or living with a partner (see Table 10, for patient 
socio-demographics).The clinical variables of the patient sample showed the majority being newly 
diagnosed (85%), with 46% having a diagnosis of cancer of the oral cavity  (Table 11,for patient 
clinical factors). 
 
The mean scores for the four QoL domains (WHOQOL-BREF; scale 0-100) by patient demographic 
variables are displayed in Table 25. The table also shows the overall mean score and 95% 
confidence interval for each domain for the total sample (n=90). 
 
Table 25 Socio-demographics and HNC patients’ Quality of life before treatment (n=90) Mean and SD of 
WHOQOL-BREF domains  
  WHOQOL-BREF Domains  
 
  Physical Psychological Social relationships Environmental 
  Mean 95% CI Mean 95% CI Mean 95% CI Mean 95% CI 
Overall Mean Score for HNC 
patients 
N=90 66.01 61.60-
70.87 
65.38 60.15-
68.60 
74.68 65.50-
78.86 
74.68 70.98-
78.38 
 
Socio-demographics 
  
         
Age N Mean SD Mean SD Mean SD Mean SD 
18-59 32 66 23.19 65.91 15.77 65.91 15.77 72.19 18.00 
60-74 38 70.05 23.62 67.53 14.59 67.53 14.59 76.71 19.30 
75-95 20 57.35 20.96 60.45 15.94 60.45 15.94 74.80 13.85 
Gender                   
Male 65 67.43 23.32 66.37 13.72 75.88 19.42 75.55 16.28 
Female 25 62.32 22.88 62.80 19.15 71.56 21.42 72.40 21.09 
Education                   
None 41 60.32 22.11 64.15 14.77 73.46 19.86 73.61 15.92 
G.C.S.E/ALEVEL/Equivalent 26 66.42 24.68 65.92 18.28 73.12 17.82 73.04 20.99 
Higher Degree 22 74.86 20.93 66.86 13.57 77.91 22.94 77.73 16.86 
Marital status                   
Married/Living with partner 59 68.15 23.13 66.46 13.43 76.37 19.51 77.37 16.67 
Single 18 71.89 18.48 69.50 15.93 75.39 17.61 76.61 14.57 
Divorced/Widowed 13 48.15 22.27 54.77 19.29 66.00 24.11 59.77 19.79 
Ethnicity                   
White British/White Other 75 68.71 21.08 65.95 14.72 75.77 19.01 77.35 15.99 
Ethnic Minority 15 52.53 28.90 62.53 18.69 69.20 24.21 61.33 20.15 
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Table 25 shows, patients aged 75 and over, those who were divorced or widowed, ethnic minority 
patients and patients with lower education are showing lower mean scores across the four QoL 
domains.  The statistical significance of these differences is shown in Table 26. Divorced and 
widowed patients showed particular low scores within the social relationships domain. The table 
showed small differences in all four QoL domains between single patients and those with a partner.  
 
Table 26 univariate linear regression model of statistically significant socio-demographic variables 
and 35patient QoL before treatment 
N=90     
Quality of life 
domain 
Socio-demographic  
 
Predictor variable 
 
36Percentage 
change 
95%[CI] 
p value 
Physical     
 Age 75+ 22[4-37] 0.07 
 Education Higher degree -32 [-62 to -8] 0.03 
 Marital status Widowed/Divorced 29 [10-43] 0.01 
 Ethnicity Ethnic Minority 22 [3-37] 0.02 
     
Psychological     
 Marital Status 
 
Widowed/Divorced 16 [2-30] 0.03 
Environmental     
 Ethnicity Ethnic Minority 27 [10-39] 0.01 
 Marital status Widowed / Divorced 28 [11-42] 0.01 
     
 
Table 26 shows, patients aged 75 and over (n=20) had a 22 per cent lower score in the physical QoL 
domain when compared to patients 18-59 (n=32), and patients aged between 60 and 74 (n=38). 
Also patients with a higher degree reported 32%37reported better physical QoL when compared to 
patients with no qualifications and G.C.S.E/Equivalent. Also In the physical domain, widowed or 
divorced patients showed 29% lower physical QoL, when compared to patients who were married 
or living with a partner. This association was also shown within the psychological and 
environmental domain. Ethnic minority patients were also reporting 22% lower physical health than 
White British/ White other patients, and 27% lower environment QoL. There was no statistically 
                                                          
35 No significant statistical association between socio-demographic variables and social relationships. 
 
37 For regression modelling to take place the WHOQOL- bref was log transformed, this was then back transformed to give a percentage 
change in coefficient values. When the scale was log transformed due to the negative skew of the original WHOQOL-BREF domains, the 
scale was transformed and converted the negative coefficients to represent a positive change i.e. negative coefficient shows better quality 
of life. Thus the direction of change in the transformed variables are represent; negative coefficient meaning a positive change i.e. better 
quality of life, and a positive coefficient meaning a decrease in quality of life scores The standard interpretation of coefficients in a 
regression analysis is that a one unit change in the independent variable results in the respective regression coefficient change in the 
expected value of the dependent variable while all the predictors are held constant. Interpreting a log transformed variable can be done in 
such a manner; however, such coefficients are routinely interpreted in terms of percent change  
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significant association between; gender and the four WHOQOL domains, (p>0.05), or age and the 
psychological, social relationships or environmental domains (p>0.05). Also, there was no significant 
statistical difference between educational level and the psychological, social relationships and 
environment domain of QoL (p>0.05).  
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 Clinical variables and Quality of life  
Descriptive data for clinical variables and patient QoL before treatment is summarised in Table 27. Table presents the mean and SD for each QoL domain 
by clinical variables before treatment. 
Table 27 Clinical variables and HNC patients’ Quality of life:  Mean and SD of WHOQOL-BREF domains before treatment 
N=90  WHOQOL- BREF domains  
 
Clinical Variables  Physical Psychological Social relationships Environment 
              
   Mean SD  Mean SD  Mean SD  Mean SD 
Cancer First Cancer  66.35 22.99  65.53 15.49  75.35 18.45  74.61 17.05 
  Recurrent cancer  64.00 25.17  64.46 15.37  70.69 27.93  75.08 21.84 
Stage of Cancer Early stage  71.53 25.20  67.20 13.15  79.40 13.44  77.6 15.83 
  Loco-regionally advanced  62.95 21.94  64.70 16.76  72.57 22.70  72.75 18.97 
SCC SCC  66.47 23.43  66.13 15.39  75.33 19.51  75.31 17.34 
  Not SCC  63.00 22.18  60.50 15.15  70.42 23.21  70.58 20.09 
Site of Cancer  Oral Cavity  68.88 20.94  65.32 16.48  79.29 16.27  77.61 17.21 
  Oropharynx  65.35 24.44  66.17 15.5  71.48 24.96  73.52 17.97 
 38Other-  61.25 26.39  64.67 14.58  69.58 20.23  70.25 18.57 
 
Table 27 shows before treatment, there were small differences in mean scores across the four quality of life domains. The largest differences were found 
between site of cancer and stage of cancer which are shown in Figure 27 and Figure 28. However, the differences in site of cancer may be explained by the 
grouping of the variable, as the other category contained a heterogeneous HNC sites (nasopharynx, larynx, and salivary gland) which we were unable to 
analyse separately due to small size.
                                                          
38 nasopharynx, larynx, salivary gland 
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Figure 27  Clinical Variables and Patient QoL before treatment: Site of Cancer 
 
 
 
Figure 27 shows patients diagnosed with cancer in the 39nasopharynx, larynx, and salivary gland are 
reporting slightly lower mean scores in all four domains, however these differences were not 
statistically significant (p>0.05) 
                                                          
39 These sites were grouped into one category due to small patient numbers within each site.  
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Figure 28 Mean scores of stage of cancer and patients QoL before treatment (n=90)  
 
 
*40p=0.06 (trend towards significance)41 
 
Figure 28 shows before treatment, patients with loco-regionally advanced disease are reporting 
lower mean scores within all four quality of life domains. There was no statistical difference within 
the physical, psychological, social relationships and environment domain however the physical 
domain did show a trend towards significance [40β%=16, 95% CI -1 to 30, p=0.06].  
 
 
 
 
                                                          
40 Regression analysis (β represents percentage change of back transformed coefficient) 
 
 
71
67
79 77
*62 64
72 72
0
10
20
30
40
50
60
70
80
90
Physical Psychological Social
Relationships
Environment
M
e
an
 S
co
re
Quality of life domains
Stage of Cancer
Early stage
Loco-regionally advanced
n=90
 106 
 
 HNC patients QoL before treatment and 6-12 months following diagnosis 
 
Fifty-nine HNC patients completed the QoL measure before treatment and 6-12 months following 
treatment Table 28 presents the mean, median and standard deviation (SD) of QoL scores over the 
two time points. The largest decline in QoL is shown within the physical QoL domain, followed be 
social relationships domain, which shows a 10 point change in its mean score (p<0.001). 
 
Table 28 shows the mean, median and SD of changes in patients scores before treatment and 6-12 months 
post diagnosis: (N=59) 
N=59 Before Treatment 6-12 months  
WHOQOL-BREF-Domain: 42Median Mean SD Median Mean SD 43P-value 
Physical  81 72.26 21.57 56 53.32 13.17 
 
0.001* 
Psychological  69 68.21 13.4 69 66.75 21.92 0.80 
Social relationships 75 76.67 20.05 70 68.23 24.42 0.001* 
Environmental  81 78.26 15.09 75 72.68 22.31 0.001* 
 
Table 28 shows there was a statistically significant difference before treatment compared to scores 
6-12 months following diagnosis in the physical, social and environmental QoL domain. In the total 
sample, there was no difference over time within the psychological domain. 
 
 Changes in mean scores of patient QoL by clinical variables 
 
Table 29 presents descriptive mean scores showing the changes in patients’ QoL before treatment 
and 6-12 months following diagnosis based on clinical variables.  
                                                          
42 The WHOQOL-BREF questionnaire was not normally distributed, hence the descriptive table presents the median values of each 
domain. Many studies have presented the Mean values of the WHOQOL-BREF (including the authors of the questionnaire) therefore to 
allow for comparisons across the research, both median and mean values of each domain have been presented.   
 
43 Statistical differences measured by non -parametric test the Wilcoxen matched paired test as the WHOQOL-BREF was not normally 
distributed.  
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Table 29 Descriptive statistics (N, Mean and standard deviation) showing HNC patient QoL by clinical variables over two time points (n=60) 
                                                          
44 The missing 12 patients under went, chemo-radiotherapy (this group was excluded from the analysis due to small sample size. 
45 Nasopharynx, larynx, salivary gland and unknown primary were grouped into one category due to small sample size of individuals sites. 
WHOQOL-BREF Domains 
  Physical Psychological Social relationships Environmental 
  Mean  
(SD) 
Mean 
(SD) 
Mean 
(SD) 
Mean 
(SD) 
Clinical Variables  N Before 
Treatment 
6-12 
months 
Before 
Treatment 
6-12 
months 
Before 
Treatment 
6-12 
months 
Before 
Treatment 
6-12 
months 
Treatment          
Surgery alone  23 70.52 54.26 65.65 62.87 72.35 67.96 78.48 72.13 
  (25.40) (13.48) (13.90) (25.33) (24.00) (27.98) (17.70) (23.92) 
Surgery & adjuvant   25 75.64 54.32 71.40 71.12 83.24 70.08 79.44 74.40 
  (18.37) (11.57) (11.59) (18.40) (12.11) (20.55) (13.21) (23.17) 
44Missing data 12         
Site:          
oral cavity 25 73.88 53.60 67.60 68.80 79.28 73.80 81.00 73.88 
  (19.44) (13.91) (14.90) (21.90) (16.54) (22.47) (12.06) (18.13) 
Oropharynx 15 70.53 53.47 69.73 70.20 77.13 65.57 75.93 72.27 
  (26.70) (9.36) (11.91) (20.20) (24.06) (24.03) (19.48) (25.87) 
45other-  20 71.94 52.94 68.06 59.44 71.88 61.06 76.00 69.67 
  (21.31) (15.96) (13.34) (23.59) (22.03) (27.48) (15.47) (26.04) 
Cancer          
First cancer 50 74.19 54.53 69.81 68.17 78.87 70.57 79.19 72.67 
  (19.69) (13.36) (12.55) (19.81) (16.83) (21.67) (13.05) (22.10) 
Recurrence 10 63.20 47.60 60.70 60.10 66.30 57.50 73.90 72.70 
  (28.37) (11.04) (15.37) (30.42) (30.16) (33.79) (22.83) (24.50) 
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Table 29 shows a decline in mean scores within the QoL domains over the two time points. However, the differences within the clinical variables were 
small. For example, 6-12 months following treatment, there was no difference in physical QoL between patients who underwent surgery compared to 
patients who underwent surgery and adjuvant treatment.  There was a very small difference in mean scores within the physical domain and site of cancer. 
The largest difference in mean scores was shown between site of cancer and the psychological domain and social relationships domain; where patients 
within the: Nasopharynx, larynx, salivary gland and unknown primary group showed a decrease in mean scores, particularly when compared to Oral cavity 
patients. Also, patients with recurrent cancer, showed lower mean scores within all four QoL domains 6-12 months following diagnosis. In contrast to time 
point 1, there were small differences in the mean scores between early and loco-regionally advanced disease patients. 
 
 
  
                                                          
46 Staging based on *Descher,D.G. & Day, T, (2008)  American joint committee on Cancer (AJCC), Early stage  disease: Stage I,II Locoregionally advanced: Stage III or IV 
 
46Staging          
Early 24 76.67 55.13 69.92 68.58 80.50 73.79 79.83 75.09 
  (18.97) (14.69) (9.39) (22.58) (12.28) (24.73) (12.53) (22.78) 
Loco regionally advanced 30 69.67 51.80 67.80 65.93 74.60 64.45 76.90 71.00 
  (23.20) (12.55) (15.91) (22.17) (24.54) (23.93) (17.46) (22.33) 
Missing 6         
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Stage of cancer and QoL. Before treatment, univariate analysis showed association between stage 
of cancer and physical QoL and patient with 47loco-regionally advanced disease [β%=16 95% CI -1-
30, p=0.06] however, there were no statistical differences between these factors and the 
psychological, social, or environmental domains p>0.05. Interestingly, there at 6-12 months 
following treatment (n=59), there was no statistically significant differences (p>0.05) between the 
loco regional advanced disease patients and those with early stage disease. Both patient groups 
reported similar levels of QoL within all four QoL domains. 
 
New cancer and recurrent cancer patients and QoL. There was no statistical difference between 
new cancer and recurrent cancer patients before treatment in the four domains of quality of life 
(p>0.05), However, patients with recurrent cancer (n=11), at time point 2 reported 30% lower 
scores within the physical domain [β%=30, 95%CI 3-49, P=0.03] and within the social relationships 
domain (p=0.09) when compared to new head and neck cancer patients. However, due to the small 
sample size of this patient group, this finding must be approached with caution. 
 
Treatment and QoL. Patients who received radiotherapy alone (n=4) or received chemo-
radiotherapy (n=9) were excluded from analysis as patient groups were too small for results to be 
generalised. There were no statistically significant differences between patients who underwent 
surgery alone compared to patients who underwent surgery and adjuvant treatment (P>0.05) before 
treatment or 6-12 months following treatment (p>0.05).  
Site of cancer and QoL. There were no statistically significant associations between site of cancer 
and patient reported quality of life within all four domains before treatment or 6-12 months 
following treatment.  However, 6-12 months following treatment within the social relationships 
domain, there was a difference between the mean scores of oral cavity and oropharynx, which 
although not statistically significant is of clinical relevance (Table 29). 
 
 
 
 
                                                          
47 The Cancer staging was performed in accordance with the AJCC staging system for head and neck cancer. *Descher,D.G. & Day, T, 
(2008)  American joint committee on Cancer (AJCC), Early stage  disease: Stage I,II Locoregionally advanced: Stage III or IV  
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 Conclusions: Socio-demographic and Clinical factors on patient QoL  
 
Socio-demographic factors and patient QoL: In summary, results showed patients age 75 and over, 
ethnic minority patients and individuals with more advanced disease as potential predictors of 
patients physical quality of life before treatment. Patients who were widowed or divorced also 
showed significantly lower physical QoL than patients who were single, married or living with their 
partner.  
Clinical variables and patient QoL: There were no statistically significant associations between stage 
of cancer, tumour Site, on the psychological, social relationships and environment domains of 
patient QoL before treatment or 6-12 months following treatment. These findings suggest these 
clinical variables play a minimal role on patients’ perceptions of their quality of life.  
Also, although, patients staged with loco-regionally advanced disease were reporting lower quality 
of life score within the physical domain, when compared with early disease patients before 
treatment, there was no difference 6-12 months following diagnosis. Both groups reported similar 
levels of QoL within all four domains. Also, there was no significant statistical difference between 
new cancer and recurrent cancer patients before treatment in the four domains of quality of life 
(p>0.05). Similarly, there were no statistically significant associations between site of cancer and 
patient reported quality of life within all four domains before or 6-12 months following treatment.  
In conclusion, the present findings identified; age, marital status, ethnicity and cancer staging as 
significant predictors of patients physical quality of life before treatment. However, at 6-12 months 
there were no statistical differences between treatment, stage of cancer, or tumour site, where 
patients are reporting similar levels of QoL within these domains.  These findings strengthen the 
evidence that clinical variables may play a minimal role in the impact on patients’ perceptions of 
their quality of life.  
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 Overall summary of quantitative findings 
 
The aims of the quantitative analysis were to firstly measure the prevalence levels of psychological 
distress in patients and their caregivers and secondly, examine the association of patient and 
caregiver psychological distress on patients QoL. 
 
 Research aim 1: Summary of prevalence of psychological distress in patients and 
caregivers  
 
A longitudinal analysis showed a significant proportion of HNC patients had high prevalence levels 
of psychological distress, particularly depression 6-12 months following diagnosis. The strength of 
these findings are prevalence levels were collected at two time points and therefore show 
differences in prevalence levels before treatment and 6-12 months following diagnosis.  Depressive 
symptoms were found to increase over time, with 17% of patients reporting scores of 8 and above 
on HADS-depression scale. This increased to 27%, 6-12 months following diagnosis. This is 
significantly higher than the 10% prevalence levels reported within the general population (Mitchell 
et al., 2013). Anxiety did not follow this pattern and decreased over time.  The high prevalence 
rates of depressive symptoms are of particular clinical significance and highlight that a significant 
proportion of HNC patients are experiencing high levels of psychological distress. These results 
indicate these elevated levels of psychological distress post diagnosis may be indicative of patients 
who are finding the adjustment to cancer more difficult.  
Similarly, a second key finding within the analysis of prevalence of psychological distress was 
caregivers; particularly the partner of HNC patients reported significantly higher levels of anxiety 
and depressive symptoms than HNC patients. Longitudinal analysis showed, these high prevalence 
rates were reported before treatment and 6-12 months following diagnosis. This suggests a subset 
of caregivers is experiencing high prevalence of psychological distress which does not subside 6-12 
months following diagnosis. These high prevalence rates suggest HNC cancer is not an individual 
experience and appears to have as much of an impact on caregivers psychological wellbeing as HNC 
patients. 
 Research aim 2: Patient and Caregiver psychological distress associated with 
patient QoL 
 
 Findings showed higher degrees of anxiety and depression was associated with patient QoL, with a 
negative impact on all four QoL domains. There was also some tentative evidence that the 
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increased level of caregiver psychological distress had a negative impact on patients QoL, thus 
supporting our proposed hypothesis. However, wide confidence intervals and small sample size 
question the strength of these associations. Nevertheless, a multivariate regression analysis and 
descriptive analysis showed caregivers with elevated symptoms of depression in particular showed 
a decrease in QoL. The current study also presented some evidence to suggest that pre-treatment 
psychological distress may predict QoL 6-12 months following diagnosis. These findings were based 
upon univariate analysis thus it would be prudent to not over interpret these as firm findings. 
However, as an exploratory model, these findings show that there is scope for patient and 
caregivers psychological distress to influence patient QoL 6-12 months following diagnosis with the 
descriptive findings supporting this hypothesis. 
 
 Research aim 3: To explore the “lived experiences” of HNC patient-partner 
couples, where partners reported high levels of psychological distress before 
treatment (qualitative) 
 
To further explore the quantitative findings and to assist with further understandings of the role 
psychological distress may play on patients QoL, qualitative interviews were conducted on a sub 
sample of patient-partner couples.  
The next chapter of the thesis introduces the qualitative findings of the study, where partners of 
HNC patients who showed elevated psychological distress before treatment were purposively 
selected and interviewed to further understand the underlying mechanisms that contributed to 
increased levels of psychological distress.   
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4. Qualitative study  
 
This chapter specifically focuses on the qualitative component of this thesis and includes a review 
of the current qualitative literature within HNC, an introduction to the qualitative method used and 
details of how participants were selected. Firstly, there is an overview of each participant who was 
interviewed and a description of the data analyses. The results are then presented, followed by a 
discussion of the key findings, including an evaluation of the methodology.   
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 Qualitative study Abstract  
Title:  “We got cancer”- an interpretative phenomenological analysis of the lived experience of 
head and neck cancer patients and their distressed partners. 
 
Aims: The primary aim of the qualitative study was to gain a deeper understanding of the lived 
experiences of HNC couples, with specific focus on patients who have a partner showing an 
elevated level of psychological distress prior to treatment. 
 
Sample: A purposive sample of six participants, (three HNC couples) took part.  Patients were aged 
between 50 to 65 (mean age 58) and partners between 50 to 61 (mean age 55).  All three patients 
had been diagnosed with HNC in the last 12 months with no previous history of cancer. Partners 
were ‘healthy’ with no reported physical health problems. 
 
Method: HNC patients whose partner reported elevated levels of psychological distress (HADS) at 
diagnosis were purposively selected.  A single interview was conducted with each participant. 
Interviews were recorded and transcribed verbatim. 
 
Analysis: An interpretative phenomenological analysis (IPA) allowed an in-depth exploration of 
HNC couples’ thoughts, beliefs and behaviours regarding their cancer experience. 
 
Results: Three core themes were identified in the HNC couples interviews, 1) “We got cancer”, 2) 
“It doesn’t shine as bright as it once did,” 3)”What would have helped?”. These emergent themes 
were highlighted by HNC patients and their partners, while they experienced significant changes in 
their identity and quality of their relationship following the HNC diagnosis. They highlighted an 
increase in relationship conflict, hostility and irritability towards one another. The couples reported 
that this resulted in significant changes in the quality of their relationship that contributed to their 
levels of psychological distress. Partners of HNC patients also revealed detrimental effects on their 
own physical health since their partners’ diagnosis.  
 
Conclusion: There is now consistent evidence that couples react as an ‘emotional system’ to cancer 
diagnosis, thus, healthcare professionals should begin including the partner in the basic support 
offered to patients. This is especially important as we now know that the distress in spouses can 
often be higher than in patients. The consequences of this effect on partners’ physical and 
psychological health raises questions on the level of social support that they can be expected to 
provide to the patient in the long term, particularly as they run the risk of developing medical and 
psychological problems themselves. 
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 “We got cancer”- an interpretative phenomenological analysis of lived 
experience of head and neck cancer patients and their distressed partners 
 
 Introduction: 
As presented in the literature review in chapter one, studies that have measured the prevalence of 
psychological distress in partners of HNC patients found that partners reported higher levels of 
psychological distress than patients (Hodges et al., 2005; Humphris & Ozakinci, 2008). These 
findings were further supported from quantitative results from this thesis (see chapter five). The 
clinical implications of such findings are significant as consequences of an increase in psychological 
distress in partners appear also to have a negative impact on HNC patients’ quality of life (QoL). 
Qualitative methodology was applied to explore this association further. This allowed an insight 
into ‘real life’ explanatory models of the HNC experience for patients and their partners, rather 
than ones based on the preconceived notions of researchers.   
 Qualitative literature review 
There has been a steady increase in the number of studies within head and neck cancer utilising 
qualitative methodology. This reflects the increasing interest in patients’ experiences of HNC, but 
also in the importance of examining quality of life from different methodological perspectives.  
The following studies summarise the qualitative literature that has examined the experiences of 
HNC patients and their partners.  
 
A recent systematic review by Lang et al (2013) examined 29 qualitative studies exploring the 
psychological experiences of patients living with HNC. Findings highlighted how the physical 
symptoms affected QoL, particularly eating, working life and social relationships. Patients also 
consistently reported an ‘emotional roller coaster’ of experiences across the different stages of the 
illness trajectory. This included the emotional impact of the diagnosis which was accompanied by 
‘feeling a loss of control’ and a new sense of awareness of their mortality Lang et al (2013) also 
highlighted that the increased psychological distress in patients was due to increased feelings of 
guilt when perceiving their dependency on others. (Lang et al, 2013). Lang’s review identified some 
of the multiple factors that have an impact on patients’ psychological distress that go beyond 
physical symptoms and side effects of treatment. This was also supported by a recent study 
conducted by Parker and colleagues (2014), which explored the experiences of cancer patients who 
underwent surgery for HNC. Participants identified difficulties arising from receiving insufficient, 
confusing, and often untimely information. Patients also reported the ‘shocks and aftershocks’ 
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following treatment and reported feeling emotionally unsupported after surgery. Although patients 
emphasised their physical constraints, they reported greater impact from the emotional 
consequences of the treatment, for which they felt less prepared (Parker, Bellamy, Rossiter , 
Graham, Britton, Bennett, 2014;). The emotional distress experienced by HNC patients was a 
common theme in the qualitative studies, as well as the guilt and burden experienced when 
patients felt they had become reliant on partners and family for support (Moore, Ford, & Farah, 
2013;  Moore, Chamberlain, & Khuri, 2004). O’Brien (2012) explored the perceived changes in 
intimacy of patients' relationships following HNC. Data were collected from 16 HNC patients who 
were at least one year post-treatment. Patients reported changes in their relationships with friends 
and family, but in particular with their partners. This included difficulty resuming former intimate 
relationships with their partners, but this went beyond physical intimacy. Patients described 
significant changes within their relationship which in turn had caused further emotional distress. 
(O’Brien, Roe, Low, Deyn, & Rogers, 2012). 
 
The review of the qualitative literature in HNC patients opens up insights beyond the information 
available from the quantitative literature. Findings reveal a need to address the multifaceted impact 
of HNC that goes beyond the medical model of illness with qualitative and focusing on the 
significant emotional impact of the disease. The literature clearly demonstrates that patients are 
not simply affected physically by their experience of HNC. 
 
Interestingly, at the time of the initial review of the qualitative literature in 2011, to our knowledge 
there had been no studies conducted specifically in partners of HNC patients. However, since 2011 
the following three qualitative studies have been reported, showing a steady increase in the 
importance of this area.   
 
Nund et al (2014) explored the experiences of twelve partners of HNC patients specifically focusing 
on caring for someone with dysphagia (problems with swallowing). Their qualitative analysis showed 
that partners found it difficult to function within the caregiver role. Partners highlighted their 
increased emotional distress and reported a decline in their physical health (Nund, Ward, Scarinci, 
Cartmill, & Kuipers, 2014).  In a similar study, Patterson and Rapley (2013) interviewed seven HNC 
couples that were living with someone with dysphagia. Partners reported a transformation from 
partner to carer, which brought new responsibilities with changes to their normal way of life 
(Patterson & Rapley, 2013). There is increasing evidence that cancer can not only lead to increased 
psychological stress, but can also lead to positive changes. Ruf et al (2009) asked 31 patients with 
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HNC and 25 female partners one open-ended question: whether they had experienced any positive 
changes since the cancer experience, often referred to as ‘post traumatic growth’. Both the majority 
of patients as well as their partners (81% and 84%) reported positive personal changes primarily 
related to areas of attitudes towards life, personal strength and relationships. There was a small 
proportion of their sample who reported no positive changes (19% patients and 16% partners). The 
main findings from the partners’ perspective were that they felt their relationship was more intense 
since diagnosis, with improved communication, mutual understanding, and more tolerance of 
certain habits. Also, positive changes in relationships were reported significantly more by the female 
partners than by the patients (Ruf, Büchi, Moergeli, Zwahlen, & Jenewein, 2009). A similar study in 
prostate cancer patients found both patients and their partners reported a positive attitude toward 
life, personal strength, and relationships. Partners reported significantly more positive changes in 
relationships, especially within the partnership (Lavery & Clarke, 1999). 
However, both studies assumed that reporting more positive changes was associated with higher 
posttraumatic growth. An alternative interpretation could be that reporting more positive changes 
could be related to different communication skills, i.e., women have been found to be more verbal 
about their emotions than men (Hagedoorn, Sanderman, Buunk, & Wobbes, 2002) and therefore 
their findings may be biased by sex effect concerning communication, as both samples were biased 
to female partners and male patients.  
   
 Summary of qualitative literature 
A consistent theme that emerges from qualitative studies of HNC patients is how patients seek 
emotional and psychological support from their family, specifically their partner. Partners of HNC 
patients reported significant changes in their QoL but more strikingly, partners also showed a 
decline in their physical health.  Partners reported that the HNC diagnosis had changed their lives; 
with one study (Ruf et al 2009) showing partners experiencing positive changes within their 
relationship.  
 
However, there have been very few qualitative studies in HNC couples, particularly where the 
patient’s partner is reporting elevated psychological distress. By examining the experiences of these 
couples, I was able to explore further the underlying mechanisms contributing to their elevated 
psychological distress and examine what impact this distress was having on patients QoL. To my 
knowledge, this is the first study to examine this issue. 
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 Aims  
The primary aim of the qualitative study was to gain deeper understanding of the lived experiences 
of HNC couples, with specific focus on patients who have a partner with a high level of 
psychological distress before treatment. The main objective of the qualitative study was to 
understand the underlying factors contributing to patients’ and partners’ psychological distress, 
and how this had an impact on patients’ overall quality of life. 
 Qualitative Methodology 
This section introduces interpretative phenomenological analysis (IPA), which was the selected 
qualitative methodology used to answer the qualitative research question. I will begin by 
introducing IPA including its theoretical constructs followed by the rationale of choosing IPA over 
other qualitative methods.  
 
 What is Interpretative phenomenological analysis (IPA) 
Interpretative phenomenological analysis (IPA) is a qualitative approach that explores how 
participants make sense of their own experiences. IPA engages with the meaning that experiences, 
events and actions hold for participants. At the same time, it recognises that the researcher’s own 
conceptions are required to make sense of the personal world of participants that is being studied 
through a process of interpretative activity (Smith, Flowers, & Larkin, 2009). IPA utilises small, 
purposively selected samples to allow in-depth, detailed examination of phenomena within an 
individual’s experience. 
 Theoretical constructs of IPA 
IPA is underpinned by three theoretical constructs; 1) Phenomenology: the philosophical approach 
to the study of experience, 2) Hermeneutics: the theory of interpretation, and 3) Idiograpy: the 
unique experience of an individual (Smith et al., 2009). 
 
Phenomenological analysts seek to capture the meaning and common features, or essence, of the 
experience or event. However, IPA recognises that, in order to be able to understand another’s 
relationship with the world, there is a need for interpretation. Hermeneutics is the theory of 
interpretation. Heidegger 1962 (as cited in Smith. Flowers & Larkin, 2009) believed that seeking 
meanings from individuals’ experiences (phenomenology) cannot be done without interpretation. 
Thus, the meanings of words and experiences need to be examined and interpreted within the 
context of the experience. The third major influence upon IPA is idiography, which examines the 
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‘particular’.  In IPA, this is applied by grouping individuals into ‘unique’ experience groups, for 
example partners with depression. Examining individuals with this ’particular’ enables a sense of 
detail about that experience, and therefore a depth of analysis.  IPA also uses a social cognitive 
paradigm (Fiske & Taylor, 1991) that is founded on the premise that human speech and behaviour 
reflect individuals’ cognitions and perceptions.  
 Why choose IPA?  
Whilst IPA and discourse analysis (Potter & Wetherell, 1987) share a commitment to the 
importance of language, they differ in regard to the status of cognition. Discourse analysis is 
sceptical of the possibility of mapping verbal reports onto underlying cognitions, whereas IPA is 
concerned with understanding what the respondent thinks or believes. The interpretive nature of 
IPA means that analysis can be underpinned by psychological theory. Using IPA allows the 
researcher to make a link between the physical conditions, the individual’s cognitions about the 
condition and how they verbalise these cognitions. Recognising this requires interpretive work by 
the researcher. IPA also assumes that the participants’ accounts will provide a representation of 
their underlying perceptions; therefore it is best suited to the present research objective.  
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 Method 
Recruitment for qualitative study took place 12 months following the commencement of the 
original study.   
 Participants 
A triangulation method for patient sampling was undertaken where participants were selected on 
the basis of their pre-treatment HADS scores in the quantitative phase of the study. The HNC couples 
that were eligible to take part had to fulfil the following criteria: 
1. Both patient and partners had completed the hospital and anxiety questionnaire before 
treatment and 6-12 months post treatment 
 
2. Partner of patient had a 48total score of 15 or above on the HADS questionnaire.  
See qualitative recruitment flow chart in Figure 29 for eligible participants. 
  
                                                          
48 Total HADS score (HADS-Anxiety score + HADS-Depression score). A score of 15 is the recommended cut off indicative of high 
psychological distress (Mitchell et al., 2010).  
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49  
                                                          
49  Recruitment for qualitative study commenced 12 months following the quantitative study 
Eligible partners 
N=13 
  
Low psychological distress 
N=11 
  
High Psychological distress  
N=19 
Total partners   
N=30 
Not 
eligible 
Recruited 
N=3 
 
Case Study 1 
 
 
 
Declined  
N=10 
 
Case study 2 
 
 
 
Case study 3 
 
Sample according to HADS score 
Approached  
N=13 
 
 
 
Figure 29: Eligible participants for Qualitative recruitment 
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 Sample 
A purposive sample of six participants, (three HNC couples) took part. This comprised of 2 male 
patients and their female partners, and 1 female patient and male partner.  
Although this is a relatively small sample size, which limits the generalisability of the results, this is 
not the primary aim of a qualitative study. The emphasis is not on hypothesis testing but rather on 
generating new hypotheses and gaining insight into the lived experiences of this sample. 
Patients were aged between 50 to 65 (mean age 58) and partners 50 to 61 (mean age 55). All three 
patients had no previous history of cancer. Partners were ‘healthy’ with no reported physical health 
problems (see Table 30 for clinical details of patients). Pseudonyms have been used to ensure 
anonymity.   
 
  Summary of sample 
 
Case study 1: Mr and Mrs Smith 
Mr Smith was a white British man aged 59 who had been married for 26 years. The couple had no 
children and lived with their two cats. Preceding his diagnosis, Mr Smith was in full-time 
employment in a senior position in the public sector. However, following diagnosis, he made the 
decision to take early retirement.  
 
His wife, aged 54 was in full time employment at the time of interview and also worked in a senior 
position within the public sector. She reported no physical health problems and described herself as 
being fit and well with no past history of depression. 
 
HNC history: Mr Smith was diagnosed with a loco-regionally advanced, laryngeal squamous cell 
carcinoma. His treatment entailed primary surgery, where he underwent a laser resection. This took 
place 2 weeks following his diagnosis. Mr Smith was otherwise fit and well and reported no 
additional comorbidities. At the time of interview Mr Smith was 12 months post treatment.  
  
Case study 2: Julie and Jake 
Julie is a white British woman aged 50 and at the time of the interview had been living with her 
partner for 18 months. They had no children together, however, Julie had 3 children from a 
previous relationship. Her children were aged between 13 and 22 years. She also had one 
grandchild. Julie was not in employment at the time of the interview, but preceding diagnosis had 
worked full-time in a private business as a full-time administrator. She reported no additional 
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health problems and no previous history of cancer. However, she did report a past history of post-
natal depression. Her partner Jake was white British man, aged 50 and worked as self-employed 
labourer. He had no children and no history of physical health problems. Jake did report a past 
history of depression. 
 
HNC history: Julie was diagnosed with early stage, salivary gland adenoid cystic carcinoma, 
(T2N0M0), for which she had primary surgery (neck dissection) followed by a 6 week course of 
radiotherapy. Julie was 10 months post treatment at the time of the interview. 
 
Case study 3: Mr and Mrs Jackson 
Mr Jackson is a 65 year old, white British man, married for 30 years. He had three grown up children 
and several grandchildren, all of whom lived in close proximity. Mr Jackson took early retirement 
following diagnosis, but had previously worked in the public sector as an engineer. Mr Jackson 
reported no past history of depression. 
 
HNC history: Mr Jackson was diagnosed with early stage, oropharyngeal squamous cell carcinoma, 
(T1N0M0). Two weeks following his diagnosis, he experienced a myocardial infarction and 
underwent a heart bypass preceding the HNC treatment. His treatment for his SCC was a laser 
resection and photo dynamic therapy. However, due to a recurrence 9 months later he was 
undergoing radiotherapy treatment at the time of the interview. 
 
Mrs Jackson, is white British, aged 61 who worked part-time as an administrator in the public 
sector. She describes herself as ‘fit and well’ and reports no history of physical health problems and 
no past history of depression. 
 
See Table 30 for participant demographics and clinical details, including HADS scores of 
psychological distress. 
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Table 30 Participant demographics and clinical details including scores of psychological distress 
 
 
Table 30 shows the demographics and clinical details of three HNC couples that took part in qualitative interviews. HNC couples eligible for interviews 
were purposively selected based on total HADS score (HADS-Anxiety score + HADS-Depression score). A score of 15 is the recommended cut off indicative 
of high psychological distress (Mitchell et al., 2010). The table also includes details of participants past history of depression.
Case Study Participant 
Interview 
no. 
 
Participant 
 
Gender 
 
Age 
 
Marital 
status 
(years) 
 
 
Primary site and treatment 
Months 
since 
diagnosis 
No months 
since 
treatment 
Total HADS 
Score 
≥15 
Past 
history of 
depression 
1  
1 
 
Patient 
Male 59 Married 
(26) 
Loco regionally advanced, laryngeal Squamous cell 
carcinoma,T1N1M0 SCC Right vallecular,  Primary 
surgery, (laser resection) 
 
14 
 
12 
 
No 
 
No 
 2 Partner Female 54 Married 
(26) 
 14  Yes No 
2 3 Patient Female 50 Co-habiting 
(1) 
Early stage, salivary gland adenoid cystic carcinoma, 
(T2N0M0), primary surgery (neck dissection) plus 
radiotherapy 
14 10 Yes Yes 
 4 Partner Male 50 Co-habiting 
(1) 
 14  Yes Yes 
3 5 Patient Male 65 Married 
(30) 
Early stage, oropharyngeal squamous cell carcinoma, 
T1N0M0, primary surgery laser resection, plus 
radiotherapy 
12 In treatment 
(due to 
recurrence) 
No No 
 6 Partner Female 61 Married 
(30) 
 12  Yes no 
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4.7 Procedure 
As this was a mixed methods design project, written informed consent for questionnaires and 
agreement to take part in an interview were obtained by the researcher at first contact (diagnosis).  
Consent was obtained from all participants to allow for purposive sampling to take place, a method 
commonly used within a mixed methods design. All participants who took part in the qualitative 
interview had previously taken part in the prospective study. 
 
HNC patients whose partner reported high levels of psychological distress at 6 months post diagnosis 
(high scores of depression and anxiety on hospital and anxiety scale: HADS) were selected to take part. 
All participants were interviewed at their homes. A single interview was conducted with each 
participant. All interviews were conducted separately and each partner was assured of confidentiality 
from the other partner. A break was provided after 30 minutes to prevent fatigue. Interviews lasted 
between 30- 90 minutes. Interviews were recorded and transcribed verbatim. 
4.8 Ethical considerations 
The study was performed in accordance with good clinical practice within the principles of research 
ethics and was approved by the NRES Committee London, Camberwell St Giles -. REC 
reference:12/LO/0351. Ethical concerns regarding any potential emotional effects caused by the 
qualitative interview design meant that the interviewer was on alert and took into account the 
negative consequences recounting potential emotive experiences may yield. The present study was 
carried out in close association with the participants’ clinical team, which meant that if any need for 
support was required the researcher could refer to the clinical care team. In addition, due to the nature 
of the study, permission and consent from persons with HNC were required before their partners could 
be approached to participate.    
4.9 Interview schedule 
The interview schedule was based on the following topic areas: diagnosis and treatment, social support 
and relationships, psychological impact, changes in QoL and service improvements. A semi-structured 
interview schedule was constructed (see Table 31 for topic guide). This allowed for flexibility during 
interview where answers and stories could be further probed. The same topic guide was used for 
patients and their partners. 
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Table 31 interview schedule topic guide 
Topic guide for interview: 
Topics Patient or Partner 
Background to diagnosis “Can you tell me how your diagnosis/partner’s diagnosis 
of head and neck cancer came about? 
 
Prompts: What happened? How did you feel? How did 
you cope? 
 
Social support and relationships “Can you tell me about your relationship with your 
partner since your diagnosis?” 
 
Prompts: partner, family, friends 
Can you give me an example? 
Psychological distress following 
diagnosis 
“Can you tell me a little more about how you have felt 
since your/partner’s diagnosis?” 
 
Prompts: Most difficult, How did you cope? 
Quality of life How do you think your life has changed since your 
diagnosis? 
 
Prompts: What does QoL mean to you? 
Service received  How do you think the head and neck cancer services could 
be improved? 
 
Prompts: patients, partner and family. 
 
4.9.1 The interview 
The interview was semi-structured and was carried out as a conversational encounter, thus it was 
relatively unstructured, but guided by topic areas. The questions were open-ended, with cues and 
prompts if the participant was not engaging. Participants were encouraged to speak freely as this 
allowed insight into the areas affecting their lives to become more prominent.  
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4.9.2 Transcription 
Interview data was recorded on digital voice recorder and transcribed verbatim. All the transcripts 
were transcribed by the primary researcher. Particular behaviours were transcribed including crying, 
elevated voice and long pauses. Each transcript was verified and validated by listening to original 
recordings in conjunction with the transcript. This was further validated by a research assistant. Each 
interview was numbered and line numbers were added to the typed transcripts.  
 
4.10 Analysis 
The transcripts were subjected to detailed systematic qualitative analysis case by case (IPA). 
A detailed step by step process of the analysis is available is the appendices (see sections 8.3)  
 
Summary of IPA stages 
(See sections 8.3 for detailed step-by-step guide of stages of IPA analysis). 
 
Stage one involved reading transcripts several times to gain a holistic picture of individuals’ accounts. 
Each read-through highlighted new insights with unfocused notes relating to anything within the text 
that appeared interesting or significant.  
 
In stage two, the transcripts were examined further and conceptual themes were created that were 
felt to capture the essence of the participants’ accounts.  
 
In stage three, the emergent themes were listed and connecting themes were sought, with those 
related being clustered under appropriate super-ordinate conceptual headings. During this data 
organisation process continuous referral to interview transcripts were made to ensure themes selected 
were representative of individuals’ personal accounts. The themes reflected the most salient meanings 
within the participants’ narrative.  
 
Stage four reflects the resultant framework where four super-ordinate themes emerged with sub 
themes within each cluster. The themes were corroborated by an experienced psychiatrist 50(AK) who 
checked and corroborated the themes against the data. 
 
                                                          
50 Professor Ania Korszun.  
 128 
 
4.11 Qualitative Results 
 
This section reports on the three superordinate themes derived from the analysis. The first theme 
presents how the HNC couples coped with the diagnosis of cancer providing insight into their 
emotional coping responses and behaviours. This is followed by the second theme where the effect of 
the cancer on the HNC couples relationship was highlighted, particularly the negative impact. The final 
emergent theme revealed how certain stages of the cancer were particularly difficult for the HNC 
couples and highlighted the types of support that would have been beneficial during these stressful 
periods. 
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4.12 Summary of themes: 
 
Table 32 Master themes and subthemes from IPA analysis 
 
 
 
 
  
Table of Master themes 
Superordinate themes and Subthemes 
 
1. “We got cancer” 
 
 Coping with the bad news  
 Being the perfect cancer partner 
 
 Being the perfect cancer patient 
 
2. “It doesn’t shine as bright as it once did” 
 
 “You don’t give a shit, so why should I?” 
 “I’m at the end of my tether” 
 
 Communication and secrecy 
 
 Changes in intimacy 
 
3. What would have helped? 
 
 Willingness to accept emotional support  
 ‘Fear of the unknown’  
 What can we do?  
 
Table 32 presents the superordinate and subthemes from the qualitative analysis of HNC couples 
interviews. 
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4.13 Superordinate theme one: 
“We got Cancer” 
 
The superordinate theme of “We got cancer” reflected the reciprocal effects of the cancer experience 
identified by the HNC couples. Nested within this theme were the following subthemes:    
 Coping with the bad news: This subtheme described the HNC couples’ emotional and 
behavioural reactions to the diagnosis. 
 Being the perfect cancer partner and being the perfect cancer patient:  These subthemes 
were the self-defined identities patients and partners felt represented their changed roles.  
 
4.13.1 Coping with the ‘bad news’ 
Each HNC couple shared a different experience and coping response to the HNC diagnosis, highlighting 
the difficulty in predicting an individual’s coping response to cancer.  
 
Finding emotional support from your partner has been shown to be an effective way of maintaining 
emotional health during a stressful period such as cancer diagnosis. However, what the following 
quotes highlight are the difficulties the HNC patients were faced with when having to ‘break the bad 
news’ to their partners and family. The analysis highlighted how the reactions and behaviours of one 
partner particularly affected the emotional and behavioural response of the other.  
 
Mr Smith described how difficult he found telling his wife about his diagnosis. He reported that he had 
found this experience as distressing as the diagnosis itself. This was a common theme amongst the 
HNC patients. Mr Smith felt significant guilt and anxiety for placing the burden of his cancer on his wife. 
As a consequence, he emotionally withdrew from Mrs Smith to help him cope with these negative 
emotions. His quote also illustrates how he was unable to say to his wife that he had cancer: not having 
to directly name the cancer suggests how difficult this experience was. 
 
“I showed her the neck and throat cancer book and said look. She didn’t take it particularly well” 
(Case study 1: Mr Smith, Patient, p2: 53-55) 
 
When Mrs Smith was told of the diagnosis by her husband, she reported feeling helpless, believing she 
had no control over the situation in which she had been placed.  
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“It was the way he told me, he went off to get the results, then came back and told me (whilst still in 
work) so he wasn’t very thoughtful on that. You’ve just told me this. How do you want my reaction? All 
he did was touch my arm.”  
(Case 1: Mrs Smith, Partner, p2. 35-44) 
 
Her quote shows how she wanted to be comforted by her husband (patient) and felt angry that she 
was left to deal with the diagnosis alone. 
 
In case study 2, Julie (patient) also struggled with the diagnosis. 
 
 
During her diagnosis, Julie described how her anxiety was increased due to the surgeon’s reluctance to 
name the disease as cancer. She felt because the surgeon had called it a carcinoma he was trying to 
minimise the seriousness of her disease. This meant she was left to name the cancer, and effectively 
‘break the bad news’ to herself which increased her level of distress.  
 
Julie’s partner Jake was not present at the consultation and was told of the diagnosis by Julie over the 
phone.  
 
“I had the strong belief and conviction that she would be ok”  
(Case 2: Jake, Partner, p11 246-247) 
 
The language he uses to describe his coping response, (’strong’ and ‘conviction’) reflect the ideologies 
that are often associated with cancer i.e. ‘staying strong’ and ‘being positive’. By redefining his 
cognitive appraisal into a positive belief (i.e. the cancer was treatable), he felt he was able to support 
his partner better. 
 
In case study 3, Mr and Mrs Jackson shared similar perceptions and coping responses to the cancer. 
They appraised the cancer as being treatable as they felt this helped them cope with the negative 
impact of the diagnosis.  
“I heard the word carcinoma and I said go back did you say carcinoma? And he said yes and I said its 
cancer isn’t it? And he said yes I’m afraid it is. Then my daughter burst into tears.”  
(Case 2: Julie, Patient, p5: 107-109) 
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In Mrs Jackson’s quote, the persistent use of ‘we’ highlighted how the diagnosis affected the couple as 
a unit and not as independent individuals.   
 
HNC patients also discussed the difficulties in managing their own emotions, as well as having to cope 
with the emotional reactions of others.  
 
“I came into the house and I said it’s cancer. My daughter said ‘it can’t be, it must be a mistake, they 
got it wrong’, I said ‘no’. I didn’t tell my son. I told him it was a lump and I was going to get it sorted. I 
think everyone was shocked. It’s difficult because you’re trying to deal with your own emotions, but 
they’re your kids so you’re worrying about your kids’ emotions.”  
(Case 2: Julie, Patient p8:163-183) 
 
The quote highlights how difficult Julie found it to juggle her role as a mother and as a patient. She felt 
her identity as a mother was being taken over by the cancer which made her feel guilty and increased 
her levels of distress. This was a consistent theme within the HNC patients’ narratives regarding the 
cancer diagnosis, where they revealed that having to contain the anxieties of others was as challenging 
as coping with the diagnosis itself. 
Partners of HNC patients also expressed the same emotional demands. They not only felt responsible 
for the emotional wellbeing of their ill partner, but also for the additional responsibility of providing 
emotional support to other family members.  
 
“I rang my daughter immediately. And she was in floods of tears, and I said stop it, just stop it – we 
don’t need that. He doesn’t need that and you’ve got to be strong. Got to be strong to get through all 
this.”  
(Case 3: Mrs Jackson, Partner, p5: 102-107)  
  
“I thought oh well, what’s next, I guess if you 
prepare that it’s going to be cancer, then when 
they tell you it’s not a shock. There you go, let’s 
get it treated, let’s move on, it was something 
I’ve got to have it done and I’ve got to be 
treated and sooner the better.”  
Case 3: Mr Jackson, Patient, p3:47-51 
“You’ve got to get on with it, do it, we still don’t 
know what is going to be the outcome but we 
just try our best.”  
 
 
 
Case 3: Mrs Jackson, Partner,p5:116-118 
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Similar to Julie, Mrs Jackson highlighted how, as a mother, she also felt protective for her children in 
addition to her role as a wife needing to care for her husband. Her new identity as ‘cancer partner’ 
meant she felt she had to stay optimistic and ‘strong’, which is clear from her quote. This leads us to 
the next subtheme which further exemplifies how patients and partners felt the need to fulfil their new 
identities as ‘cancer patients’ and ‘cancer partners’. 
 
4.13.2 Being the ‘perfect’ cancer partner 
When an individual is diagnosed with cancer, the partner is usually counted upon to become the 
primary caregiver. As well as contending with this new role, the partners are expected to offer 
emotional support, adapt to the lifestyle changes, whilst having to contend with their own emotions 
and distress. Over time, partners revealed this became more difficult to sustain. 
 
Partners of HNC patients reported they had acquired a new identity as the ‘cancer partner’. This meant 
they were to behave in a manner that was expected of them rather than in the way they would 
normally behave within the relationship. This new identity was as much a social expectation as a moral 
one and partners reported that they were regularly suppressing their own anxieties and fears, in order 
to be supportive of the patients’ needs. All partners revealed that they believed that their new role 
identity meant that they had to remain positive and optimistic and hide their emotions about the 
cancer. The following quotes highlight examples of this new identity as the ‘perfect cancer partner’. 
 
“I remember when she first got diagnosed, I went ‘you’re not going to die, you’re going to be here to  
talk about it, don’t worry’. I didn’t actually believe it at the time.” 
 (Case 2: Jake, Partner, p34:799-802)  
 
 Jake revealed his fears of losing his partner to cancer, but felt it was part of his new identity as a 
‘cancer partner’ to remain positive and optimistic, even when this challenged his own thoughts about 
the cancer. Partners reported frequently suppressing similar negative thoughts, with the belief if they 
discussed worries with the patient it could jeopardise their well-being. They became over-protective 
towards the patients but also began to feel underlying resentment and hostility.  
 
 “It’s responding, but not showing my emotions because he’s dealing with his own, and he can’t deal 
with his own, so he certainly can’t deal with mine.” 
 (Case 1: Mrs Smith, Partner, p7:1163 -1166) 
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Mrs Smith highlighted how she experienced significant emotional distress, and felt alone in the 
relationship. She felt she had been forced to put her shock and trauma regarding the cancer aside in 
order to provide comfort to her husband. This was acknowledged as another key role in the identity of 
the being the’ perfect cancer partner’.  
 
The justification for this new identity was the ‘guilt of health’, where partners accepted having to deal 
with the negative emotional consequences within the ‘cancer journey’ because they were healthy. Mrs 
Smith’s quote highlights this;  
 
“You don’t want to unload your concerns, because they’re already dealing with theirs. You don’t want 
to off load that just comes across really selfish.” 
 (Case 1: Mrs Smith, Partner, p41:932-936) 
 
Mrs Smith’s language in the above quote, in her use of the phrase ‘off load’, reflects the burden she 
experienced. Partners in the interviews often used this kind of terminology to express their problems 
and anxieties, again avoiding clinical words such as ‘burden’ or ‘anxiety’ as these would be a reflection 
of them failing in their identity as a the perfect cancer partner. 
 
Partners reported another key role in the identity of ‘being the perfect cancer partner’ was to avoid 
any cancer related conversations as partners believed feared upsetting the patient. 
 
“All I can imagine with me getting upset and getting tearful is she might think ‘oh he thinks I’m going to 
die. Is it worth me carrying on if he thinks I’m going to die? Is it worth me trying? If he gives the 
impression that he doesn’t think that I’m going to live’. I didn’t want to give her that impression. The 
only impression I wanted to give her were positive ones. Even though at times I thought this is getting a 
bit heavy.” 
 (Case 2: Jake, partner, p39-:911-916) 
 
Jake’s quote particularly highlights the internalised fear he had about losing his partner. This shows the 
significant emotional burden he had bottled up. The quote from Jake shows how partners were 
suppressing these difficult emotions and choosing not to share them with their partner or family 
members for fear of being perceived as being unable to cope in ‘being the perfect cancer partner’.  
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All three partners discussed deterioration in their physical health and wellbeing within the first twelve 
months of their partner’s diagnosis, which demonstrates the potential adverse health implications for 
caregivers of cancer patients. 
 
“I know I’m under stress, I’m really suffering from shoulder pain, and it’s the tension. “ 
(Case 1: Mrs Smith: Partner, p38:863-864) 
 
“My own health hasn’t been good. Been smoking, my smoking doubled with stress. There is also that 
feeling of ‘what’s the point?’ You start getting ‘what’s the point’ attitude.”  
(Case 2: Jake partner. P31- 724-728) 
 
“I have come out a bit rashy at the moment – I think this is how the stress has come out – I’ve got 
steroids and God knows what, but it’s very strange it’s all come out now. I think stress comes out in 
different ways doesn’t it?” 
(Case 3: Mrs Jackson, Partner, p16:372-379)  
 
These quotes emphasise how the impact of cancer not only affected the partners emotional wellbeing 
but also had a negative impact on their physical health. This has significant implications for the kind of 
support that partners are able to provide to patients if their own physical health becomes 
compromised. 
 
4.13.3 ‘Being the perfect cancer patient’ 
Further evidence of the interdependence of the patient-partner relationship was shown within this 
subtheme of ‘being the perfect cancer patient’.  
 
HNC patients believed they also had the moral and social pressure to become the ‘perfect cancer 
patient’. The persistent emphasis on ‘staying positive’ and ‘fighting cancer’ was causing an increase in 
psychological distress. This is highlighted in Julie’s quote. 
 
“I felt guilty that I wasn’t doing enough, but I didn’t have the energy to do anymore – I really isolated 
myself. I felt guilty because I didn’t want to bring everyone down.”  
(Case 2: Julie, Patient, p17: 381-388) 
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In Julie’s quote she disclosed her difficulty in staying optimistic throughout the course of her cancer 
experience She highlighted how she felt responsible for not just her own emotions and wellbeing but 
also her partner’s and family’s. When she was unable to continue being ‘the perfect cancer patient’ she 
highlighted how she became emotionally detached from her family, which compromised her abilities to 
cope with the cancer.  
 
The extract by Mr Smith presents an example of the significant anxiety he was experiencing but would 
not disclose to his partner. 
 
“My cancer became all-consuming and I found myself thinking about it more and more and it got to the 
stage where I was thinking about it all the time. Everything reminded me of it – my swallowing, I had 
problems swallowing which is a natural after effect following surgery so I was having trouble 
swallowing and having trouble speaking. If I was speaking for a long time I was aware. When I shaved I 
was aware of my scar, and still am, and so it was everything – all my thoughts were CANCER CANCER 
CANCER.”   
(Case 1: Mr Smith, Patient, p8: 191-200) 
 
‘Being the perfect cancer patient’ meant patients were unwilling to express any negative emotions to 
their partner or family, as this would reflect their weakness and make their families think they were 
‘giving up’. Instead, they engaged in avoidant coping behaviours such as disengaging from them and 
held negative cognitive appraisals of themselves, such as feeling like a failure.  
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4.13.4 Summary of “We got cancer” 
The theme of ‘we got cancer” highlighted the reciprocity of emotions, where patients and their 
partners reported emotional responsibility for one another. Couples reported similar feelings of guilt, 
fears, and anxieties related to the diagnosis and throughout the cancer journey. They also adopted 
similar coping strategies (emotional withdrawal and avoidance) to deal with these negative emotions, 
particularly following the diagnosis. The analysis also revealed the need for HNC couples to present 
themselves as being the ‘perfect’ cancer patient or partner. This new identity became an antecedent to 
increased distress, particularly when they felt they were unable to fulfil the roles of staying positive 
and optimistic.   
 
Patients and partners both revealed changes to their relationship following the diagnosis. This is 
commonly reported in cancer, however, in this study an increase in relationship conflict and irritability 
towards one another was revealed. This resulted in significant changes to the quality of their 
relationship with frequent desires to leave the relationship. This is the focus of the next theme “It 
doesn’t shine as bright as it once did” 
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4.14 Superordinate theme two: 
“It doesn’t shine as bright as it once did” 
 
The second superordinate theme “it doesn’t shine as bright as it once did” reflects the negative 
changes within HNC couples’ relationships since the cancer diagnosis. Partners, in particular, reported 
how they found the transition from treatment to ‘resuming normal life’ particularly challenging.  
 
The subthemes included:  
 
 ‘You don’t give a shit, so why should I?’ Partners’ indicated the lack of appreciation from 
patients for the support they were providing which led to increased hostility towards the 
patient. 
 ‘I’m at the end of my tether’: Highlighted the increased relationship conflict reported by HNC 
couples since the cancer diagnosis. 
 Communication and secrecy: Revealed the difficulties HNC couples showed in communicating 
about the cancer to one another. 
 Changes in intimacy: HNC couples gave examples of the changes in the quality of their 
relationship following treatment. 
 
 
4.14.1 ‘You don’t give a shit, so why should I?’ 
In most relationships there are times when one partner feels they are giving more or may feel 
unappreciated for what they contribute in the relationship. This was a particularly strong theme as the 
HNC couples struggled with feeling their care was not good enough and/or were feeling unappreciated.  
 
This imbalance of emotions caused increased distress but also contributed over time to increased 
hostility towards the patient. 
 
“He should show his appreciation more, just so I know it’s there.”  
(Case 1:  Mrs Smith, Partner, p35: 804-806) 
 
Mrs Smith’s quote showed how she felt her increased responsibilities, paired with the lack of 
emotional support from her husband (patient) contributed to her feeling her care and support was 
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being undervalued. A consequence of these negative perceptions was that Mrs Smith reported feeling 
critical and less tolerant of her husband. 
 
“No, you are not ill, you have cancer. Of course it’s an illness but you’re being treated. You are being 
helped.” 
(Case 1: Mrs Smith, Partner, p28:638-643) 
 
Mrs Smith’s quote revealed the underlying resentment she had developed towards her husband, 
which, she explained, was due to feeling she was putting more into the relationship than she was 
getting in return. She justified these negative feelings by believing he was no longer ill thus allowing 
her to feel anger towards him: he was being treated and helped, unlike her having to deal with 
everything alone. The extent of Mrs Smith’s hostility was revealed in the following extract from the 
interview. 
 
 
(Case 1: Mrs Smith, Partner, p17:378-404) 
 
Mrs Smith’s extract shows her deep resentment towards the patient, which she revealed was due to a 
culmination of internalising her own emotions, lack of emotional support and inability to share and 
discuss the cancer with her husband. 
 
Similarly Jake also revealed increasing resentment towards his partner. 
  
“I started to think, if you don’t give a shit, why do you want me to? I used to get annoyed.” 
(Case 2: Jake, Partner, p19:453-455) 
Mrs Smith: “There’s a little part of me, which still in the back of my head thinks he won’t live much 
longer, so you don’t need to walk away, because eventually, that will be dealt with. It’s a terrible 
thing to say, but it would solve an awful lot of problems if the cancer does come back and finish him 
off.” 
 
Interviewer: “How often do you feel that way?” 
 
Partner: “More regularly then I should. I can’t say it’s every day, it’s when he has an appointment or 
something like that, that’s the way it is.” 
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Jake also expressed a negative attitude towards his partner Julie during treatment, where he criticised 
the way she was dealing with her illness.  
 
“There was times when she was having radiotherapy and she didn’t want to go, I came down and I was 
fuming, and I thought ‘how am I going to word this in a way that she will go?’ So I basically turned it 
around and said ‘there’s people who aren’t going to get this chance because they are dead, because 
cancer killed them, so you are disrespecting all these dead people so you better get off your ass and get 
dressed, you’re making a mockery of all those people up there looking down on you, looking down on 
you, thinking I would love to be in your shoes.’ I tried to put a positive spin on it to make her believe 
‘yeah he’s right’.”  
(Case 2: Jake, Partner, p8:186-202) 
 
The quote had an underlying aggressive tone illustrated by the language used in Jake’s quote; (‘fuming’ 
‘dead’ ‘mockery’).   
 
The contrasting quote from his partner Julie highlights her passivity and vulnerability during treatment 
period, with a desire for partner to give her ‘permission’ to be able to convey emotions which she still 
felt the need to internalise. This is an example of how negative support i.e. hostility from partner may 
contribute to increased feelings of helplessness in patient. 
 
“When I was having radiotherapy, I used to sit there and say I don’t want to go; I don’t want to go 
today. He would say ‘you will go, you will be fine, chop chop’, I didn’t want him to let me cry but 
sometimes I would’ve liked him to have said ‘cry today, let it all out’.” 
 (Case 2: Julie patient, p9:194-196) 
 
 
4.14.2 ‘I’m at the end of my tether’ 
All three HNC couples revealed an increase in conflict within their relationship since the cancer 
diagnosis. Unexpectedly, partners were more open to reveal the causes of the conflict than the HNC 
patients.   
 
One explanation given by partners was feeling emotionally hurt, as they felt their care was being 
undervalued.  
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“Sometimes I think she felt that I weren’t good enough, I weren’t doing enough, and I weren’t saying 
the right thing.” 
(Case 2: Jake, partner, p12:266-268) 
 
“I used to say ‘there ain’t no fucking manual on how to get someone through cancer’.” 
(Case 2: Jake, partner, p34:790-792) 
 
Jake’s quotes highlighted how his feelings of failing in his caregiving role shifted into feelings of 
frustration with his partner. He revealed how he had started to question why he was trying so hard to 
satisfy Julie’s emotional needs. He reported feeling resentment and anger towards her and disclosed 
that he became less tolerant of her cancer. 
 
“I come almost to the end of my tether, because she was doing all of the wrong things, and I would get 
annoyed.” 
 (Case 2: Jake, Partner, p22:512-521) 
 
Similarly, Mrs Smith revealed an increase in irritability with her husband, but similar to Jake, she also 
felt she was becoming more emotionally withdrawn from her husband. 
 
“He would snipe, snipe and I got worn down, so I thought I don’t need this.” 
(Case 1: Mrs Smith, Partner. p9:214-216) 
 
Partners revealed how their emotional withdrawal from patients was a sign of their dissatisfaction 
within the relationship. Partners discussed how their increased hostility, coupled with their feelings of 
resentment, resulted in thoughts of leaving the relationship.  
 
“I felt claustrophobic, is a good way of describing it. I felt like I didn’t want to be here at times. I thought 
I don’t want to be.”  
(Case 2: Jake, Partner, p29:650-653) 
 
Feeling trapped in the relationship was a common theme from the partners who felt the cancer had 
taken over their lives and their relationships.  
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“I still love the woman, but it doesn’t seem too bright as it once did.”  
(Case 2: Jake, Partner, p21:487-489) 
 
Jake’s use of metaphor reflects how he perceived a change in his relationship, exposing the cancer as a 
period of darkness. 
 
Patients and their partners revealed how the increase in conflict contributed to their low mood but 
more significantly revealed their frequent desires to want to leave the relationship. 
 
“Before treatment, I said I would do anything for our relationship to work. After the treatment, I 
couldn’t be bothered, couldn’t care less.” 
 (Case 2: Julie, Patient, p11:250-253) 
 
“We both thought a few times we would split up, you know, I think she probably thought the same 
thing.” 
 
(Case 2: Jake, Partner, p22:506-510) 
 
The quotes from Jake and Julie demonstrate their desire to leave the relationship. For Jake, the 
combination of increased responsibilities (emotional and practical) paired with the perception of 
feeling his support was not good enough resulted in him feeling unappreciated and alone. Over time, 
this had developed into feeling hostile and resentful towards Julie, particularly once her treatment had 
ended. He also reported anger, and resentment when he felt his emotional and practical support was 
being taken for granted. Similarly, Julie felt her inability to openly discuss her emotions with Jake 
combined with her increased fatigue and side effects contributed to her increased levels of 
psychological distress but also impacted on her all aspects of her quality of life and wellbeing. 
 
Another significant indicator underlying the HNC couples increased reports of distress, that contributed 
to their relationship dissatisfaction was the communication breakdown between them.  
 
4.14.3 Communication and secrecy 
All three couples revealed a negative communication pattern throughout the cancer experience.  
Both patients and partners avoided discussion about the cancer. This pattern was especially shown in 
partners. Partners frequently worried about saying the wrong thing and felt by disclosing emotions 
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about the cancer they could hinder the patient’s wellbeing. The following quote by Jake highlights his 
own desire not to talk about the cancer for his own wellbeing as well as his partners. 
 
“If you have too many nights where you are discussing it, it will weaken your resolve. I won’t get up to 
go to work the next day because I can’t sleep. I’m not saying you have to shove it aside, but sometimes 
you have to, it doesn’t go away, it doesn’t go away, but you can’t keep talking about it too much or 
worrying yourself” 
 (Case 2: Jake, Partner, p7:142-147) 
 
Jake’s quote highlighted the increased emotional burden he felt from the cancer and the impact on his 
own well-being. The contradictions within his quote particularly show the difficulty he found coping 
with his partner’s cancer, and he avoided cancer-related conversations for his own wellbeing as much 
as for his partner’s. Again the language he uses within the quote, ‘weaken’, highlights the challenges in 
staying strong throughout the cancer experience.  
 
Subsequently, patients often reported feeling the burden and guilt of making their partner anxious. 
They revealed how they would have felt less burdened if their partner and family members disclosed 
their fears and worries about the cancer, which then would have helped to normalise their own 
feelings.  
 
“We had a row and he said ‘don’t you think I have thoughts of your funeral and the future without you’. 
I said I’m glad you actually said that because thank God you did have those fears which are normal. I 
needed to hear them.”  
(Case 2: Julie, Patient, p10:208-216) 
  
Julie’s quote indicates how she craved validation that her thoughts were not dysfunctional. She talked 
of her need for emotional validation and was relieved that her partner was able to communicate his 
emotions, as for Julie this meant that he did care about her which validated her insecurities about their 
relationship.  
 
As demonstrated in the previous theme, the dysfunctional communication related to the cancer was 
often the underlying cause to increased conflict in relationships. This included patients choosing not to 
share information about the cancer with their partners, which resulted in partners feelings isolated and 
unappreciated.   
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An example of lack of communication included patients choosing to attend appointments without the 
support of their partners. Mrs Smith revealed how she felt that she wasn’t trusted and was pushed 
away by her husband, which contributed to feelings of helplessness. In contrast, Mr Smith (patient with 
cancer?) felt he was being protective of her feelings and not wanting to burden his partner. This 
highlights how due to the lack of communication, the emotional appraisal was influenced by their own 
perceptions of the event, which, when in a highly stressed environment, was more likely to be 
appraised negatively. Mr Smith’s quote (below) also highlights how he avoids any cancer related 
conversation with his partner, which Mrs Smith revealed contributed to her increased anxiety as she 
was left to ‘think the worst’. Mrs Smith was extremely tearful through her interview and cited the lack 
of communication within her relationship regarding the cancer as the underlying cause of her elevated 
distress, but also the increased hostility and resentment she felt towards her husband. 
 
  
“I’m a very private person and I would say since 
that day (diagnosis) we have hardly ever spoken 
about it, we never spoke about how I feel really, 
we never really speak.” 
 
(Case 1: Mr Smith, Patient, p9:227-232) 
“He’s never ever wanted me at any appointment, 
and I have to respect that, that’s what he wants 
me to do (cries).” 
 
 
(Case 1: Mrs Smith, Partner p2:47-49)  
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There were also several conflicting accounts within couples in how they perceived changes in their 
relationship.   
 
Patient Partner 
“We have a strong relationship, we have been with 
each other 26-27 years so we have a strong 
understanding relationship.” 
 
 
 (Case 1: Mr Smith, Patient, p16:393-396) 
“I would have happily left him because of the 
lack of emotion and just (being) fed up. He 
can be a difficult person. Not to others, but to 
those close to him he’s an absolute bastard.”  
 
(Case 1: Mrs Smith, Partner, p9:200-203) 
  
“Wife is more important to me than anything else.” 
  
 
(Case 1: Mr Smith, Patient,p16:406-408) 
“If the prognosis was short term, that’s what I 
am saying, it would sort things out. Then I 
could get on.”  
(Case 1: Mrs Smith, Partner, p22:500-502)  
 
“If me and my partner can get through it, which I’m 
sure we can.”  
(Case 2: Julie, Patient, p11:245-246) 
“I still love the woman it doesn’t seem too 
bright as it once did.”  
(Case 2: Jake, Partner, p21:487-489) 
 
The extracts here show how patients retained hope in maintaining their relationship, in contrast to 
partners, who expressed increased hostility and resentment towards the patient.  
This emphasised the unique challenges to communication encountered by HNC couples and the 
consequences of negative impact of poor communication regarding the cancer.   
The interviews revealed that the communication between HNC couples is not straightforward. Some 
patients wanted to communicate, whereas other did not. A similar pattern was found in partners. The 
problems occurred when one person within the couple wanted to communicate and the other was 
resistant to talking about the cancer. A quote from Jake illustrates this: 
 
“There were a few times I would come home from work and say I do not want to come home and talk 
about fucking cancer. I can’t keep talking about it. A couple of times we had dinner and she brought it 
up and I went ‘do we have to talk about it now?’ I didn’t want to. We knew it was going on, none of us 
were stupid we all knew what was going on.”  
(Case 2: Jake, Partner, p37:869-87) 
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Jake’s quote is an example of how a partner’s negative response may discourage open communication 
between the couple. Jake’s partner Julie revealed how she found Jake’s inability to communicate 
contributed significantly to her levels of anxiety and distress related to the cancer. 
 
The interviews reveal that lack of communication not only had an impact on distress in couples but also 
affected quality of patient-partner relationship.  
 
4.14.4 Changes in intimacy 
The absence of activities and spending ‘quality’ time together was reported by all three couples. HNC 
couples’ definition of intimacy was multifaceted as they reflected on the relationship that existed prior 
to diagnosis and treatment. The narratives of HNC couples highlighted not only the loss of physical 
affection but also the loss of the sense of belonging within the relationship.  
 
This was illustrated in the below quotes from Julie. 
 
“I think he started to get fed up with me because I was in a bad mood all the time, sex life was gone, 
not interested.”  
(Case 2: Julie, Patient, p13:289-293) 
 
“I did think, ‘I wonder if he will go off with someone else.’ I started thinking who is going to want to be 
with me. Because when I met him I was quite positive and energetic. I started thinking I’m not the 
person he met so he’s not going to want to be with me.” 
 
 (Case 2: Julie, Patient, p25:574-579) 
 
Julie’s quotes highlight the issues of self-esteem and insecurities, but also paranoia she experienced 
within the relationship, particularly as her partner Jake, had become more distant.  
 
“I suppose we have become a little (more) distant from each other than before, without even realising 
it.” 
 (Case 2: Jake, Partner, p18: 409-411). 
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Jake (partner) described how the changes in the relationship occurred after the treatment. He felt it 
was this period that was most difficult, where the challenge was to try and rebuild the relationship 
following the roller coaster of emotions throughout the cancer experience. 
 
“We both thought a few times we would split up, you know, I think she thought the same thing too, this 
is after we went through it all (treatment).” 
 (Case 2: Jake, Partner, p22:506-510) 
 
In Jake’s extract, he revealed how the thoughts and desires of leaving the relationship occurred after 
the treatment had ended. This was a frequent theme amongst all the HNC couples that reflected the 
difficulties patients and partners experienced when trying to return their lives to normal. The 
resentment in partners was more prevalent at this period when they reported finding it difficult to 
return to the relationship they had before the cancer. 
 
There was an undercurrent in the HNC couples of mourning and loss for the relationship that existed 
prior to the diagnosis. Partners particularly expressed a sense of loss of a close relationship. This was 
particularly highlighted in quote from Mrs Jackson (partner). 
 
“I think you feel it’s a bit unfair as well you know. You’re just getting to your 60s which is comparatively 
young. We’ve always been healthy. You think ‘oh you can start relaxing now’ more and then you know.”  
 
(Case 3: Mrs Jackson, Partner, p11:239-243) 
 
Mrs Jackson’s narrative reflected mournful and resentful undertones, where she felt cheated by the 
cancer for taking over her life as well her husband’s. She questions why this would be happening to 
them as a couple, which further reflected her grief. 
 
“We miss our breaks, because we cancelled our holiday which was supposed to be big. Because we’re 
older now we must start doing these things so we, we, we cancelled that. We had a weekend away, but 
we had to cancel that, a friends 60th. Because obviously treatment comes first. It would be nice to just 
clear off somewhere. NEVERMIND.”  
(Case 3: Mrs Jackson, Partner, p8:186-196) 
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Although Mrs Jackson did not directly state that she blamed her husband for the changes to her 
relationship, the language and examples she chose to present to the researcher indicated the loss she 
perceived. Indirectly, she was blaming her husband and his cancer for the loss of her ‘quality of life’. 
 
 
4.14.5 Summary of “it doesn’t shine as bright as it once did” 
 
The theme ‘it doesn’t shine as bright as it once did’ demonstrates the significant impact and emotional 
strain that is placed on the relationship of couples living with HNC cancer. HNC couples showed high 
levels of relationship dissatisfaction, including hostility towards one another, resentment and in some 
cases a desire to leave the relationship. The lack of communication was the most common identifiable 
cause of negative thoughts and feelings between couples. Interestingly, couples reported the changes 
in relationship were even more marked once the treatment had finished, where the adjustment back 
to ‘normal’ life was more difficult than expected.  
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4.15 Superordinate theme three: 
What would have helped? 
 
The final superordinate theme, What would have helped?, highlighted patients’ and partners’ 
perceptions of the care they received and introduced their views and recommendations on what they 
would have found helpful during their experience of living with cancer. Each couple revealed various 
stages of the cancer that they found most difficult and the type of support that would have been 
beneficial during these difficult periods. 
 
Subthemes included: 
 
 Willingness to accept emotional support explores the partner’s reluctance to accept 
emotional support. 
 ‘Fear of the unknown’ examines a need for better emotional support for patients, but also for 
the partner and family, particularly during times of increased emotional distress i.e. diagnosis, 
and treatment.  
 What can we do? Reports suggestions and recommendations for the type of support patients 
and partners would be willing to accept. 
 
4.15.1 Willingness to accept emotional support 
Patients highlighted feeling excessive guilt and anxiety for placing the burden of cancer on their 
partners and believed that if there had been emotional support available for their partner it would 
have made them less anxious. Julie’s quote below is an example of this. 
 
“I would’ve felt better, definitely. Because I wouldn’t have felt guilty. I would’ve been quite happy if he 
had the chance to off load to somebody. Go talk to someone else about that. I knew he was scared, it 
irritated me why he kept doing the stiff upper lip.” 
 
(Case 2: Julie. Patient, pg35 802-808) 
 
The quote reveals the guilt and anxiety Julie felt for placing the burden of cancer on her partner. As 
demonstrated in the previous themes, these feelings of guilt eventually resulted in negative emotional 
responses including increased resentment and anger. Therefore the benefits of emotional support for 
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partners could have a direct effect in decreasing patient’s psychological distress and improving their 
quality of life, by lifting their burden of guilt.  
 
However, there was a clear conflict within partners’ dialogue in relation to receiving emotional 
support. Partners identified a need but felt conflicted as to whether they ‘deserved’ any emotional 
support. An example of why partners were reluctant to accept support is demonstrated in the below 
extract from Mrs Smith: 
 
“I don’t think the non-victim takes it up (support) the same way the victim does because I think you feel, 
how do I word this. You (patient) need it because it’s happening to you. I don’t need it because it’s not 
happening to me. Are my needs therefore different? Is it a sign of weakness? Does it look like a sign of 
weakness?  
 
“You’re the one who needs everything because you are in the middle of it. I don’t need anything, because 
I should be stronger and see things through. (Cries)… Equally, it’s like now, look at me I’m a mess but it’s 
where do you separate the feeling of what’s happening from the whole package? I don’t think you can. I 
therefore, I think it is unjustified to have somebody to speak to.”  
(Case 1: Mrs Smith, Partner, p28-29: 647-664) 
 
Mrs Smith’s quote indicates her conflicted emotions. Emotional support had become a reward which 
she felt she did not deserve. Her husband was the ‘victim’ and therefore not responsible for the cancer 
so he was entitled to sympathy and support unlike her as the ‘non-victim’. Mrs Smith acknowledged 
she needed support, but held a belief that if she were to accept, she would be failing in her role as the 
perfect ‘cancer partner’. She also highlighted the stigma attached to receiving support for emotional 
wellbeing, particularly the belief that seeking and accepting emotional support would be a sign of 
‘weakness’. This would have challenged the ‘staying strong’ obligation she felt she had to retain in 
keeping with her identity as the ‘perfect’ cancer partner. These themes were consistent in the 
narratives amongst the HNC partners, who felt conflicted between needing support and their 
willingness to accept support.  
 
Mrs Smith suggested there is a need for an ‘automatic appointment’ for partners from diagnosis. She 
highlighted that if there were a compulsory appointment, she would have not felt as if she was ‘asking’ 
for help thus would not be confronted by her perception of emotional support being a sign of 
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weakness. Having a compulsory appointment would have allowed her an outlet to discuss worries and 
fears related to cancer without the concern of being judged. 
 
Mrs Smith: “It should be an automatic appointment almost that you can’t get out of. Because I think 
for most people it would be that initial appointment that would be the hardest to go to, probably at 
diagnosis because it would make you feel part of it. So you make a connection.” 
 
Interviewer: “Would you want Mr Smith to attend the appointment with you?” 
 
Mrs Smith: “Oh God, not with, never with, no no noooo.” 
(Case 1: Mrs Smith, Partner, p30:688-702) 
 
 
4.15.2 ‘Fear of the unknown’ 
This subtheme examines the increased psychological distress partners experienced following 
treatment. All three HNC partners reported that the first contact they had with the patient following 
the surgery was particularly distressing. They revealed it was at this point that they realised the reality 
of HNC and how it was going to change the rest of their lives. 
 
“I found it hard to walk into the ward because I didn’t know what I would find (cries). I think that’s 
when you need someone (professional) to go in with you. If it’s somebody that has made a connection 
with you already then that would be supportive because then you can talk to them after. They would be 
there to say that was perfectly normal. You don’t know what you’re going to see. That is probably when 
I was at my worst.” 
(Case 1: Mrs Smith, Partner, p32:732-747) 
 
Mrs Smith’s quote shows her increased distress following her husband’s surgery. This occurred from 
not knowing what to expect and therefore not being mentally prepared for the reality of seeing her 
husband looking vulnerable. This was consistently reported amongst partners who felt psychologically 
unprepared for the first contact following treatment. Partners revealed seeing their partner looking ‘ill’ 
triggered the negative thoughts and feelings experienced at diagnosis. These included the worries 
about their future together but also the fears of losing their partner. It was suggested by partners that 
emotional support during this time, would have been beneficial to help cope with these thoughts and 
feelings.  
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The couples, who had experienced adjuvant radiotherapy treatment, reported how they would have 
also benefited from having better written and verbal information about the psycho-social impact of the 
treatment. This is specifically highlighted in Jake’s quote. 
 
“The radiotherapy, what is does to your relationship it’s bad. It’s not good. It’s not just the six weeks. 
It’s the six weeks after. 12 weeks. Three months, a lot of turbulence. A lot of mood swings, you know.” 
 
 (Case 2: Jake, Partner, p49:1158-1166) 
 
Jake’s quote suggests the significant impact of the treatment on his relationship with his partner. He 
believed if he was given more information about psychological side effects, such as increased 
irritability and fatigue, he would have been better prepared to deal with these factors. 
 
“I suppose if there is something you could do, most people who have had the operation and the cancer 
removed (surgery) most people don’t know what they still have to come, we didn’t. We were too busy 
patting ourselves on the back. ‘Oh it’s out-brilliant.’ We’ve only got the radiotherapy to go. When really 
the radiotherapy was bigger than the actual operation and what it can do to your relationship and then 
you see that person ill. So if there is something you could do. You could probably ante up on trying to get 
people to understand after the operation that there is a lot more to come. Because we were totally 
unaware of what radiotherapy entails. The radiotherapy is actually worse than the operation to live with 
as a partner.” 
(Case 2: Jake, Partner p48:1134-1139) 
 
4.15.3 What can we do? 
This subtheme identified possible systems of support that HNC couples felt would have helped improve 
their emotional needs and reduce psychological distress. 
 Cancer buddies 
HNC couples found comfort in speaking with friends who had been through similar experiences but felt 
they did not want to continuously burden them with talking about their cancer. They revealed they 
would have liked to have had an external source of support, for example a former patient, to be able to 
talk with from diagnosis.  
 
Julie: “It would’ve been nice to have talked to another patient that had been through the same thing.” 
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Interviewer: “At what point would you have felt that would have been useful?” 
 
Julie: “As soon as I was diagnosed I think and through the whole thing.” 
 
(Case 2: Julie, Patient, p29:668-675) 
 
Patients believed another patient who shared their diagnosis and been through a similar journey, 
would have allowed them to communicate their treatment concerns or simply share thoughts about 
their cancer which they felt unable to do with their partners and clinical team members in the busy 
clinical environment. 
 
“I often felt the clinical team was too busy and they have got so much to do. I would always go ‘yes I’m 
fine’ because I didn’t want to burden them with more because I knew what a big job they were doing.”  
 
(Case 2: Julie, Patient, p36-7:839-857) 
 
Julie’s quote highlighted her continual worries about being a burden, and felt that an anonymous 
service where patients could openly discuss their fears and worries within a controlled environment 
would have also been beneficial. This would have reduced her fears of being judged and also reduced 
the emotional responsibilities on others. 
 
“Somebody to waffle on to about how I felt. Similar to I suppose like you have Samaritans or Child Line. 
Sounds silly but do you know what I mean. Where you, I suppose, have semi-professional people 
because they would know what you are talking about, like a counsellor like that at the end of the 
phone. When everyone else is asleep and I’m awake at 3am and sometimes choked up and someone 
then to talk to rather than thinking is this normal and Googling and frightening myself more.” 
 
(Case 2: Julie, Patient, p36:839-846) 
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 Couples counselling  
Partners reported the same emotional needs and concerns as the patients and felt they would have 
also benefited from talking to other cancer partner’s about their experiences.  
 
“It needs to be someone who experienced it, not someone who is experiencing it.”  
(Case 1: Mrs Smith, partner P44.1004-1005) 
 
In addition, partners emphasised a need for improvement in communication within their relationship, 
as they believed the lack of communication was the underlying factor to the increased levels of conflict 
and relationship dissatisfaction following the diagnosis.  
 
“I think there is definite room for couples’ counselling.” 
(Case 1: Mrs Smith, partner p34. 784-791) 
 
Mrs Smith believed couples’ counselling would have helped facilitate better communication between 
her and her husband, which had completely broken down following the diagnosis. The difficulty in 
communication was reported amongst all HNC couples, where poor communication and emotional 
avoidance became the common coping strategies when faced with cancer related problems.   
 
Therefore, improving communication channels between couples during the cancer may have assisted 
with couples’ overall relationship quality and therefore improved their quality of life. 
4.15.4 “What would have helped summary” 
Currently, in the treatment of HNC, emphasis is quite rightly placed mainly on physical functioning and 
increasingly health-related quality of life factors are also highlighted during consultations. However, 
minimal focus, if any, is applied to the emotional impact of the cancer and there is no specified 
multidisciplinary team member assigned to this role. There appears not only to be a significant need 
for this service, but also for an additional shift to provide emotional support to the partner and family 
members. Overall, patients were satisfied with the health services they had received for their cancer. 
Several suggestions by patients and their partners were made which highlighted the lack of emotional 
support currently available within HNC service. However, there is a potential barrier between offering 
support and willingness to accept support, particularly within partners of HNC patients.  
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4.16 Summary of Qualitative findings 
 
The findings of this and other studies show that partners play an integral part within a patient’s 
rehabilitation process and that the impact of the cancer on the partner of HNC patient is as significant 
as the impact on the patient. Partners of HNC sufferers essentially became ‘secondary patients’ with 
levels of emotional distress similar, if not higher than the patients’ with additional consequences on 
physical health. 
 
The present findings indicate that partners who show increased levels of distress pre-treatment may 
find it more difficult to adjust to the emotional challenges across the cancer experience. The most 
frequently reported concerns of partners were finding the best ways of being supportive whilst 
contending with own distress. This was challenging as they were experiencing such high levels of 
psychological distress themselves. Therefore, they found it more difficult to internalise their own fears 
and anxieties as well as contending with the patient’s fears and anxieties. Over time internalising their 
distress became more difficult and due to their increasing levels of distress, partners were more likely 
to be sensitive to the negative aspects of the disease, struggling to remain positive and optimistic.  
 
HNC couples reported a decline in satisfaction in their relationship which was reported to contribute to 
an increase in their levels of psychological distress. An exploratory model of the findings is reported in 
Figure 30. 
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Figure 30: An Exploratory model showing the impact of HNC on patients and their partners. 
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Figure 30 shows an exploratory model of the findings from the qualitative study. The model shows 
the relationship between patients and their partners’ psychological distress and how this impacts 
patients’ QoL. The analysis found partners’ psychological distress before treatment contributed to 
each of the following constructs: cognitive response, social support from partner, cognitive self-
appraisals and patient psychological distress. The results of this study show that patients’ and 
partners’ coping behaviours, perceptions of support and cognitive self-appraisal (for example 
negative cognitions of guilt, blame, burden) were affected by each other’s responses. Also, patients’ 
psychological distress was directly affected by their coping style, perceived support from partner as 
well as their partner’s psychological distress, coping style, and perceived social support. The same 
factors were found for partners’ psychological distress. The model also explains how our findings 
showed patient-coping style, perceived partner-support, and appraisals of cancer were related to 
each partner’s coping style, social support and appraisals of cancer. Furthermore, relationship 
satisfaction during treatment and following treatment was reported as the most significant 
contributing factor in patient and partner psychological distress. All these factors affected HNC 
patients overall QoL. 
 
This model proposes that partners who show high levels of distress before treatment are less able 
to engage in this coping process effectively and therefore this will have a negative impact on 
patients’ psychological distress, poorer quality of support and maladaptive coping responses e.g. 
avoidant coping response, therefore effecting patient QoL. 
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4.17 Qualitative Discussion 
 
To the knowledge of the author, this is the first qualitative study that specifically examines the 
experiences of HNC couples, where the patient’s partner reported high levels of psychological 
distress before commencement of treatment.  
 
In summary, three key themes were raised within the present analysis. “We got cancer”, which 
reflected the reciprocal effect of the cancer, ”it doesn’t shine as bright as it once did” highlighted 
the negative impact of HNC with couples relationship and “what would have helped?” introduced 
views and recommendations from the HNC couple presenting recommendations for what would 
have helped during their cancer experience. 
 
The analysis of interviews highlighted how when one partner is diagnosed with the cancer, both 
partners experienced stress associated with the illness. A dominant theme was the notion of 
adhering to an ideal of being the ‘perfect cancer partner’ which was entrenched in patients’ and 
partners’ perceptions of how they believed they should behave when faced with the cancer. Both 
held preconceived ideas of what was expected from them in their new identities. They revealed 
feeling obliged to present a constant persona of ‘fighting the cancer’ and ‘staying strong’. However, 
what was clear within participant’s narrative was the inability to sustain this positivity, which led to 
feelings of inadequacy, self-blame and guilt. Reave, (1997) highlighted how staying positive during 
cancer opens the possibility for blame and guilt when patients with cancer are unable to sustain 
this way of thinking (Reave, 1997). This raises the question of positive and negative thinking in 
cancer care. The psycho-oncology literature concerned with coping strategies suggests that the 
coping style of thinking positively and maintaining a fighting spirit is correlated with the cancer 
patient’s overall level of mental health and mortality rates (Allison, Guichard, Fung, & Gilain, 2003). 
Our findings showed this coping style could also represent an additional stressor for cancer 
patients. In this case, thinking positively does not represent an accurate report of how one thinks, 
but rather a conversational idiom, summarising a socially normative moral requirement. This is 
supported by Petticrew and colleagues, (2002) who found no clear association between a thinking 
positively coping style and recurrence or survival in cancer (Petticrew, Bell, & Hunter, 2002). 
Petticrew et al (2002) concluded that people with cancer should not feel pressured into adopting 
particular coping styles to improve survival or reduce the risk of recurrence. As our sample was 
purposively selected to include partners with psychological distress at diagnosis, this may explain 
why this sample in particular were finding it more difficult to maintain a ‘positive thinking’ and 
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‘fighting spirit’ during their cancer experience.. When an individual is experiencing elevated 
symptoms of psychological distress, they may be more likely to adopt a negative thinking pattern, 
which was highlighted within the interviews. This may explain why patients and partners found it 
more difficult to adhere to the ‘perfect cancer partner’ role. Future studies examining HNC couples 
that are not experiencing elevated symptoms of psychological distress could help determine 
whether these findings are limited to individuals who are more vulnerable to the effects of stress. 
As our quantitative findings showed, prevalence of partners with psychological distress in high (40% 
depressive symptoms at diagnosis: see Figure 14), therefore the partners interviewed may not be 
exceptions. 
 
 
The second emergent theme within the data was “it doesn’t shine as bright as it once did”, which 
reflected the negative changes that occurred within the patient-partner relationship. A dominant 
theme found within the interviews was the negative exchanges within the patient-partner 
relationship. HNC couples revealed increased hostility, relationship conflict and resentment 
towards one another. This increased hostility and resentment towards patients raises several 
clinically relevant implications.  
 
Firstly, it highlights the significant demands that are placed on partners of cancer patients. These 
demands result in caregiver strain and possibly caregiver burnout. Caregiver burnout has been 
described as a measure of emotional and cognitive response to caregiving, and has two key 
concepts. Emotional exhaustion, which refers to a loss of emotional resources and to a feeling that 
one lacks the energy to invest relationships and depersonalisation, which refers to a negative and 
indifferent attitude toward patients (Ybema et al., 2002).  
 
For caregiving partners, caregiver burnout may be a consequence of increased emotional 
exhaustion over time, with the increased hostility and resentment towards patients indicating 
depersonalisation. This would explain why some partners of HNC patients showed increased 
hostility and started to show dysfunctional thoughts and resentment towards the patient. A second 
clinical implication of increased hostility towards the patient is the quality of support provided by 
the ‘well’ partner who holds these dysfunctional thoughts. Negative social support, particularly 
negative behaviours has been found to increase psychological distress in patients and therefore 
decrease QoL (Manne, Taylor, Dougherty, & Kemeny, 1997; Manne, Ostroff, Winkel, & Grana, 
2005).  
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Finally, increased hostility towards the patient was reported as the antecedent to increased 
relationship conflict consequently increasing stress to the patient, which may contribute to 
elevated psychological distress and affect patent QoL. Our findings would suggest that partners 
who experienced elevated psychological distress pre-treatment were more susceptible to show 
increased hostility within the relationship.   
 
Another key finding from the qualitative interviews was the negative impact of poor 
communication between couples. Manne et al (1997) highlighted two types of communication 
strategies that were commonly employed amongst patients with cancer. First was ‘positive 
communication’ which suggests the benefits of open communication, including disclosure of 
feelings and concerns to one’s partner, and second was ‘negative communication’, which involves 
criticising one’s partner, avoiding cancer related concerns and or pressuring ones partner to discuss 
ones concerns (Manne et al., 1997). All three couples within the study indicated ‘negative 
communication’ where patients were less willing to communicate with their partners about the 
cancer. The consequences of such behaviours meant that there were frequent misunderstandings 
between couples with increased withdrawal from one another. Negative communication 
contributed to increased hostility and resentment within the relationship.  
 
Similar findings have been supported by larger quantitative studies which have shown how negative 
communication such as avoiding cancer related conversations have been associated with greater 
distress for both partners (Manne, Ostroff, Winkel, Grana, 2005). Our findings identify the potential 
clinical need to improve communication amongst HNC couples, particularly where one or both 
partners are experiencing heightened psychological distress. Better communication between 
couples would facilitate reciprocal influence, which in turn would have a positive effect on intimacy 
between the couple and improve the patient and partner outcomes. 
 
Currently within HNC, details regarding physical functioning and health related quality of life factors 
are often highlighted during consultations. Minimal focus, if any, is applied to the emotional impact 
with no specified multidisciplinary team member assigned to this role. There appears to be a 
significant need for this service, but also an additional shift to provide emotional support to the 
partner and or family member. Overall, patients were satisfied with the services they had received 
for their cancer, but suggested emotional support for their family and partners would be beneficial 
for their wellbeing in addition to their partners.  
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However, unexpectedly, partners were resistant to accept direct emotional support. One 
explanation for this resistance may be that the partner might perceive acceptance of help as a 
failure in their role as the caregiver. This is supported by Thoits (1991; as cited in Hagedoorn et al 
2002) who suggested that if taking care of your partner is an important part of one’s identity, 
problems in this area or failing in caregiving task (for example asking for help) will cause 
considerable distress. This may explain a partner’s resistance to accept emotional support. 
Hagedoorn et al (2002) argued this may be especially relevant in women, as maintaining social 
relationships and taking care of the spouse and children have been mainly the responsibility of 
women Hagedoorn et al., 2002). Our findings would suggest, although partners of patients are 
reporting elevated symptoms, if offered emotional support for this distress, partners may be 
unwilling to accept it.  
 
The majority of studies that have examined relationship satisfaction following cancer treatment 
show how relationships were strengthened and couples emerged more tightly bonded (Lavery & 
Clarke, 1999). The disparity between the present findings may be explained as the present study 
was purposively selected to interview partners who were showing increased psychological distress. 
These individuals may be more likely to report lower relationship satisfaction as Hagedoorn et al 
(2008) found a negative association between elevated levels of psychological distress and marital 
satisfaction (Hagedoorn, Sanderman, Bolks, Tuinstra, 2008; Manne, Taylor, Dougherty, & Kemeny, 
1997). The unique aspect of the present study is the insight into lived experiences of HNC couples 
who are showing elevated levels of psychological distress which appear to show a difference in 
adjusting to the cancer when compared to findings that have examined couples adjustment to 
cancer, not accounting for levels of psychological distress (Lavery & Clarke, 1999). 
4.17.1 Strengths of qualitative study 
One of the strengths of the qualitative findings is the use of the IPA method for analysis allowing an 
exploration of the explanations underlying HNC couples’ thoughts, beliefs and behaviours regarding 
their cancer experience. It allowed for a deeper more personal analysis into the lived experiences of 
HNC patients living with a partner experiencing psychological distress before treatment. These 
findings provide a deeper insight and complement the quantitative findings. 
Another strength is that participants were purposively recruited to present a homogeneous sample 
in terms of the levels of partner psychological distress, therefore giving a unique perspective into 
the underlying factors contributing to this distress. Although the sample was small, it was still 
sufficient enough to provide in-depth analysis of HNC related issues, revealing new insights and 
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identifying several clinical implications for further research and application. As open-ended 
interview was utilised; the data collected from HNC couples represented topics and themes that 
were important for the participants and not researcher-led.  
 
Furthermore, a good rapport was gained with all participants who answered all questions, including 
the most sensitive. In future work it might be even more useful to have, shorter interviews over a 
longer period to provide richer data and allow for greater engagement with participants which may 
give even deeper insight into HNC. 
4.17.2 Limitations 
The explorative nature of the present study has its methodological limitations. Firstly, the sample 
comprised predominantly white British couples, with more male than female patients. Although 
there are more male than female HNC patients in the general population, a more diverse sample in 
terms of ethnicity and gender might have revealed different findings. For example, previous studies 
have suggested that there are ethnic/cultural differences with regard to the level of comfort that 
individuals have with depending on their partners for emotional support (Kagawa-Singer, & 
Wellisch, 2003). Because so little is known about differences with regard to couples communication 
and intimacy across different ethnic groups, future studies would benefit from evaluating cultural 
differences. 
 
There was a low rate of study acceptance for the qualitative interviews, which suggests the 
difficulty HNC couples may have in expressing their narratives of the cancer experience. Study 
refusers may also have been more distressed at 12 months when approached which may have 
biased the present results towards less distressed individuals. There is the risk that the couples that 
were willing to participate were those who had a great need to narrate their experiences. The 
nature of the study may also mean people may struggle to express what they are thinking and 
feeling as there are things they do not wish to self-disclose, wanting to present themselves in the 
best possible manner. However, I would argue that we achieved a great deal of openness from our 
participants with open verbal dialogue regarding sensitive issues. 
 
Analysis of findings was interpretative and thus dependent on the researcher’s ability and 
experience. An experienced psychiatrist (AK) was involved in the process of analysis, providing 
constant comparisons and discussion of findings that strengthened the validity of the 
interpretation. 
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4.17.3 Assessing validity 
The centrality of researcher subjectivity within IPA means that traditional research evaluation 
criteria such as representative samples are irrelevant (Smith et al., 2009). Each theme is supported 
by verbatim extracts providing a ‘grounding in examples’ (Brocki & Wearden, 2006, p. 97) which 
show validation of themes.  
 
51Lucy Yardley’s four broad principles for assessing the quality of qualitative research were followed 
to assess the validity of the present findings (Yardley, 2000). This involves attention to four broad 
principles; sensitivity to context, commitment and rigour, transparency and coherence and impact 
and importance. 
 
Sensitivity to context: Within the present study sensitivity to context is presented by each 
emergent theme being validated by quotes from the participants. In addition, a key aspect of IPA is 
validating each theme with the existing literature, which is presented in the discussion. 
 
Commitment and rigour: Commitment was demonstrated in several ways within the present study. 
Firstly, there was a degree of attentiveness to each participant within the study. Secondly, the 
interviews were listened and re-read multiple occasions. Thirdly, transcripts were transcribed 
verbatim and checked by two independent auditors to check audio matched each script. 
Rigour refers to the thoroughness of the study. The sample was carefully selected to address our 
principle research question. The analysis was conducted systematically following several stages of 
interpretation to reach the final themes. To reduce researcher bias, an independent auditor was 
involved in the process of analysis, providing constant comparisons and discussion of findings which 
strengthened the validity of the interpretation.  
 
Transparency and coherence: Each stage of analysis is detailed within the qualitative methods 
section 4.6 and appendix 8.3. In terms of coherence, the emergent themes were consistent with 
existing literature and supportive of quantitative findings. 
 
Impact and importance: The analysis has identified key areas for future research and presented a 
unique insight into the underlying factors that contribute the HNC couples’ psychological 
adjustment and factors that impact on QoL. Therefore findings are of clinical relevance and 
importance. 
                                                          
51 Yardley, L. (2000). Dilemmas in qualitative health research. Psychology & Health, 15(2), 215–228. 
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Within IPA, and the qualitative paradigm in general, there is more of a focus on the possible 
transferability of findings from group to group rather than generalisation. Smith et al. (2009) also 
argue for ‘theoretical generalisability’, where the reader may be able to ‘assess the evidence in 
relation to their existing professional and experiential knowledge’ Thus it can be argued that 
idiographic qualitative research such as IPA has much to contribute to our understanding of 
phenomena, as it can complement actuarial claims derived from quantitative studies. 
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4.17.4 Implications for clinical practice? 
 
These findings clearly show that patient and partner distress are related.  Recommendations from 
the present findings would be; including partners in clinic conversations, paying attention to their 
questions and concerns and including them in treatment plans (if patient agrees). Another 
recommendation would be facilitating positive communication i.e. encouraging patients to be open 
about their cancer to their partners, as communication difficulties dominated poor adjustment to 
cancer in both patients and their partners. 
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4.18 Overall Qualitative Conclusions 
 
In my repeated listening, transcribing and re-reading through the transcripts, some very clear 
themes within the couples were soon apparent. Interestingly, without any prompting, the 
structures of the narratives often followed the trajectory of the disease. From the diagnosis, 
multiple hospital procedures, treatment phase to their point of interview (12 months post 
diagnosis). These are all times when an intervention could be made to improve the patients cancer 
treatment outcome. 
 
Other features within the interviews included descriptions of diagnostic procedures, stories of the 
endless waiting in hospitals, initial denial of symptoms but most dominant was the impact of the 
cancer on the patient-partner relationship. Unexpectedly, there was very little talk of pain and 
discomfort from the patients, and although the topic of the impact of HNC on patient’s physical 
health was raised by the interviewer, participants did not particularly engage with this question. 
 
After close examination for similarities and variability between the three case studies, I feel the 
themes that have been presented share the ‘lived’ experiences of head and neck cancer within this 
sample the next step would be to look at couples with low distress or different cultural backgrounds 
to get even more insight into our patients lives. 
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5 General discussion 
This final chapter discusses the overall conclusions that can be drawn from the quantitative and the 
qualitative results of this study. Firstly, a summary of the data is presented and how these relate to 
the original aims of the thesis. The methods are also critically discussed with suggestions for 
possible improvements. Finally, a discussion of the clinical significance of these findings with 
reference to future proposed clinical interventions for patients and their caregivers are reported. 
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5.1 Aims and Findings 
This study, to the best of my knowledge, is the first to assess the impact of caregivers’ psychological 
states on HNC patients’ QoL. To address this issue, a mixed methods longitudinal design was 
undertaken. This was a key strength of the study as the quantitative phase was able to give an 
insight into the prevalence of psychological distress, and assess and explore factors involved in the 
association between psychological distress and QoL. The qualitative findings further complemented 
the quantitative results by providing a deeper understanding of the ‘lived experiences’ of HNC 
couples.  
 Prevalence of psychological distress in patients and caregivers 
 
One of the aims of this study was to measure the prevalence of psychological distress (anxiety and 
depression) in patients and their caregivers (partners and family members) before treatment and 6-
12 months following treatment. The present findings showed 17% of HNC patients reported clinical 
levels of depressive symptoms before treatment, increasing to 27% 6-12 months following 
diagnosis. This increased prevalence suggested a proportion of patients experienced a significant 
period of stress associated with the cancer which continued at least up to 6-12 months following 
diagnosis. This indicates that measuring psychological distress pre-treatment may identify patients 
who are at greater risk for distress at 6-12 months following diagnosis. This is supported by Funk et 
al, (2006) who found pre-treatment scores of depression were predictive of patients’ scores 12 
months following diagnosis (Funk et al., 2012). The longitudinal assessment of psychological 
distress is a significant strength of this study, as previous studies have only presented prevalence 
levels at one time point (Akira Kugaya, Akechi, Okuyama, & Nakano, 2000; Pandey et al., 2007;  
Rogers et al., 2006). Caregivers, particularly the partners of patients, reported significantly higher 
symptoms of depression and anxiety than the patient at both time points. These findings support 
the study by Braun et al 2005 who found 40% of spouse caregivers of advanced cancer patients 
(lung and gastrointestinal) showed elevated symptoms of depression compared to 20% in patients 
(Braun, Mikulincer, Rydall, Walsh, & Rodin, 2007).  
Measuring the prevalence of psychological distress in partners and family enhances the current 
caregiving literature by providing a prospective measurement of psychological distress within head 
and neck cancer, but more importantly it also lends weight to the assertion that caregivers of HNC 
patients have higher levels psychological distress than patients.  
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 Why is the prevalence of psychological distress higher in caregivers than in HNC 
patients? 
One explanation for the disparity in psychological distress levels may be due to the changes in 
emotional demands made over time. Before and during treatment great physical and emotional 
demands are placed upon caregivers, not only to provide emotional support to patients, but also 
practical support, such as attending appointments and caring for them following treatment 
(Stenberg et al., 2010). In contrast, patients themselves receive active support from the health care 
team and therefore may also feel more supported emotionally. This would explain the differences 
in prevalence levels particularly before treatment, where partners show significantly higher 
symptoms of psychological distress than patients (43% v 17%). Differences between patients and 
their caregivers did become smaller over time.  Patients showed increased levels of psychological 
distress 6-12 months following diagnosis, whereas caregivers’ levels slightly decreased. This may be 
explained by changes in the emotional demands of HNC once treatment has finished or nearing 
completion. Patients are often expected to begin making the transition of ‘getting back to normal’ 
with less support from the clinical team than they may have received within the first few months of 
diagnosis. This is when patients may be left to adjust to the many changes that HNC has imposed 
upon their lives. Those patients who report psychological distress, particularly depressive 
symptoms, maybe those who are finding the adjustment back to ‘normality’ more difficult. At the 
same time, 6-12 months following diagnosis, caregivers may strive for a return to their normal lives 
after providing both practical and emotional support to patients.  
 
However, further and more detailed explanations for the increase in psychological distress 
specifically in partners were revealed through the qualitative interviews. Partners reflected on the 
difficulties and challenges of dealing with their own emotions during diagnosis and discussed the 
increased burden by this new identity as the ‘cancer partner’ whose role was to remain positive and 
support patient. Feelings of guilt ensued if they were to indulge in these negative emotions and 
therefore they chose to internalise anxieties and worries. These feelings were particular dominant 
at diagnosis and thus may be one of the explanations for increased anxiety shown by elevated 
HADS scores during this time. This explanation is supported by Stenberg et al (2010) who reported 
effects on caregivers when caring for a patient with cancer, with the most commonly reported 
being emotional problems and the increased responsibilities during and after treatment and 
rehabilitation.  
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Gender differences may provide an alternative explanation to the disparity in prevalence of 
psychological distress between patients and their caregivers, as women partners and family 
members dominated the caregiver sample.  Women within the general population are more likely 
to acknowledge and report elevated symptoms of depression and anxiety (Piccinelli & Wilkinson, 
2000) and therefore the present findings may have reflected these differences.  However, the 
findings from breast cancer studies where the caregivers are predominantly male (Braun et al., 
2007; Hannum, Giese-Davis, Harding, & Hatfield, 1991; Manne et al., 1997),  support the present 
results and have shown that male partners also report higher symptoms of psychological distress 
than patients, which would therefore question this possible explanation.  
 
 Association between patient and caregiver psychological distress and 
patient QoL 
 
A second key aim of the present study was to examine the association between patient and 
caregiver psychological distress and patient OoL. The findings showed HNC patients with 
psychological distress showed significantly lower scores in the physical, psychological, social 
relationships and environment QoL domains. Multivariate analysis showed depressive symptoms 
were the strongest independent predictor of patient QoL at both time points, supporting the 
findings by Howren and colleagues (2010) who found that depressive symptoms before diagnosis, 
were associated with poorer HRQOL one year later. The present findings expanded on Howren’s 
study (2010), and suggested depressive symptoms in patients not only affected their physical QoL, 
but also factors associated with social relationships and environmental factors (i.e. work and 
financial). This gave a greater insight to the impact of psychological distress on a wider construct of 
QoL. These findings suggested that HNC patients’ emotional state during cancer, not only affected 
their physical wellbeing, but also every aspect of their day-to-day lives. In addition to these findings, 
a more pertinent result was patients who had a caregiver (partner and family members) showing 
psychological distress also showed poorer QoL. To the knowledge of the author, this result is the 
first within HNC to show this association. Further to this finding, the current study also presented 
evidence which showed patients had lower QoL 6-12 months following diagnosis if their caregivers 
reported high levels of psychological distress before treatment. However, these findings were 
based upon univariate analysis and as previously stated, it would be prudent not to over-interpret 
them as firm findings. However, as an exploratory model, these findings showed that there is scope 
 171 
 
for patient and caregivers psychological distress to influence patient QoL 6-12 months following 
diagnosis. 
 
Why would caregivers’ psychological distress affect patients’ QoL? 
 
There could be several explanations why caregivers’ psychological distress had a negative impact on 
patients’ QoL. 
 
Caregivers who were suffering from increased psychological distress, particularly at diagnosis, may 
have become less emotionally resourceful and utilised more negative coping behaviours, such as 
avoidance or emotional withdrawal, to alleviate the negative thoughts about a patient’s cancer.  
These avoidant coping behaviours may have resulted in caregivers becoming less emotionally 
available for the patient which would have a negative impact on the quality of social support 
caregivers were are able to offer and thus in turn resulting in poor social support for the patient. 
This explanation is based upon the Lazurus and Folkman’s transactional model of stress and coping 
which proposes that increased stress can impact individuals coping response which can result in 
negative coping behaviours such as avoidance (Folkman & Lazarus, 1986; Hulbert-Williams, 
Morrison, Wilkinson, & Neal, 2013; Lazarus .and Folkman, 1984).  This may therefore have a 
negative impact on a patient’s QoL due to poorer social support from the caregiver. Northouse et al 
(2001) showed when spouse caregivers were highly distressed, cancer patients reported more 
problems adjusting to the illness over time (Northouse, Templin, & Mood, 2001) 
  
Furthermore, the qualitative study highlighted how distressed partners (i.e. partners who reported 
psychological distress at diagnosis) reported increased resentment, hostility and anger towards the 
patient over time, which resulted in increased relationship conflict and relationship dissatisfaction 
(see chapter 6 add section number qualitative discussion). Findings by Manne et al (1997) found 
that patients reported higher symptoms of psychological distress and lower QoL, when they 
perceived their partners to be showing negative behaviours towards them. Therefore, negative 
social support from caregivers may have also been a contributing factor to patients’ lower QoL. 
 
 
The recognition that social relationships can be a source of strain is not new, but there appears to 
be a great need to further examine the consequences of negative social support particularly within 
cancer, as the present findings suggest that caregivers’ own psychological distress may reverse the 
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positive ‘buffering effects’ of social support as originally proposed by Cohen and colleagues (Cohen 
& Wills, 1985).  
 
Although it is tempting to discuss the association of findings in causal terms, assumptions of 
causality cannot be made based from the present. For example, high psychological distress in 
partners and caregivers may be a reaction to the patient's psychological distress and vice versa. 
However, what the present findings showed was the importance of the caregiver’s role in HNC, and 
how their psychological functioning had an effect on the patient’s functioning.  
With consistent evidence showing that couples react as an ‘emotional unit’ to cancer diagnosis, 
healthcare professionals should begin including the partner in the basic support they offer to 
patients. This is especially important as our findings have shown distress in caregivers; particularly 
in partners, where it can be higher than in patients. If partners or family members are to become 
active agents of help for the patient, it is proposed they should first be prepared psychologically for 
the task. 
 
Do clinical factors have affect patients’ QoL? 
 
The present findings also showed 6-12 months following diagnosis there were no statistical 
differences between treatment, stage of cancer, or tumour site. Patients reported similar levels of 
QoL within these domains.  These findings strengthen the evidence that clinical variables may play a 
minimal role in the impact on patients’ perceptions of their QoL. 
One explanation for these findings may be that the WHOQOL-BREF may lack sensitivity when 
identifying differences between HNC symptoms and side effects as the physical domain captures an 
overall picture of physical health and is not focused on specific symptoms. However, the strength of 
using this measure was that it gave a more holistic representation of how HNC affected each aspect 
of patients’ life, which was more beneficial due to the heterogeneity of our HNC sample. If used in 
clinical practice the WHOQOL-BREF would assist clinicians in making judgement about the areas in 
which a patient is most affected by disease, and making treatment decisions.  
 
Another explanation for this finding is how the HNC patients perceived their QoL. Carr et al (2001) 
proposed that an individual’s perception of QoL may be based more on their expectations and 
experiences of health, rather than the disease itself.  If the expectations do not match the 
experience of health, the level of QoL will be low. Conversely, someone who has adapted his 
expectations to the change in his or her health due to a severe illness might experience a significant 
improvement of QoL (Carr et al., 2001).  This suggests that QoL may become more influenced by 
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perceptions of the illness and expectations of treatment rather than the actual illness itself. This 
implies the psychological experience of the cancer may have a greater impact on patients’ QoL than 
the physical experience.  
 
These findings suggest that health care professionals should not assume that everyone will respond 
the same way to a given disease or given stage of disease. There will be patients who are diagnosed 
with advanced disease who are resilient due to personality or due to a history of life experiences 
that has enabled them to cope with the current trauma in a healthy way. In other words, all people 
with advanced disease may not report poor QoL. Similarly, one cannot assume that someone who 
has been diagnosed with a very early and easily treatable disease will respond with a mild level of 
distress that dissipates with time. 
 
There may be other factors in a patient’s life, like whether they have support available and whether 
they are facing other life trauma that may determine of how they respond to their disease.  An 
example of this was shown in a study by Vartanian et al (2009) who showed the majority of patients 
considered a radical surgical procedure an acceptable treatment and reported a good quality of life. 
They found that over 90% of patients reported that they would undergo the same treatment if they 
had it to do again, and 95% reported that they would not like to exchange their present outcome 
for another treatment option with a lower chance of cure but with a possibly improved quality of 
life (Vartanian & Kowalski, 2009).  
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 Methodological evaluation 
 
A particular strength of the present study was that recruitment took place at two cancer sites, 
covering two large London areas. This increased the availability of new HNC patients and also 
reduced selection bias which can result from single site studies. However, unfortunately due to 
language constraints and lack of validated measures in other languages, 85% of our sample was 
white British or white other with the exclusion of 17% of eligible patients being unable to 
participate due not having English as their first language. Therefore the current findings can only be 
generalised to this sample. This is a limitation of the results as currently very little data exists 
examining the impact of HNC on an ethnically diverse sample.  
 
A second strength of the study was its longitudinal design. This allowed for more conclusive findings 
in the patterns shown in the data, particularly in terms of prevalence of psychological distress. 
However, longitudinal design studies require a large sample size which was a limitation of the 
present study, albeit, a good proportion of patients and their caregivers agreed to take part with 
only 20% declining initial participation.  Considering these were newly diagnosed patients and 
caregivers, this response rate was better than anticipated and above what has previously been 
reported in similar studies (Puts et al., 2009)  However, the difficulty in maintaining patient and 
caregiver contact , particularly at a time of intense stress was reflected in follow up numbers.  
Firstly, there was a 20% mortality rate of patients which contributed to attrition, but also it was 
difficult to retain both patient and their caregivers. Several reasons were cited for non-
participation, including the experience of undertaking research too stressful at the present time. 
This further highlights the challenges of conducting research in this sample. Several strategies were 
employed to improve participant attrition. One technique was to ask participants to complete 
questionnaires at their follow-up appointments. This significantly improved response rates in 
patients, however the caregiver did not always attend each appointment with the patient so direct 
contact was not always possible. I also retained contact with all patients and caregivers following 
consent through telephone calls and at follow-up appointments. Reminder letters were also sent, 
however I was mindful of how difficult the first 6 months of HNC can be. Postal returns may have 
further increased the burden already experienced by the caregiver and patient.  Variability in 
timings of returned questionnaires could have also confounded the results, with patients returning 
questionnaires when feeling less psychologically distressed or better physically. The variability of 
time was accounted for by examining the mean differences between participants who completed 
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questionnaires at six months compared to those who completed questionnaires 7-12 months. 
There were no statistically significant differences between these two groups. This supports previous 
findings which have shown small changes in QoL and psychological difference between 6 and 12 
months (Funk et al, 1997; Hammerlid et al, 1999). Another issue with the timing of questionnaires 
was at 6 months some patients may still have been in treatment which may have confounded the 
results. It was difficult to control for this variable due to the heterogeneity of HNC sites included in 
the current sample. This meant treatment periods and modalities differed. Also treatment 
complications and cancer recurrence were common amongst the HNC patient sample, therefore 
strict time guidelines were difficult to adhere to.  
 
Although the follow-up sample size was small, this did not significantly affect the 
representativeness of the data. Analysis of non-respondents characteristics revealed no differences 
concerning disease site variables, such as tumour stage, site and treatment. The only difference 
that was found was patients with loco-regionally advanced disease were less likely to complete 
questionnaires 6-12 months following diagnosis.  However, 51% of the final sample was loco 
regionally advanced disease patients therefore the results were not biased to early disease 
patients.  
 
The small sample size also limited the sub group analysis that could be undertaken. This may have 
been a particular limitation when analysing the clinical factors, particularly site of cancer as 
heterogeneity of each site can result in very different treatment and QoL outcomes. Previous 
studies have found large differences in QoL and symptoms by type of HNC (Hammerlid & Taft, 
2001). This highlights the need for more homogenous groups in HNC research, particularly when 
examining caregivers as different HNC cancers may place more burden on the partner or family of 
these patients.  A homogenous sample of HNC patients would control for this variability, however 
due to the short recruitment time frame and rarity of some HNC cancers, sample size would still be 
an issue. 
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 Data Analysis 
 
The relatively small data set meant that there was a limitation in conservative statistical analysis 
that could be undertaken. However, a strength of the data was I was able to transform the data 
from the WHOQOL-BREF which was not normally distributed which meant a parametric regression 
model could be fitted which is a robust statistical method for assessing association compared to a 
non- parametric analysis. Although transforming data means the original scale is changed, it is a 
common statistical method and I was able to 52back transform the transformed coefficient to allow 
the data to become more clinically relevant and interpretable. Although, the small sample meant 
that limited data modelling could be conducted on the longitudinal data and the wide confidence 
intervals observed highlights the potential variability in data.  However, statistically significant 
associations and differences do not necessarily translate to clinically significant relationships (see 
de Vet et al., 2006).  I would argue that the present findings still showed several important clinically 
significant findings which are applicable and relevant to clinical practice.  
 Measures  
 HADS 
The questionnaires in the study were well tolerated and accepted by the patient with minimal 
missing data. The strength of using the HADS questionnaires was it was short, easy for participants 
to complete and the ease of scoring suggests it could be readily applied within a busy clinical 
environment. Also, the HADS has been frequently used in general population sample and cancer 
population which meant that I was able to use this measure in both patients and their caregivers, 
which allowed for direct comparison in psychological distress based on the same measure. The 
HADS has also been consistently validated within HNC population and is one of the most commonly 
used questionnaires for identifying psychological distress (depression and anxiety) in oncology 
patients. (Archer, Hutchison & Korszun, 2008; Drabe, Zwahlen, & Büchi, 2008; Hodges & Humphris, 
2009; Jenewein et al., 2008; Katz, Kopek, Waldron, Devins, & Tomlinson, 2004; Shiraz, Rahtz, Bhui, 
Hutchison, & Korszun, 2014) 
                                                          
52 The standard interpretation of coefficients in a regression analysis is that a one unit change in the independent variable results in the 
respective regression coefficient change in the expected value of the dependent variable while all the predictors are held constant. 
Interpreting a log transformed variable can be done in such a manner; however, such coefficients are routinely interpreted in terms of 
percent change.to make the data clinically meaningful the coefficients were back transformed to represent a percentage change. This 
percentage change allowed interpreting the effect of the variable on the outcome variable 
 
 177 
 
The cut off scores for psychological distress were carefully selected where a 85% specificity in 
clinical levels of depression in cancer patients when a score of ≥8 was selected (Mitchell et al., 
2013).  A lower cut off score would have given increased sensitivity, however this may have diluted 
the results with a false positive sample.  
 
Interestingly, a study by Katz (Katz et al., 2004) suggested in HNC patients a cut off score of 5 was 
optimal score yielding a sensitivity of 100%, specificity of 89.6% and a positive predictive value of 
68.8%.  There have been few studies that have opted for this lower cut off score, however future 
studies utilising this score may be of value as the present study may have missed patients based 
upon a pre-determined cut off score, which is always a disadvantage of using categorical data. 
 WHOQOL-BREF 
This project introduced a holistic method to examining QoL in HNC patients. QoL was defined as a 
state of physical, mental and social wellbeing and what has been presented represents the 
complexity of measuring such a subjective construct. The WHOQOL-BREF questionnaire was 
selected as the main outcome measure as it fulfilled the task of presented multi-dimensional 
perspective of QoL. The advantages of this measure were that it presented an alternative 
perspective of HNC patients’ QoL, which has not previously been shown within this field. If used in 
clinical practice, the WHOQOL-BREF would assist clinicians in making judgement about the areas in 
which a patient is most affected by disease, and making treatment decisions. However, the 
WHOQOL-BREF is purely a subjective measure of QoL, it may be less useful in providing an objective 
measure of physical functioning e.g. symptom or treatment related pain which may be a limitation 
if used in a clinical environment.   
To my knowledge, this is the first study in the UK to have used this questionnaire within a HNC 
sample, therefore, adding further originality to this thesis. 
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 Reflection 
 
The recruitment of HNC patients was one of the most challenging yet crucial processes in the PhD 
study. Table 33 reflected on the several challenges faced and presents solutions used to overcome 
each obstacle. 
 
Table 33: General methods recruitment challenges 
Challenge Description Solution 
Increasing patient numbers This study was initially a single site 
study, recruiting only at Bart’s NHS 
trust. 
 
 
However, applied for an ethics 
amendment to include another site 
(University college of London 
Hospitals, UCLH). 
Lack of new HNC patients  
The initial inclusion criteria involved 
only patients who were to be treated 
by surgery. This stringent inclusion 
criterion meant that there were 
limited new patients to recruit (less 
than one a month). 
 
 
 
 
Applied for an amendment for the 
study to allow for surgery and 
adjuvant treatment patients. 
 
Also included new recurrent cancer 
patients  as this made up a proportion 
of new cancers and limited research 
on the patient sample 
 
Lack of partners After a couple a months in clinic, it was 
quickly recognised that many patients did 
not have partners. This was due to several 
reasons: 
 
A proportion of patients were widowed 
 
Due to lifestyle factors such as excessive 
alcohol consumption a large proportion of 
patients were single, separated or 
divorced 
 
Patients frequently attended with family 
members particularly those from ethnic 
minority backgrounds 
Applied for amendment to include family 
members’ as they were primary 
caregivers, providing care for the patient. 
Therefore the impact on their wellbeing 
may be just as important as that of 
partner. 
 
This helped increase recruitment 
numbers  
Identifying patients 
 
Identifying new patients was very difficult 
in busy clinical environment 
 
Attended weekly MDT meeting 
 
Patients were highlighted at MDT by chair 
person 
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Follow up clinics and new clinics run 
within the same clinic. There was no 
system of identifying new patient via the 
lists.  
e.g. ENT, OMFS, oncology clinics all same 
day 
 
 
 
 
 
Registrars also notified researcher when 
new patient is diagnosed. 
 
Access to NHS computerised records, 
 
Checking patient notes and MDT lists. 
 
 
Consenting patients Difficult time for patients, as often 
receiving diagnosis of cancer. 
 
 
 
 
 
 
 
 
I was introduced by the consultant to  
each potential patient and became part 
of the clinical team, therefore present  
during new diagnosis consultations 
 
Introduced by clinicians as member of 
clinical team. 
 
A clinical judgement was made at the 
appropriateness of consenting at first 
contact. This was discussed with the 
clinical team. If it was felt inappropriate, I 
arranged to meet with patients at their 
next appointment. 
 
Completion of questionnaires Initially, participants were given 
questionnaire to take away and complete 
at home. This resulted in minimal patients 
completing and returning questionnaires. 
 
 
I decided to consent patients at clinic; 
and if they were willing they were asked 
to complete questionnaires at point of 
consent.  
 
This helped not only to collect data but 
establish rapport with participants which 
was critical for follow up.  
 
This resulted in excellent return rate in 
questionnaires and patients’ were more 
willing to take part, once rapport was 
established. 
 
 
Follow up Pre-treatment, 6 months 
 
Follow up was extremely difficult in this 
patient group as treatment happened very 
quickly (diagnosis to treatment sometimes 
less than 2 weeks) 
 
Another challenge was patient death, 
which was emotionally challenging. 
After patients had been consented, A 
photocopy of consent form was sent in 
the post with thank you letter. In 
addition, when questionnaires had been 
received, a letter of  acknowledgement 
was also sent. 
 
Next appointment was documented to  
ensure follow-up in clinic 
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Aim to do follow up questionnaires in 
clinic before there appointment time.  
 
If this was not possible, participants were 
called to notify that they will receive a 
follow up questionnaire in the post. 
Practicalities of conducting 
research in clinics, e.g.  rooms 
to see patient 
Minimal space in clinics to undertake 
consent 
This was a continual problem. Established 
liaison with nursing and administration 
staff to ensure clinic room was available 
to discuss project with patients. 
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 Future developments in treatment of HNC patients 
 
The results from this thesis raise several clinical issues, with the following suggestions 
recommending how these findings can be applied within clinical practice to improve QoL and 
wellbeing of HNC patients.  
 
Screening for psychological distress: 
Increased identification of psychological distress is particularly important because depression in 
cancer is readily treatable. Given the time constraints in most clinics, easy screening techniques 
would be of greatest interest to surgeons and oncologists. Screening patients for psychological 
distress at significant time points during the cancer trajectory may allow identification of those at 
greater risk. Also, due to the heterogeneity of HNC, it is recommended that measuring 
psychological distress may give a better indication to a patient’s adjustment to cancer than 
measuring QoL. 
A further extension of this screening would be a recommendation to screen a patient’s caregiver for 
psychological distress. By screening partners and caregivers pre-treatment, HNC clinicians can 
identify individuals that may be at higher risk of poor adjustment to cancer, particularly as our 
findings show the reciprocal effects of psychological distress. This means that, in a relationship, 
when one person is emotionally distressed, it’s more than likely the other person will also become 
distressed regardless if they are the patient or the partner. 
 
Emotional support 
Another recommendation would be for a support intervention to be in place specifically for 
partners and caregivers. As highlighted within the qualitative interviews, partners are reluctant to 
discuss their fears and worries about the cancer with the patient as they fear this would have 
negative impact on their wellbeing.  Having an intervention or support system in place for 
caregivers would not only reduce burden for caregivers, but also relieve patients of worrying about 
their partner, which was also documented within the qualitative interviews. A targeted intervention 
for caregivers and patients with elevated distress would be beneficial, particularly those who 
identify increased distress at point of diagnosis. These individuals are at greater risk of showing 
elevated distress at later stages and may be finding cancer adjustment more difficult.  
 
Despite the increased levels of psychological distress amongst HNC patients, depression in 
particular remains under diagnosed and under treated amongst cancer patients. In an interesting 
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study by Fabio and colleagues, 2008 patients were asked what they would most like the surgeon to 
attend to on a clinic visit and also asked the surgeon to rate what they think is important to the 
patients from a lot of possible answers(Fabio, Koller, & Nascimbeni, 2008). They found that whilst 
26% of cancer patients wanted surgeons to attend to their emotional state, none of the surgeons 
thought that this was important to the patients. This shows just how important it is to continue 
alerting clinicians to the psychological impact of cancer.  
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6 Final conclusions 
 
There were three key findings within the present study.   
 Firstly, psychological distress in caregivers, particularly partners was higher than in HNC 
patients.   
 Secondly, HNC patients who had a caregiver with psychological distress showed lower QoL 
and  
 Finally, the qualitative study showed the negative impact of HNC on the patient-partner 
relationship. Utilising a mixed methods design was a significant strength to the final results. 
The quantitative and qualitative methods used together added a greater insight and 
understanding to the aims of this thesis that might have been missed if only a single 
method was used.   
 
This thesis has presented a unique perspective into the measurement of QoL, and presented 
findings that have not previously been shown within this clinical population. 
 
This thesis was titled “We got cancer” which came from a quote from a partner of a HNC patient 
who stated that when her husband was diagnosed with the cancer, she also was ‘diagnosed’.  This 
reflected the interdependence of cancer which was demonstrated throughout this thesis. HNC 
affects both the individual and his or her collective social network. Like other serious illnesses, it 
changes lives by changing people's psychology, their life span, and their quality of life.  
 What this study has shown is the importance of the caregiver’s role in HNC, and how their 
psychological functioning has an effect on the patient’s functioning. If partners or family members 
are to become active agents of help for the patient, they should also be prepared psychologically 
for the task. 
 
 “There ain’t no fucking manual on how to get someone through cancer” 
(Partner extract, case 2: p34 790-792) 
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8.3.1Step by step process of IPA stages of analysis: 
 
The following section presents a step by step process of IPA analysis as recommended by Smith and 
colleagues (2009). Table 34 presents a summary of the six steps.  
 
This step by step guide presents an example of how “it doesn’t shine as bright as it once did” 
became a superordinate theme.  
 
Six stages of IPA analysis 
 
Table 34  Six stages of IPA analysis 
                                                          
53 A superordinate theme involves putting like with like and developing a new name for the cluster 
 
Stage of 
Analysis 
Description of analysis 
Step 1:  
 
Reading and re reading 
The first transcript is read and re-read and examined a number of times. Reflection at each reading was recorded 
to allow active engagement with the data. At each read the text was annotated with comments. 
Step 2:  
 
Initial noting 
With each reading, the text was annotated with initial comments.  Examination of semantic content and 
language was also analysed.  
 
The aim was to provide a detailed set of notes and comments on the data. Descriptive comments focussed on 
describing the content of what the participant had said. Linguistic comments focussed on the use of specific 
language. Conceptual comments focused on engaging at a more interrogative and engaging level. 
(These three concepts are referred to the as interpretive noting) 
Step 3: 
 
Developing emergent themes 
Transforming the comments into emergent themes that capture succinctly the essential features of initial 
reading.  
 
Mapping the interrelationships, connections and patterns between explanatory notes.  
 
Step 4:  
 
Searching for connections across emergent themes 
The emergent themes were listed and connecting themes were sought, with those related being clustered under 
appropriate 53super-ordinate conceptual headings – this is known as abstraction. 
 
During this data organisation process continuous referral to interview transcripts were made to ensure themes 
selected were representative of individuals’ personal accounts. The themes reflected the most salient meanings 
within the participants’ narrative.  
  
Step 5:  Moving to next case 
Repeating procedure for each case. Each case was treated on its own terms, with new themes incorporated 
within analysis. 
Step 6:  Looking for patterns across cases 
The resultant framework showed the emergence of the three super-ordinate themes, with sub themes within 
each cluster. The themes were corroborated via an independent ‘auditor’ who checked the themes against the 
data (see appendix 3). 
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STEP 2: Initial noting taking 
Table 35: Step 2 initial note taking, extract from case study 2 
Step 2: Initial noting taking 
With each reading, the text was annotated with initial comments.  Examination of semantic content and language was also analysed.  
The aim was to provide a detailed set of notes and comments on the data. Descriptive comments focussed on describing the content of what the 
participant had said. Linguistic comments focussed on the use of specific language. Conceptual comments focused on engaging at a more interrogative 
and engaging level. 
 
 
Language 
 
Interview extract 
 
 
 
Descriptive comments 
 
Interpretation/ conceptual 
 
Page and line 
number 
Will 
Chop chop 
 
Let it all out 
When I was having radiotherapy, I used 
to sit there in the morning and say ‘I 
don’t want to go; I don’t want to go 
today.’ 
“You will go, you’ll be fine, chop chop” 
But I didn’t want him to let me cry, but 
sometimes I would’ve liked him to have 
said ‘cry today. Let’s just let it all out.’  
 
Probing a reaction out of partner-for him to 
show he cares? Or wanting him to show his 
emotions? 
 
Increase in conflict, patient feeling partner was 
not allowing her to be upset. Wanting to share 
the experiences with him- and for him to allow 
her to be upset. 
 
Craving the emotional attention from 
partner resulting in behaviours which she 
wants him to react to- acting out behaviour-
regressing to adolescent- parent role. 
 
Wanted her to ‘let it all out’ suggesting she 
was exhausted with keeping her emotions 
and feeing in. Internalising these feelings 
was leading to increased resentment and 
increase in conflict within their relationship. 
 
P9 
194-196 
 
Row 
 
We had a row and he said 
‘Don’t you think I have thoughts of your 
funeral, the future without you’ and I said 
‘I’m actually you said that, because thank 
God you did have those fears which are 
normal, I needed to hear them.’ 
 
Fears of her dying 
(partner didn’t disclose this in interview) 
 
Reaction patient wanted- which showed that he 
does care but also normalising his feelings. 
 
. 
Needing reassurance, highlighting patient’s 
insecurities about the relationship but also 
confirmed her anxieties and potentially 
fuelled the guilt she felt about being a 
burden to family and partner. 
P10 
210-211 
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STEP 3: Developing emergent themes 
 
Table 36: Step 3: Developing emergent themes 
 
Step 3:  Developing emergent themes 
Transforming the comments into emergent themes that capture succinctly the essential features of initial reading.  
Mapping the interrelationships, connections and patterns between explanatory notes.  
 
 
Emergent themes Language/ 
Linguistic 
Interview extract  
 
 
Descriptive comments interpretation/ conceptual Page and line 
number 
Relationship discord 
 
Lack of open 
communication related 
to cancer 
Will 
Chop chop 
 
Let it all out 
When I was having radiotherapy, I use to 
sit there in the morning and say ‘I don’t 
want to go; I don’t want to go today.’ 
“You will go, you’ll be fine, chop chop” 
But I didn’t want him to let me cry, but 
sometimes I would’ve liked him to have 
said ‘cry today. Let’s just let it all out.’  
 
 
Probing a reaction out of partner-for him to 
show he cares? Or wanting him to show his 
emotions? 
 
Increase in conflict, patient feeling partner was 
not allowing her to be upset. Wanting to share 
the experiences with him- and for him to allow 
her to be upset. 
 
 
Craving the emotional attention from 
partner resulting in behaviours which she 
wants him to react to- acting out behaviour-
regressing to adolescent- parent role. 
 
Wanted her to ‘let it all out’ suggesting she 
was exhausted with keeping her emotions 
and feeing in. internalising these feelings 
was leading to increased resentment and 
increase in conflict within their relationship. 
 
P9 
194-196 
 
Increased conflict  Row 
 
We had a row- and he said 
‘Don’t you think I have thoughts of your 
funeral, the future without you’ and I said 
‘I’m actually you said that, because thank 
God you did have those fears which are 
normal, I needed to hear them.’ 
 
Fears of her dying 
(partner didn’t disclose this in interview) 
 
Reaction patient wanted- which showed that he 
does care but also normalising his feelings. 
 
. 
Needing reassurance, highlighting patient’s 
insecurities about the relationship but also 
confirmed her anxieties and potentially 
fuelled the guilt she felt about being a 
burden to family and partner. 
P10 
210-211 
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STEP 4: Searching for connections cross emergent themes
Step 4: Abstraction leading to the development of a super-ordinate theme “it doesn’t shine as bright as it once did” 
 Searching for connections across emergent themes 
 
The example shows how the theme of “it doesn’t shine as bright as it once did” became the superordinate theme 
 
The emergent themes were listed and connecting themes were sought, with those related being clustered under appropriate super-ordinate conceptual 
headings.  
 
During this data organisation process continuous referral to interview transcripts were made to ensure themes selected were representative of individuals’ 
personal accounts. The themes reflected the most salient meanings within the participants’ narrative. 
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Table 37 Searching for connections across themes “it doesn’t shine as bright as it once did” 
STEP 4 continued: Searching for connections across emergent themes 
Emergent themes across cases  Subthemes 
 
  
Superordinate theme  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“it doesn’t shine as 
bright as it once did” 
Lack of emotional support   
 
 
Feeling support not good enough  ‘You don’t give a shit, so why should I’ 
 
 
    
Resentment to partner for not meeting 
expectations resulting in increase in 
conflict 
  
 
 
    
Conflict of emotions between guilt and 
resentment. 
   
    
Increase in relationship conflict   
‘I’m at the end of my tether’ 
 
    
Increased irritability in patient 
 
   
    
Wanting  to leave partner 
 
   
    
Paranoia- partner was going to leave 
 
  
Communication and secrecy 
 
 
    
Emotionally detached: Lack of 
communication about the cancer with 
partner 
   
    
Social withdrawal due to avoiding cancer 
related conversations 
  
Changes in intimacy 
 
 
Lack of intimacy in relationship 
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Step 5 and Step 6: Moving to next case and repeating 
procedure for each case. 
 
Step 5: Comparing emergent themes across cases, moving to next case. 
Repeating procedure for each case. Each case was treated on its own terms, with new themes incorporated 
within analysis. 
 
(Emergent themes within “it doesn’t shine as bright as it once did” 
Case 1 Partner   Patient 
 
Closed communication about cancer   
Emotionally detached: Lack of communication about the 
cancer with partner 
 
Not attending appointments   
Perceives wife as loving and caring, expectations of wives role 
- cancer wife 
 
Communicating about cancer   
Positive support he receives from his wife indicating little 
conflict- opposite to what wife feels. 
 
Patient choosing hide the cancer 
from others 
  Not sharing the emotional impact with partner 
 
Patient emotional reaction to 
diagnosis 
  Protective husband role? 
 
Anger at patients behavioural 
reaction to cancer 
  
Belief of having strong relationship **Opposite to what 
partner reports 
 
Perception of impact of cancer on 
husband 
  
Change in gender role having to do ‘female role’, cooking etc. 
 Hiding emotions from patient    
 
Social expectations of being the 
‘cancer wife’ 
  
 
 ‘Cancer wife’- social expectations     
 Husband unsupportive for her needs    
 Lack of intimacy     
 Impact of cancer on relationship    
 Conflict of own emotions    
 Increase in Marital conflict    
Case 2      
 Moving on following diagnosis   Increase in conflict 
 
Cancer partner role   
Expectations of perfect cancer partner- supportive, partner 
unavailable for emotional support 
 
Changes in relationship – not 
the same since cancer 
  
Resentment to partner for not meeting expectations- 
resulting in increase in conflict 
 Increase in marital conflict   Wanting to leave partner 
 Feeling support not good enough   Lack of intimacy in relationship 
 
Resentment when patient not 
behaving as perfect patient 
  Paranoia- partner was going to leave 
 
Internalising / hiding own emotions   
Increase worry for partner- conflict of emotions between 
guilt and resentment. 
 
Wanting to leave relationship   
Anger at self for making everyone else feel better-wanting to 
be cancer patient’ 
 Needing respite    
 
No emotional support from her 
family 
   
 Social support from friends    
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 Anger, resent, anxiety    
Case 3      
 
Cancer partner role- ‘positive’ 
fighting spirit 
  Positive support from partner 
 
Changes in roles, increased 
responsibilities 
  
Feelings of guilt as partner experiencing stress related 
physical symptoms 
 
Frustrations in change to lifestyle- 
making sacrifices for husband. 
  Increasing worry in patient 
 
“we”- secondary patient- hospital 
visits, attending treatment 
   
 
Social withdrawal- due to avoiding 
cancer related conversations 
   
 Increased irritability in patient     
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Master table of themes from qualitative analysis 
 
Table 38 Master table of themes including description of each theme and subtheme  
Master table of themes from qualitative analysis 
Superordinate theme Description of theme 
 
1.“We got cancer” 
The superordinate theme of “we got cancer” 
reflected the reciprocal effects of the cancer 
experience highlighted by the HNC couples.   
 
 Coping with the bad news:  This subtheme described the HNC couples’ 
emotional and behavioural reactions to the 
diagnosis 
 
Being the perfect cancer partner 
 
Being the perfect cancer partner and being the 
perfect cancer patient were the self-defined 
identities patients and partners felt represented 
their changes in roles.  
 
Being the perfect cancer patient 
 
2. “It doesn’t shine as bright as it once 
did” 
The second superordinate theme “it doesn’t shine as 
bright as it once did” reflected the negative changes 
within HNC couples’ relationships since the cancer 
diagnosis. Partners in particular reported how they 
found the transition from treatment to ‘resuming 
normal life’ particularly challenging.  
 
“You don’t give a shit, so why should I You don’t give a  shit, so why should I’: Partner’s 
indicated the lack of appreciation from patients for 
the support they were providing which led to 
increased hostility towards the patient. 
 
‘I’m at the end of my tether’ 
 
‘I’m at the end of my tether’: Highlighted the 
increased relationship conflict reported by HNC 
couples since the cancer diagnosis. 
 
Communication and secrecy 
 
Communication and secrecy: revealed the 
difficulties HNC couples showed in communicating 
about the cancer to one another 
 
Changes in intimacy 
 
Changes in intimacy: HNC couples gave examples of 
the changes in the quality of their relationship 
following treatment 
3.What would’ve have helped The final superordinate theme; ”what would have 
helped” highlighted patients’ and partners’ 
perceptions of care received, and introduced views 
and recommendations to what was felt would have 
helped during their cancer experience. Each couple 
revealed various stages of the cancer that they 
found most difficult and highlighted the support and 
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types of support that would have been beneficial 
during these difficult periods. 
 
Willingness to accept emotional support  This subtheme revealed partners reluctance to 
accept emotional support. 
 
‘Fear of the unknown’  This subtheme highlighted a need for better 
emotional support for patients but also for the 
partner and family, particularly during time of 
increased emotional distress i.e. diagnosis, and 
treatment.  
 
What can we do?  These were suggestions and recommendations for 
the type of support patients and partners would be 
willing to accept. 
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The images used in this thesis were produced by Mark Gilbert during a three year period as artist-in-residence in the 
Department of Oral and Maxillofacial Surgery at St. Bartholomew’s and the Royal London Hospital.  The paintings portray 
the faces of patients before, after and in some cases actually during their Head and neck cancer surgery. 
Initiated and sponsored by surgeon Iain Hutchison, the paintings were conceived as a way of conveying to the public the 
possibilities of today’s facial surgery whilst at the same time communicating the strength of spirit which can enable people 
with facial disfigurements and trauma to lead full and happy lives.  Portraits of the patients are displayed in the exhibition 
which was launched in spring 2002 at the National Portrait Gallery and has since toured extensively in the UK, Europe and 
the USA. 
  
